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Abstract 
Bacterial restriction-modification (RM) systems act as a form of primitive immune 
system that aims to prevent foreign DNA from establishing itself within a bacterium.  
RM systems often function with two complementary activities; DNA methylation to 
label “self” DNA and DNA cleavage of unlabelled, “non-self” DNA.  These two 
enzymatic activities require strict temporal control to prevent over-methylation or auto-
restriction; the endonuclease induced degradation of genomic DNA.  In some RM 
systems a third, controller (C) protein is employed to act as a transcription factor to 
control the expression of the two enzymes.  Previous study, using the Esp1396I RM 
system as a model, has revealed how the C-protein binds to its DNA operator 
sequences.  Unlike most C-proteins, C.Esp1396I has three binding sites; OM controls the 
expression of the methyltransferase and OL & OR control the expression of the C-protein 
and endonuclease genes as a double binding site.  The binding affinities for the three 
sites vary by more than two orders of magnitude despite the small difference in DNA 
sequence.  Crystallographic analysis of C.Esp1396I both as a free protein and bound to 
its various DNA operator sites has revealed the roles of several highly conserved 
residues, many of which interact with the DNA. 
In this study, several of these DNA binding residues were mutated in an attempt to 
elucidate their individual roles in the context of protein-DNA complex formation.  
Mutations made to those residues that interact with the phosphate backbone had a lesser 
effect on the binding affinity compared to those made to residues that bind to the DNA 
bases.  Crystallographic analysis of the mutant C.Esp1396I proteins showed that the 
mutations had not affected the overall structure of the protein.  However, what was 
revealed were further details of C.Esp1396I in its free state, especially the high degree 
of flexibility in a loop region that is key to DNA binding. 
During the course of this study, wild type C.Esp1396I was co-crystallised with two 
different DNA duplexes containing part or all of the OR site.  Since there were no 
biologically relevant interactions in the co-crystal structures with the OR operator 
sequence, this gave the opportunity to observe the structure of the DNA in the un-bound 
state. The structure of the complex with a longer DNA fragment showed that the major 
groove at the OR site is opened up and prepared for C-protein binding when OL is 
occupied, reducing the binding penalty for this intrinsically weak operator site. 
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Chapter 1: Introduction 
1.1 Transcriptional regulation 
Transcription is the process during which an RNA molecule is synthesised, by an RNA 
polymerase, with a complementary sequence to a DNA template.  This process is under 
tight regulatory control and requires multiple other protein components that prepare the 
DNA template for transcription including DNA helicases, which separate the DNA 
duplex into separate strands, and transcription factors that stabilise DNA-RNA 
polymerase interactions.  Once transcription of a DNA section is complete, the DNA is 
restored to a stable double helix which can be used as a template for future transcription.  
The RNA molecules generated by transcription are found throughout cells and carryout 
a variety of necessary functions.  These include messenger RNA (mRNA) which carries 
genetic information for protein synthesis, ribosomal RNA (rRNA) which has enzymatic 
activity within the ribosome and transfer RNA (tRNA) which is used to correctly 
position amino acids during protein synthesis. Only around 2 % of the human genome 
codes for proteins while the remaining genetic information is involved in regulatory 
processes. Several other RNA species play key roles in gene regulation such as 
microRNAs and siRNAs through the process of RNA interference in eukaryotes 
(Bushati and Cohen, 2007) with the related CRISPR RNAs system in prokaryotes 
(Sorek et al., 2008).  Protein synthesis is carried out by the ribosome, a complex 
ribonucleoprotein machine that has recently been revealed in fine molecular detail by a 
series of X-ray crystallography structures (Yusupova et al., 2006, Ben-Shem et al., 
2011, Wimberly et al., 2000). Individual amino acids are covalently linked to a tRNA 
molecule with an anti-codon sequence that is complementary to a trinucleotide sequence 
on the mRNA.  Each trinucleotide sequence codes for a specific amino acid allowing 
the sequential addition of amino acids to form a polypeptide chain.  The process of 
polypeptide synthesis from an mRNA sequence is called translation.  Together, 
transcription and translation describe the processes involved in the central dogma of 
molecular biology: 
DNA    RNA    Protein 
Transcriptional regulation in bacteria is very well studied principally due to the presence 
of a relatively small non-nuclear genome and subsequent ease of genetic manipulation.  
Ribosomes within the bacterial cell can access the mRNA directly allowing the 
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processes of transcription and translation to be coupled.  This process is more complex 
in eukaryotic organisms because of the physical barrier provided by the nucleus.  In 
eukaryotes, mRNA typically undergoes some form of post-transcriptional processing 
such as the removal of non-coding regions.  The coupling of transcription and 
translation in prokaryotes results in transcriptional regulatory processes that are unique 
in bacteria.  The lac operon in Escherichia coli provides a good example of both 
positive and negative transcriptional regulation and the trp operon gives an example of 
attenuation; a mechanism unique to prokaryotes.  The lac operon endows E. coli with 
the ability to metabolise the disaccharide lactose as a carbon source when simpler 
monosaccharide’s, such as glucose, are unavailable (Jacob and Monod, 1961). In the 
case of the trp operon, this system allows the bacterium to synthesise the amino acid 
tryptophan when it cannot be sequestered directly from the environment (Hiraga, 1969, 
Ito et al., 1969). 
1.1.1 Positive regulation 
Positive transcriptional regulation results in an increase in the expression of a gene or 
set of genes.  The E. coli lac operon consists of three genes that are under the control of 
a single regulatory region (Figure 1.1 A) (Jacob and Monod, 1961, Willson et al., 1964).  
These genes encode a β-galactosidase, which cleaves disaccharides into 
monosaccharides (lacZ gene), a lactose permease, which transports lactose into the cell 
(lacY gene), and a thiogalactoside transacetylase, which acetylates the β-D-galactoside 
(lacA gene) (Figure 1.1 A).  Together these three genes allow the bacterium to transport 
lactose molecules into the cell and break them down into glucose and galactose which 
can then be used as an energy source (Figure 1.2 A, C and D). 
If the cell is in a low glucose environment the intra-cellular concentration of cyclic 
adenosine monophosphate (cAMP) (Figure 1.2 F) increases.  The increase occurs as 
high glucose levels inhibit the enzyme which produces cAMP, adenylate cyclase.   The 
catabolite gene activator protein (CAP) binds to cAMP forming an active dimeric 
complex that can then bind to the DNA upstream of the RNAP binding site using a 
helix-turn-helix (HTH, section 1.2.3) motif which subsequently distorts the downstream 
DNA corresponding to the promoter allowing RNAP to bind with a reduced energy 
potential (Figure 1.1 B and 1.2 G) (Chen et al., 2001).  The RNAP then produces a 
polycistronic mRNA that is translated to produce the three proteins necessary for 
lactose metabolism (Figure 1.1 B) 
A 
B 
C 
D 
Figure 1.1 Positive and negative regulation of the lac operon.  
A:  Arrangement of the lac operon in bacteria with the lacl 
repressor gene (blue), operator and promoter sites (red) and the 
lacZYA operon (green).  B:  Positive regulation by the CAP-
cAMP complex initiates transcription of the lacZYA operon.  C:  
Negative regulation by the lac repressor prevents transcription of 
the lacZYA operon.  D:  The lac repressor disengages in the 
presence of allolactose (red) to allow transcription of the lacZYA 
operon. 
3 
Figure 1.2 Elements of the lac operon.  A:  Lactose.  B:  
Allolactose.  C:  Glucose.  D:  Galactose.  E:  IPTG.  F:  cAMP.  
G: CAP-cAMP complex.  The cAMP molecule is shown as 
orange spheres (Chen et al. (2001), 1O3T).  H:  The lac repressor.  
A DNA bound lac repressor dimer (Daber et al. (2007), 2PE5) 
A B 
E D C 
F G 
H 
4 
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1.1.2 Negative regulation 
The lac operon also provides an example of negative transcriptional regulation in the 
form of the lac repressor protein (Jacob and Monod, 1961, Willson et al., 1964).  The 
gene for the lac repressor, lacI, lies upstream of the lacZYA genes and is constitutively 
transcribed by the bacterium under its own promoter (Jacob and Monod, 1961).  In the 
absence of lactose, the repressor protein binds to an operator site upstream of the 
lacZYA genes physically preventing the RNAP from producing the lacZYA polycistronic 
mRNA through steric hindrance (Figure 1.1 B). The lacZ and lacY genes are expressed 
in small quantities even when the lac repressor is bound (Jacob and Monod, 1961).  
When there is an increase in lactose concentration within the bacterial cell, or more 
specifically the lactose metabolite allolactose (Figure 1.2 B), the repressor protein will 
bind to allolactose and disengage from the DNA (Figure 1.1 D).  Allolactose is formed 
randomly through transglycosylation by the β-galactosidase.  Once the lac repressor 
dissociates from the DNA, RNAP can produce the complete lacZYA polycistronic 
mRNA (Figure 1.1 D).  The lac repressor is a tetrameric DNA binding protein with an 
HTH motif that will be discussed in section 1.2.3 (Friedman et al., 1995, Daber et al., 
2007). 
1.1.3 Attenuation 
The trp operon is a bacterial series of genes that encode for the proteins necessary for 
the production of the amino acid tryptophan (Yanofsky, 1988).  As with the lac operon, 
the trp operon encodes a series of co-transcribed proteins, but unlike the lac operon, the 
trp operon is controlled through a method of regulation called attenuation (Morse et al., 
1969, Ito et al., 1969, Lee and Yanofsky, 1977).  Attenuation is only known to occur in 
bacteria as it relies upon the simultaneous processes of transcription and translation 
which cannot occur in eukaryotes due to the DNA, and therefore newly transcribed 
mRNA, being physically separated from the ribosomes in the nucleus.  Attenuation 
essentially stalls RNAP at a specific site on the DNA which results in the production of 
a truncated mRNA (Morse et al., 1969).  In the trp operon, the attenuator site contains 
four short sequences (termed 1 - 4) which contain elements that are partially 
complementary (Figure 1.3 A).  Three different hairpins can form when this is 
transcribed into mRNA; the 1-2 hairpin, the 2-3 hairpin and the 3-4 hairpin.  Not all of 
the potential hairpin structures can form simultaneously as the formation of the 1-2 
hairpin occludes attenuator site 2 which can therefore no longer bind to site 3. 
Figure 1.3 Attenuation of the trp operon.  A:  Organisation of 
the trp operon with the 4 attenuator sequences.  B:  In the 
presence of high trp-tRNA (aa = amino acid) the ribosome 
continues past attenuator site 2 causing the 3-4 transcriptional 
terminator stem-loop with a partially formed leader peptide 
(yellow).  C:  Low trp-tRNA levels cause the ribosome to stop at 
a WW site in the mRNA.  This cause the 2-3 stem loop to form 
allowing transcription to continue. 
A 
B 
C 
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The same is true if hairpin 2-3 forms; neither the 1-2 nor 3-4 hairpins can form due to 
the attenuator sequences already being structurally sequestered (Lee and Yanofsky, 
1977). 
Upstream of the attenuation site there is a DNA sequence that codes for a leader peptide 
which contains two adjacent tryptophan anti-codons (WW).  If concentrations of the 
amino acid tryptophan are high within the bacterial cell, the levels of tryptophan tRNA 
(trp-tRNA) are subsequently increased (Ito et al., 1969).  When the concentration of trp-
tRNA is suitably high, the ribosome can continue past the WW codons and physically 
occlude attenuator sites 1 and 2, preventing the formation of the 1-2 hairpin but 
allowing the 3-4 hairpin to form (Figure 1.3 B).  If the 3-4 hairpin structure is formed in 
the newly transcribed mRNA molecule, RNAP will disengage from the DNA leaving a 
truncated mRNA that does not contain the genes necessary for tryptophan synthesis.  
When trp-tRNA concentrations are low within the cell the ribosome will stall at the 
WW codon sequence and only occlude attenuator site 1.  This allows the formation of 
the 2-3 hairpin and RNAP then transcribes the entire trp operon producing the full suite 
of tryptophan synthesis enzymes. (Figure 1.3 C). 
These examples of transcriptional regulation demonstrate the key role of DNA binding 
proteins which are underpinned by an ability to recognise and bind to highly specific 
sequences in a temporal and/or concentration dependent manner. The next section looks 
at these proteins in more detail. 
1.2 DNA binding proteins 
Nature employs a vast array of DNA binding proteins that have a variety of roles within 
the cell including DNA packing, DNA repair, DNA replication, DNA modification, 
transcriptional regulation and many others.  In fact DNA is very rarely free within the 
cell.  Several structural motifs have evolved specifically for the role of DNA sequence 
recognition and transcriptional regulation.  Three of the most common DNA binding 
motifs include zinc fingers, leucine zippers and the helix-turn-helix (HTH) motif 
(Struhl, 1989).  All three of these motifs use an alpha helical protein structure which 
interacts with the major groove of DNA, often interacting with the DNA bases directly 
(Struhl, 1989, Mondragon and Harrison, 1991, Lu et al., 2012, Luisi et al., 1991, Chen 
et al., 2001, Daber et al., 2007, McGeehan et al., 2008).  These three classes of proteins 
also form dimeric, and sometimes tetrameric complexes (McGeehan et al., 2008, Daber 
et al., 2007, Schumacher et al., 2002). When these DNA binding motifs exist as part of 
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a homodimeric complex they bind to palindromic DNA sequences (McGeehan et al., 
2006, Bogdanova et al., 2008, Jacob and Monod, 1961, Mondragon and Harrison, 
1991).  
1.2.1 Zinc fingers 
Zinc finger domains rely upon the coordination of one or more Zn
2+
 ions by a group of 
spatially related highly conserved cysteines and/or histidines to maintain their 3D 
structure (Figure 1.4) (reviewed in Wolfe et al., 2000, Luisi et al., 1991).  This motif is 
found in both prokaryotes and eukaryotes and known to interact with both DNA and 
RNA (Brown, 2005).  Zinc fingers fall into several different sub-families based upon 
their secondary structure (Nieto, 2002).  Zinc fingers employ an alpha helix as a DNA 
recognition interface that can be inserted into the DNA major groove in order to gain 
access to and recognise specific DNA bases (Luisi et al., 1991) (Figure 1.4). 
Zinc fingers can be engineered to recognise any tri-nucleotide sequence and joined 
together sequentially to recognise sequences of three, six, nine and larger sets of 
nucleotides (Wolfe et al., 2000).  Zinc fingers have therefore been used as a tool in 
molecular biology with the most common example being Zinc-Finger-Nucleases 
(ZFNs) that can be engineered to cut DNA at specific sites (Kim et al., 1996).  One 
potential application of this technology is effective gene therapy in humans where the 
cell repairs the ZFN induced double stranded DNA breaks through homologous 
recombination subsequently repairing a faulty gene (Urnov et al., 2005). 
1.2.2 Leucine zippers 
The leucine zipper is another common DNA binding motif present in both prokaryotes 
and eukaryotes (reviewed in Busch and Sassone-Corsi, 1990).  Leucine zippers function 
solely as dimers and it is the leucine zipper region that is responsible for dimerisation 
(Alber, 1992, Lu et al., 2012).  Leucine side chains are positioned at regular intervals of 
seven residues to form an amphipathic alpha helix; an alpha helix with a hydrophilic 
surface and an opposing hydrophobic surface (Figure 1.5).  The helices dimerise using 
the hydrophobic surfaces created by the leucines (Busch and Sassone-Corsi, 1990).  
One of the ends of each helix does not contain a hydrophobic region resulting in a 
quaternary fold resembling a “Y” shape.  The two arms of the “Y” can interact with the 
DNA by inserting helices into the major groove of DNA to directly access the DNA 
bases (Figure 1.5). 
Figure 1.4 The Zinc finger motif.  The glucocorticoid receptor 
(Luisi et al. (1991), 1R4O) contains a two zinc finger DNA 
recognition motif’s.  The red arrows indicate the DNA 
recognition helices.  The pink spheres are the Zn2+ ions.  Each 
Zn2+ ion is coordinated by four cysteine residues.  This protein 
has a Kdim of ~1.5 μM. 
9 
Figure 1.5 The leucine zipper DNA binding motif.  A dimer of 
MafA bound to DNA.  The protein dimerises through the leucine 
zipper motif.  The leucine’s are displayed as sticks.  (Lu et al. 
(2012) 4EOT). This protein has a Kdim of ~2.5 μM. 
90° 
10 
Figure 1.6 The Helix-turn-helix DNA binding motif.  The well 
characterised cro repressor is a helix-turn-helix (HTH) protein.  
The recognition helices are shown in pink and the scaffold helix 
in orange.  Mondragon & Harrison (1991) 3CRO. This protein 
has a Kdim of ~2.0 μM. 
11 
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1.2.3 Helix-turn-helix proteins 
Helix-turn-helix (HTH) DNA binding domains are the most common DNA binding 
motifs found in prokaryotes and bacteriophages (Struhl, 1989, Ptashne, 2004, Luisi et 
al., 1991, Harrison and Aggarwal, 1990).  The major structural feature of HTH domains 
are the recognition helix and the scaffold helix (Figure 1.6) (Harrison and Aggarwal, 
1990, Mondragon and Harrison, 1991).  The recognition helix interacts with the major 
groove of DNA and contains residues primarily for DNA base interactions and therefore 
DNA sequence recognition (Mondragon and Harrison, 1991, Beamer and Pabo, 1992, 
Harrison and Aggarwal, 1990, McGeehan et al., 2008).  The scaffold helix is always 
found in the same relative orientation to the recognition helix and stabilises the position 
of the recognition helix relative to the DNA (Harrison and Aggarwal, 1990).  Many 
HTH proteins function as homodimers and therefore recognise palindromic DNA 
sequences (Harrison and Aggarwal, 1990, Mondragon and Harrison, 1991, Streeter et 
al., 2004), however others function as heterodimers (for example eukaryotic 
transcription factors (Gajiwala and Burley, 2000))  and monomers (sigma factors of 
nucleic acid polymerases (Aravind et al., 2005)).  
DNA binding proteins often act as transcriptional regulators, controlling the expression 
of other protein genes.  Bacterial restriction-modification systems use multiple DNA 
binding proteins to carry out their functions, including proteins which regulate the 
expression of the system. 
1.3 Restriction-Modification systems 
Restriction-modification (RM) systems act as a form of primitive prokaryotic immune 
system that aims to prevent the establishment of foreign DNA, such as that from phage 
viruses, within the bacterial cell (Wilson and Murray, 1991).  RM systems have two 
complementary activities; DNA methylation and DNA cleavage.  The methylation 
occurs at specific sites within the genome of the bacterium and labels the DNA as 
“self”.  Successful DNA cleavage often requires this site to be unmethylated but 
restriction does not necessarily occur at this recognition site.  RM systems have also 
been proposed to play a key role in horizontal gene transfer between bacterial species as 
the newly introduced DNA, often a plasmid, has to be at least hemi-methylated (only 
one of the DNA double strands is methylated) in such a way that it survives the 
recipient cells endonuclease activity (Akiba, 1960, Jeltsch and Pingoud, 1996).  
Hundreds of RM systems have been described and each recognises their own, unique 
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recognition site (Wilson and Murray, 1991).  RM systems have been classified based 
upon the arrangement, structure and functions of their enzymes into four classes (named 
I – IV) (Roberts et al., 2003, Tock and Dryden, 2005).  Although each class utilises both 
endonuclease and methyltransferase activities (except Type IV), each has different 
arrangements of genes, protein complexes, regulatory mechanisms, methylation sites, 
DNA recognition sequences and DNA cleavage activities. 
1.3.1 Type I 
Type I RM systems are considered to be the most complicated and are formed from 
three polypeptides; HsdR, HsdM and HsdS (Murray, 2000).  HsdR is responsible for the 
endonuclease activity of the complex as well as ATP dependent DNA translocation.  
HsdM is the methyltransferase subunit and HsdS is the specificity subunit.  The 
acronym Hsd stands for host specificity for DNA and will be omitted for clarity.  
Methyltransferase activity requires the formation of an S1M2 complex and uses S-
adenosyl methionine (SAM) as a methyl donor (Murray, 2000).  The fully active 
endonuclease complex is formed from S1M2R2 and translocates the DNA (ATP 
dependent) prior to cleavage which can occur at a location thousands of bases away 
from the original binding site (Murray, 2000, Seidel et al., 2004).  The translocation of 
the complex is stalled when the enzyme is physically blocked by another protein or 
DNA super-structure and it is at this point the protein cuts the DNA, therefore, the 
cleavage products from Type I RM systems are essentially random.  The DNA 
recognition sites of Type I RM systems are asymmetric and contain a spacer between 
the two DNA sequences used for recognition (Kan et al., 1979).  A typical site is 
observed in the EcoR124I RM system which has the recognition sequence 5’-
GAANNNNNNRTCG-3’, where N stands for any nucleotide and R for any purine (G 
or A) (Price et al., 1987). 
1.3.2 Type II 
Type II RM systems are the most studied out of the four classes and are utilised 
frequently in molecular biology as they can cleave DNA at specific sequences to yield 
predictable digestion products (Pingoud and Jeltsch, 2001).  Unlike Type I systems, 
Type II systems function as two independent enzymes which both recognise the same, 
usually symmetric, DNA sequence for both activities.  A typical example is the EcoRI 
recognition sequence, 5’-G|AATTC-3’, where the line represents the restriction site 
(Pingoud and Jeltsch, 2001).  Except for those in the Type IIM sub-class, Type II 
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restriction enzymes generally cleave only unmethylated DNA at the specific recognition 
site.  The endonuclease enzyme functions as a homodimer and each monomer cuts a 
single strand of the DNA resulting in a double strand cleavage (Pingoud and Jeltsch, 
2001).  It is the homodimeric nature of Type II endonucleases that prompted their use in 
ZFNs as each of the two monomers of the active dimer only associate when the zinc 
finger domains that are fused to the endonuclease monomer bind to their specific DNA 
recognition sequences which are engineered to be adjacent to one another (Kim et al., 
1996).  The Type IIP sub class of RM systems often employ a third protein as a 
transcriptional regulator termed a controller (C) protein (Tao et al., 1991).   This C-
protein regulates the temporal expression of the endonuclease and/or the 
methyltransferase genes in a concentration dependant manner.  This class of protein is 
discussed in detail in section 1.4. 
1.3.3 Type III 
Type III RM systems are composed of two subunits; the restriction subunit (res) and the 
modification subunit (mod) (Wilson and Murray, 1991, Roberts et al., 2003, Tock and 
Dryden, 2005).  Single mod subunits can hemimethylate the DNA unlike Type I and II 
RM systems where the DNA is fully methylated, often from a hemimethylated state.  
Successful DNA cleavage requires a res2mod2 complex to be formed (Janscak et al., 
2001).  This complex competes with itself it terms of both methylation and restriction 
often resulting in incomplete digestion.  Similarly to Type I RM systems the res subunit 
translocates DNA prior to cleavage but unlike Type I RM systems the translocation 
halts at a specific distance from the binding site unless the translocation is obstructed 
prior to this.  This results in a heterogeneous mixture of digestion products (Dryden et 
al., 2001). 
1.3.4 Type IV 
Type IV RM systems are not strictly RM systems as they do not modify, or more 
specifically methylate, DNA, however, they can only cleave methylated DNA (Tock 
and Dryden, 2005, Roberts et al., 2003).  Type IV RM systems are formed from two 
subunits (mcrB and mcrC) which are both utilised for DNA cleavage.  The McrBC 
system in E. coli cleaves one or both strands that contain a methylcytosine following a 
purine.  The two methylated sites can be up to 3000 bases apart (Stewart et al., 2000) 
and therefore the recognition site can be described as: 5’-RCm (N40-3000) RC
m
-3’ where 
R stands for any purine and “m” denotes methylation.  The complex can translocate 
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DNA utilising GTP and cleavage occurs when translocation is stalled in a homologous 
mechanism to Type I RM systems (Pieper et al., 1997). 
1.3.5 RM system evolution 
Although RM systems can be thought of as a countermeasure to invading DNA from 
bacteriophages, an RM system can also prevent potentially useful DNA from being 
established within the bacterium including other plasmid-borne RM systems.  These 
systems can therefore be thought of as selfish genetic elements similar to that of viruses 
or transposons (Kobayashi, 2001).  RM genes can also be associated with mobility 
genes adding to the theory that these elements are semi-independent (Kita et al., 1999).  
Horizontal transfer of RM systems is also common among bacterial populations and 
many bacteria contain multiple RM systems, though often only one is active at a time 
(Alm et al., 1999, Jeltsch and Pingoud, 1996, Handa et al., 2001, Akiba, 1960).  The 
possession of multiple RM systems increases the bacterium’s chances of survival and 
therefore of the RM systems themselves. 
These RM systems are of particular interest in many fields including the development of 
novel therapeutic agents that would target specific strains of pathogenic bacteria but not 
adversely affect eukaryotic cells, which do not possess RM systems.  Also, RM systems 
contain several classes of DNA binding proteins including those with the well 
characterised HTH motif which binds to specific sequences in the DNA and can control 
the expression of RM genes (section 1.1, 1.2.3 and 1.3.2).  
1.4 Controller proteins 
Controller (C) proteins control the transcription of the methyltransferase and 
endonuclease genes in several Type II RM systems (Tao et al., 1991).  Without this 
mechanism the genes would lack temporal control resulting in methylation of foreign 
DNA and/or auto-restriction; the degradation of host genetic material.  Mruk and 
Blumenthal (2008) showed that upon establishment of the PvuII RM system within a 
bacterium, endonuclease expression follows methyltransferase expression with a delay 
of ~10 minutes (Mruk and Blumenthal, 2008).  Further computational and experimental 
work showed that this delay in endonuclease expression was also related to the copy 
number of the plasmid baring the C-protein gene (Williams et al., 2013).  The five 
structurally characterised C-proteins are homo-dimeric HTH DNA binding proteins that 
interact with symmetrical binding sites on the DNA upstream of the genes they are 
regulating (McGeehan et al., 2008, Sawaya et al., 2005, McGeehan et al., 2005, 
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McGeehan et al., 2011).  Other C-proteins, with very similar amino acid sequences, 
which have been only biochemically characterised, are also shown to interact with 
symmetrical DNA sequences and are therefore thought to be homodimeric as well 
(Knowle et al., 2005, Kita et al., 2002, O'Sullivan and Klaenhammer, 1998).  C-proteins 
are encoded by an open reading frame (ORF) on the same plasmid (for plasmid-borne 
RM systems) as the RM genes that they regulate.  Based upon their DNA binding sites, 
Sorokin et al. (2009) divided the C-proteins into several classes named Motif 1 – 10. 
1.4.1 Genetic arrangement 
It was observed that the BamHI RM system contained a third ORF, besides that which 
corresponded to the endonuclease and methyltransferase, which when altered 
significantly reduced the levels of endonuclease production within the bacterium (Ives 
et al., 1992).  This third ORF was also observed with the PvuII RM system and 
subsequent genetic information revealed homologous sequences in the RM systems 
SmaI (Heidmann et al., 1989), EcoRV (Bougueleret et al., 1984), Eco721 (Rimseliene 
et al., 1995), Kpn2I (Lubys et al., 1999), Esp1396I (Cesnaviciene et al., 2003) and AhdI 
(Streeter et al., 2004, Bougueleret et al., 1984).  Firstly for the PvuII, and then 
subsequent RM systems, Tao et al. (1991) termed the protein produced from this ORF 
“controller” (C) and used the nomenclature C.PvuII.  In the PvuII RM system, one of 
the most studied in terms of C-proteins, it was observed that the levels of 
methyltransferase remained unaffected by experimentally induced frame shift mutations 
in the C gene which would have prevented the expression of an active C-protein. 
Although the genes for C-proteins are highly similar, their organisation in the RM 
systems differed greatly as do the genes that they affect the expression of.  Several RM 
systems including BamHI and PvuII have divergent endonuclease and methyltransferase 
genes where the C-protein gene is found upstream of the endonuclease gene (Roberts et 
al., 2003).  In the Kpn2I system however, the endonuclease and methyltransferase genes 
are convergent with the C-protein gene upstream if the methyltransferase gene in a 
divergent orientation.  More examples are shown of varying genetic arrangements of 
RM systems in Figure 1.7.  Also fusions between the C and R genes have been observed 
which yielded stable CR-fusion proteins that exhibited both endonuclease and 
transcriptional regulation activities (Liang and Blumenthal, 2013). 
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1.4.2 Controller protein action 
The regulatory function of C-proteins varies between RM systems despite their high 
degree of homology.  For the known systems where the C-protein (C) gene is upstream 
of the endonuclease (R) gene, the C-protein transcriptionally regulates the two genes, C 
and R, increasing their relative levels of expression (Cesnaviciene et al., 2003, 
Bogdanova et al., 2009, Streeter et al., 2004).  In some systems, including Esp1396I, the 
C-protein also affects the levels of methyltransferase expression through another 
operator site upstream of the M gene.  The Kpn2I system appears to contain a C-protein 
binding site upstream of the M gene and not the R gene (Lubys et al., 1999).  The LlaI 
RM system employs an evolutionarily diverse regulatory mechanism where the C-
protein binding site is, upstream of the methyltransferase gene but regulates the levels 
of endonuclease activity after transcription of the genes using what is proposed to be an 
RNA stabilising role (O'sullivan and Klaenhammer, 1998). 
1.4.3 Controller protein binding sites 
As more genetic information is obtained on the large variety of Type II RM systems that 
utilise C-proteins, more information is subsequently available on the putative binding 
sites of the C-proteins.  Sorokin et al. (2009) divided the C-protein family in to several 
classes based upon the sequence of their putative binding sites (Figure 1.8).  A 
controller protein binding site contains two palindromic tetranucleotide repeats, termed 
C-boxes, separated by a short space sequence.  These classes, termed Motif 1 – 10, each 
contained multiple C-proteins although the vast majority of those in the study were 
putative.  Most of the class assignments were also related to the well characterised 
C.PvuII protein (Motifs 1 – 6) and contained palindromic single or double C-box sites.  
As all known C-proteins exist as dimers it is logical that their binding sites should be 
palindromic and symmetrical, however, Sorokin et al.’s (2009) bioinformatic analysis 
also suggested non palindromic sites for those C-proteins that fall into Motif 9 although 
analysis of the amino acid sequence and structural predictions still indicate the 
formation of homodimeric proteins for this class. 
The biochemically characterised controller proteins C.AhdI (Streeter et al., 2004), 
C.PvuII (Vijesurier et al., 2000) and C.Esp1396I (Bogdanova et al., 2009) are all Motif 
2 C-proteins with sequentially similar DNA binding sites that consist of palindromic C-
boxes, a conserved central spacer and highly conserved bases outside of the C-boxes 
(Figure 1.8 and 1.9).  Their binding sites have been confirmed in vitro and consist of  
Figure 1.8 Phylogenetic tree of controller proteins.  The 
motif’s identified by Sorokin et al. (2009) are coloured according 
to the key.  The black arrows indicate Motif 2 C-protains 
described in section 1.4, the blue arrows indicate the Motif 8 C-
proteins C.Csp231I & C.EcoO109 and the orange arrow shows 
the Motif 7 C-protein C.EcoT38I.  Figure adapted from Sorokin 
et al. (2009). 
19 
Figure 1.9  Conservation of Motif  2 C-protein binding sites.  
Three different potential tetranucleotide C-boxes are highlighted 
in cyan, grey and magenta.  A fourth, trinucleotide C-box is 
shown in red text.  The 100 % conserved bases outside of the C-
boxes are highlighted in green.  The three discussed C-proteins 
are highlighted in yellow. 
GACT TACT GATT GAC 
AGTC AGTA AATC CTG 
OL OR 
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two adjacent C-protein dimer binding sites which, for C.Esp1396I has been shown 
structurally to form a tetrameric C-protein DNA complex (McGeehan et al., 2008).  The 
Esp1396I RM system also contains a third, single C-protein binding site upstream of the 
M gene that is discussed in more detail in section 1.5.  Each binding site consists of two 
palindromic tetranucleotide C-boxes with either a TACT or GACT sequence and a 
trinucleotide spacer between the two sites which is also highly conserved (Sorokin et 
al., 2009).  The binding sites for these three C-proteins (although this appears to be true 
for the majority of those in Motif 2) have a much more symmetrical distal binding site 
than the proximal one in relation to the endonuclease gene (Streeter et al., 2004, Mruk et 
al., 2007, Cesnaviciene et al., 2003) (Figure 1.9).  The distal, or OL, operator site for 
these three proteins consists of GT
 
 
ACTYATAGTCC where Y stands for any 
pyrimidine.  The proximal, or OR, binding site is often much less symmetrical than the 
OL site.  C.Esp1396I has a reduced spacer sequence in the OR site with only two bases 
between the C-boxes instead of the normal three.  C.AhdI appears to have a half binding 
site with only one C-box although the YAT spacer sequence is conserved.  The C.PvuII 
OR binding site has a notably different spacer sequence of CAA but still contains two C-
boxes.  The OR operator sites also seem to contain a third C-box sequence of GATT 
which is observed in both C.Esp1396I and C.PvuII. 
C.Esp1396I is the only C-protein to date to have been co-crystallised with its DNA 
operator sites OM (Ball et al., 2012), OL (McGeehan et al., 2012) and OR (McGeehan et 
al., 2008, Martin et al., 2013).  These structures indicate that the C-box is in fact the 
GAC (GTC on the reverse strand) trinucleotide as no direct protein-DNA interactions 
are seen with the fourth base in the classic C-box sequences.  This trinucleotide 
sequence appears to be more conserved throughout the Motif 2 C-proteins compared to 
the three tetranucleotide C-box sequences, especially in the OR operator sites (Figure 
1.9).  The conservation observed for the fourth base in the classic C-box sequence is 
likely to there in order to maintain the TATA sequence common to the majority of C-
protein binding sites. 
The other highly conserved bases appear to be a G one base before the OL site, a central 
GT dinucleotide between the binding sites and a final C after the OR site (Figure 1.9).  
The spacers between the C-boxes all contain a central adenine with the majority 
forming part of a TATA sequence which, in some of the operator sites, is the -35 RNAP 
binding site required for transcription of the genes (Streeter et al., 2004, Bogdanova et 
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al., 2008, Bogdanova et al., 2009).  Occlusion of this RNAP binding site by the C-
protein is required for the negative transcriptional regulation of an RM gene as it 
prevents the RNAP from synthesising the mRNA of the downstream genes. 
1.4.4 Controller protein sequence and structure 
As of October 2013, five C-protein X-ray crystal structures have been solved; C.AhdI 
(McGeehan et al., 2005)(1Y7Y), C.BclI (Sawaya et al., 2005)(2B4A), C.Esp1396I (Ball 
et al., 2009)(3G5G), C.Csp231I (McGeehan et al., 2011)(3LFP/3LIS) and C.EcoT38I 
(2EF8) (Figure 1.10).  The C.EcoT38I structure does not have an associated publication 
however Kita et al. (2002) showed that this C-protein can control both the endonuclease 
and methyltransferase expression levels and is similar to C.EcoRV (Kita et al., 2002).  
Sorokin et al. (2009) classified both C.EcoT38I and C.EcoRV into Motif 7 on the basis 
of their putative DNA binding sites (Figure 1.8).  This protein exhibits a fold that is 
noticeably dissimilar to the other C-protein structures (Figure 1.10 E).  C.AhdI, C.BclI 
and C.Esp1396I are all Motif 2 C-proteins and have a very homologous structure of five 
alpha helices in each monomer (Figures 1.10 and 1.11).  The lengths of each of the five 
helices vary between the three proteins but the relative orientations of each helix remain 
the same.  The C-protein C.Csp231I is the only protein from Motif 8 to have its 
structure solved and its general fold closely resembles those from Motif 2 but with an 
additional two C-terminal helices, greatly increasing the dimerisation interface and 
perhaps having functions related to complex formation at the operator sites (McGeehan 
et al., 2011). 
As Motif 2 members have both the most biochemical data together with multiple 
structural representatives in the Protein Data Bank, more structure-function 
interpretations can be drawn from this class.  This is especially true for C.Esp1396I 
which has also been co-crystallised with its three known DNA operator sites; OM (Ball 
et al., 2012), OL (McGeehan et al., 2012) and OR (McGeehan et al., 2008, Martin et al., 
2013).  From amino acid sequence alignments and structural data, groups of conserved 
residues can be seen (Figure 1.12).  There are those residues that are involved in 
protein-DNA interactions either with the bases or the backbone.  Residues which are 
key for C-protein dimerisation, a necessary function for DNA binding, are also highly 
conserved.  There are also conserved residues which are important for maintaining the 
structure of the folded C-protein including the orientation of the recognition helix.  
Residues involved in protein-protein cooperativity at double binding sites all appear to  
Figure 1.10 C-protein structures.  A:  C.AhdI (McGeehan et al. 
(2005) 1Y7Y).  B:  C.Csp231I (McGeehan et al. (2009) 3LIS).  
C:  C.BclI (Sawaya et al. (2005) 2B5A).  D:  C.Esp1396I (Ball et 
al. (2009) 3G5G).  E:  C.EcoT38I (2EF8).  The “N” and “C” 
termimi are labelled for the blue monomers in each case 
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                           1               17      25        35         46 
C.Esp1396I         --------MESFLLSKVSFVIKKIRLEKGMTQEDLAYKSNLDRTYISGIERNSRNLTIKSLELIMKGLEVSDVVFFEMLIKEI-LKHD---- 
C.AhdI             ---MQSHHDHYADLVKFGQRLRELRTAKGLSQETLAFLSGLDRSYVGGVERGQRNVSLVNILKLATALDIEPRELFC--------------- 
C.BclI             -----IMINEIEIKRKFGRTLKKIRTQKGVSQEELADLAGLHRTYISEVERGDRNISLINIHKICAALDIPASTFFRKMEEEN 
C.Plu192           ------MKKPNTIKSIFGQRVRYIRMASGMSQEAFADKCGLDRTYISGIERGVRNPTLEVINVIASGLQIELKDLFDFDAEK-KS------- 
C.Plu191           ------MKKPNAVKFLFGQRVRYFRQSSGMSQEAFADKCGIDRTYISGIERGVRNPTLEIINIIASGLQIELTDLFDFSAKP-KG------- 
C.Swi193           ----------VDICKRLGQNVRRLREEKGWSQEAYADEAGIHRTYISDIERGARNPTVKVVEKLAAPFGVPAGQLID--------------- 
C.Hne199           ----------MDIRQKFGKRLRQLREERGWSQEEFADRAGLHRTYVSAVERGVRNPTLSVLERLAKALDIKLSELVQSV------------- 
C.Sse9I            -------VTDGHLQRTFGQNLRDLRVARGLSQEALAELIGVHRTYMGGLERGERNPTLKSVERVAAHLDVDPLSLLTAESCK-SSAPGGVAS 
C.Deh205           -------MTKKTIEQRFGERIRVLRKKAEISQEELAFRAGVHRTYLGGIERGERNPSLKNIEAIAKALEVPISDLFIN-------------- 
C.Deh204           -------MTKKTIEQRFGERIRVLRKKAEISQEELAFRAGVHRTYLGGIERGERNPSLKNIEAIAKALEVPISDLFIN-------------- 
C.Det203           -------MTEKTIEQRFGERIRDLRKKAGVSQEELADRAGVHRTYLGGIERGERNPSLKNIYAISRALKVPVSDLFKT-------------- 
C.Spu165           --------MEDHLLTSFGVHLKRLRLERSFSQEQLALKADMDRTYVSGIERGQRNVSLINIFKLAKALDIPAKQLLDFTVEG-S-------- 
C.She167           --------MEDHLLTSFGTHLKSLRLERSFSQEQLALKADMDRTYVSGIERGQRNVSLINIFKLAKALDIPAKQLLDFTVEG-SL------- 
C.She166           --------MEDHLLTSFGTHLKSLRLERSFSQEQLALKADMDRTYVSGIERGQRNVSLINIFKLAKALDIPAKQLLDFTVEG-SL------- 
C.Har198           MTKDSKHSDDVSLRQKYGSRLRFAREALGISQEALAEKAGLHRTYIGQVERGERNISIDNLERLADAVGEQLWEMLRP-------------- 
C.Mpe114           --MSRGKVAHESARARLARHLRGERALRGLSQEALADLALLHRTYVGSIERCERNVSLDNVERLARALNVDIADLLAAD------------- 
C.Mpe113           --MSRGKVAHESARARLARHLRGERALRGLSQEALADLALLHRTYVGSIERCERNVSLDNVERLARALNVDIADLLAAD------------- 
C.VeiORF3519P      --------MSMTARLTFSRNLRKVRTGQGISQERLADLCDLHRTYVSSVERGERNITVDNMERLAVALGVDIRVLLNPDDAS---------- 
C.SbaI             ---MERKINPSRARVIFAHNIRKLRERQGLSQEALADLAGLHRTYIGSVERCERNISIDNIDRIASALGVSPSSLLENNQV----------- 
C.SptAI            ---MERKINPSRARVIFAHNIRKLRERQGLSQEALADLAGLHRTYIGSVERCERNISIDNIDRIASALGVSPSSLLENNQV----------- 
C.PvuII            ---MSRNTNPLSARLTLAKNVKKMRGELGLSQESLADLVGIHRTYIGSIERAERNISIDNIERIANALNVSISILMMEHENESPRSK----- 
C.BglII            ----------MDIRERFGKTVSSIRRKQNLSQEKLAEISKLDRTYIGGVERGERNLSLLNIERLSNALQMEISEVFRLMEGD-THNED---- 
C.SmaI             VPDADI--CFMDIKEILAENVRSYRNINNLSQEQLAEISGLHRTYIGSVERKERNVTLSTLIILAKALNTSVPKLLTRQGLKNEQG------ 
C.Gur068           ---MRK--ASENIRAILAENIRNFRHKKNFSQEELAEKCGLHRTYIGSVERGERNVTLSTLEVLASTLGVSVPELLSKDARP---------- 
C.SonORF4P         ---MRK--PSKKLLDNLANNVRTFRLKNGISQEQLAEICGFHRTYIGSIERGERNTTLSTLEVLAKTLNVSIAQLLNDDE------------ 
C.Lci22RP          -----------MILNFIAHRIRQLRQQQNVSQEKFAYNIGMDRSYFASVESGKRNISIINLQKIVTGLGVTLEEFFKGI------------- 
C.Fnu200           -----------MYKKKFGKAVKKLRNGKQISQEKFALEIGMDRTYLSSVEAGKRNISLENIEKISKGLGISISELFKYIEEGE-DKIG---- 
C.BstLVI           ---MRNINDRDKALRIIGNNIRLIRTWLNLSQEELAFKSGLHRTYIGAVERGEKNITILNLIKIANALEVRVQDLLDLDKEEDK-------- 
C.NmeSI            ---------MENELVEFGKRVKHYRLLNGWSQEELAEKVGLHRTYIGSVERGERNISLLNISLLAKSFSINISELVEGIK------------ 
C.Cef187           ------VTPDKKILIQLGDRLREARKQAKLSQEEVAHLSGLHRTYISLVERGGRNISVLNLLSITGVLGVDVGDIVSGLTREPRLNP----- 
C.Cgl186           ------VTPDKKILIQLGGRIRDVRKSLGISQEELAHLSGMHRTYVSSVERGERNISVLNLLSLAGVLGVDAGDLVTGLTRAPRIKP----- 
C.Cgl185           ------VTPDKKILIQLGGRIRDVRKGLGISQEELAHLSGMHRTYVSSVERGERNISVLNLLSLAGVLGVDAGDLVTGLTRAPRIKP----- 
C.Cor184           ------VVEDQRLLQEVGNRVRSARKKKGLSQESLAHLSGLHRTYVSSIERGERNLSVLNLLTLATVLDVDAATIVASLKRAPKNNV----- 
C.Cor183           ------VDNDRRLLQEIGDRLRAARKETNLSQEALAHLSGLHRTYVSSIERGERNLSILNLLTLATVLDIDASVFVSSLKRVPNE------- 
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be very highly conserved and finally there are a group of well conserved residues where 
their function remains unknown. 
Amino acid residues that were predicted from bioinformatic analysis and the free 
protein structures to interact with the DNA were confirmed when C.Esp1396I was co-
crystallised with DNA (McGeehan et al., 2008) (Figure 1.13).  The DNA binding 
residues show a high degree of conservation throughout the Motif 2 family (Figure 1.12 
and 1.14).  The arginines, R35 and R43 (C.Esp1396I amino acid numbering will be 
used throughout) are 100 % conserved in all of the C-proteins from Motif 2 as is Y37.  
The DNA base binding residues T36 and R46 show high conservation with only a few 
alterations to serine and lysine respectively.  T49 is also conserved with an 
approximately 50:50 ratio between threonine and serine throughout the class.  The 
residue S52, which is known to interact with the DNA backbone in the C.Esp1396I co-
crystal structures, is much less conserved but several other Motif 2 C-proteins have 
threonine or asparagine as the same relative position, maintaining a hydrogen bonding 
potential for DNA interactions (Figure 1.12). 
Residue N47 is also 100 % conserved in this group of structurally characterised Motif 2 
C-proteins (Figure 1.15 A).  This residue sits at the dimer interface and interacts with 
the backbone between a conserved pair of amino acids on the other monomer in the 
biological dimer.  These two residues are T49 and I50 in C.Esp1396I.  The isoleucine is 
less conserved than the threonine as mentioned above but always appears to be 
hydrophobic; isoleucine, leucine or valine.  Also, all three of the C-proteins have a 
similar sequence here of alternating hydrophobic and hydrophilic residues (NLSI in 
C.Esp1396I) which can form multiple backbone-backbone hydrogen bonds (Figure 1.15 
B).  The fifth, C-terminal helix varies the most (six – 17 amino acids) in length between 
the three C-protein structures however there are conserved elements, with the 
distribution of hydrophobic residues being the most common (Figure 1.12 and 1.16).  
C.Esp1396I has an amphipathic helix 5 which primarily dimerises with another 
C.Esp1396I monomer on the hydrophobic side.  Also, a phenylalanine-phenylalanine 
dipeptide seems to be conserved between C.Esp1396I and C.BclI, one of which aligns 
with the C-terminal phenylalanine from C.AhdI; a key dimerisation residue in this C-
protein (Figure 1.16 D). 
Two key residues appear to have a conserved structural role within the Motif 2 C-
proteins.  The residue R17 forms a salt bridge with E42 in all the Motif 2 C-protein 
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structures available (Figure 1.17 A).  E42 is at the C-terminal end of helix 3, the 
recognition helix, and it is likely that this interaction stabilises the helix orientation 
which is critical for correct and stable DNA binding.  Another totally conserved residue 
is involved in this interaction, Q24, which is within hydrogen bonding distance to E42 
as well as a partially conserved serine, S39. 
The C.Esp1396I-DNA co-crystal structure with the fully occupied double OL+R operator 
sites revealed direct protein-protein cooperativity between the two dimers (McGeehan et 
al., 2008)(3CLC) (Figure 1.13 B).  This cooperativity is in the form of a salt bridge 
between a conserved arginine of one dimer and glutamate of another (Figure 1.13 B and 
1.18).  The residue R35 is also a DNA binding residue in single sites and is 100 % 
conserved as is E25 which is also shown to interact with the DNA backbone in single 
sites (Ball et al., 2012, McGeehan et al., 2012).  Mutational and functional analyses of 
these two residues demonstrated that E25 had a key role in cooperativity whereas R35 
was also crucial for DNA binding (Figure 1.18 B). 
Several other conserved residues and amino acid sequences within the Motif 2 C-
proteins have less obvious functions despite their high degree of conservation.  All of 
the C-proteins in this class can be split into two groups, the DRTY group and the HRTY 
group, which have been shown to have different binding site consensus sequences 
(Mruk et al., 2007) (Figure 1.12).  The RTY portion of this group are all known DNA 
binding residues but the D/H have not been observed interacting with DNA in any co-
crystal structures.  The other totally conserved residue is A28 which is not making 
contact with any other residues but the side chain physically sits between the backbone 
of D34 and R35 of the D/HRTY group at the base of helix 3 (Figure 1.17).  There is 
also a conserved hydrophobic residue (L33 in C.Esp1396I) that is orientated into this 
space along with the alanine.  It is possible that these residues allow for the tight turn 
between helices 2 and 3 whilst also ensuring the necessary side chains of DNA binding 
residues are primarily directed out into space on the DNA binding surface of the 
protein.  
Only a small portion of C-proteins have been studied both biochemically and 
structurally despite the large number predicted by Sorokin et al. (2009).  The C-protein 
from the Esp1396I RM system has been studied in depth both in vivo and in vitro 
including multiple high resolution crystal structures which include protein-DNA 
complexes. 
Figure 1.13 The C.Esp1396I tetrameric repression complex.  
C.Esp1396I was co-crystallised with the double C-box sequence 
of both the OL and OR operator sites.  A:  The C-protein 
dimerisation residues.  B:  The conserved salt bridge residues E25 
and R35.  C:  The phosphate binding residues.  D:  Direct base 
readout from the conserved R35 residue.  Figure adapted from 
McGeehan et al. (2008). 
D 
A 
C 
B 
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Figure 1.14 Conserved DNA binding residues in C-proteins.  
Seven conserved residues are shown as sticks and labelled 
according to the numbering of C.Esp1396I 
C.Esp1396I is shown in Green 
C.AhdI is shown is Yellow 
C.BclI is shown in Blue 
R35 
T36 
S52 
R17 
R46 
Y37 
T49 
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Figure 1.15 Conserved dimerisation residues in C-proteins.  
A:  The conserved asparagine makes a key dimerisation contact 
with the backbone of the other monomer in the dimer.  B:  The 
conserved pattern of Asparagine-Hydrophobic-Threonine/Serine-
Hydrophobic starting with N47 in C.Esp1396I.  The threonine 
side chain has been removed for clarity.  The  dark green and 
light green correspond to separate monomers. 
C.Esp1396I is shown in Green 
C.AhdI is shown is Yellow 
C.BclI is shown in Blue 
N47 
N47 
N47 
A 
B 
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Figure 1.16 Conserved dimerisation residues in C-proteins.  
Conserved residues in helix 5 of C-proteins.  Hydrophobic 
residues are shown in red and hydrophilic in blue.  A:  Helix 5 of 
C.Esp1396I.  B:  Helix 5 of C.BclI.  C:  Helix 5 of C.AhdI.  D:  
Helix 5 from the three C-proteins showing the conservation of the 
phenylalanine. 
A 
B 
C 
D 
90° 
90° 
90° 
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Figure 1.17 Conserved structural residues in C-proteins.  A:  
E42 and R17 form a salt bridge at the N-terminal end of helix 3.  
Q28 is also within hydrogen bonding of E42 as well as the 
partially conserved S39 which is a glycine in C.AhdI.  The 
numbering is from C.Esp1396I.  B:  A28 is 100 % conserved in 
all Motif 2 C-proteins (red circle) but does not directly bond to 
anything.  It is in close proximity to a conserved hydrophobic 
residue (L33 in C.Esp1396I) as well as the key residue R35 and 
the D/H swapping residue, 34. 
C.Esp1396I is shown in Green, C.AhdI in Yellow and C.BclI in 
Blue 
Q24 
R17 
E42 
S39 
R35 
D/H34 
L33 
A28 
A 
B 
32 
Figure 1.18 Conserved protein-protein cooperativity residues 
in C-proteins.  A:  R35 and E25 in C.Esp1396I form a salt bridge 
between dimers in the tetrameric C-protein complex (3CLC).  B:  
EMSA experiments on alanine mutants of E25 and R35 using the 
OL+R dual operator sites.  The E25A mutant reduced cooperativity 
as the dimeric species was visible and the R35A mutant abolished 
DNA binding altogether.  F: free DNA, D: dimer, T: tetramer.  
(Figure from McGeehan et al. (2008). 
C.Esp1396I is shown in Green 
C.AhdI is shown is Yellow 
C.BclI is shown in Blue 
R35 
E25 
A 
B 
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1.5 The Esp1396I restriction-modification system 
The Type II RM system Esp1396I has been studied in detail both in vivo (Bogdanova et 
al., 2009, Cesnaviciene et al., 2003) and in vitro (McGeehan et al., 2008) regarding the 
transcriptional control of the R and M genes by the C-protein C.Esp1396I.  C.Esp1396I 
falls into the Motif 2 class of C-proteins with the pseudo symmetrical binding sites 
shown in Figure 1.9 (Sorokin et al., 2009).  Unlike most other C-proteins in this class, 
C.Esp1396I has a third single C-protein binding site upstream of the M gene which has 
been shown to silence transcription of the methyltransferase enzyme (Bogdanova et al., 
2009). 
1.5.1 Esp1396I in vivo 
Like most other Type II RM systems Esp1396I is formed from three genes; esp1396IM 
(the methyltransferase), esp1396IR (the endonuclease) and esp1396IC (the C-protein) 
(Figure 1.19 A).  This RM system is plasmid-borne and was first isolated from 
Enterobacter species strain RFL1396.  The C gene is located upstream of the R gene 
and the two genes can be transcribed as a single polycistronic mRNA.  The C/R genes 
are arranged in a convergent manner with the M gene (Figure 1.18).  Both the 
methyltransferase and endonuclease enzymes recognise the DNA sequence: 5’-
CCANNNN|NTGG-3’ where the line indicates the endonuclease restriction site 
(Cesnaviciene et al., 2003).  The methyltransferase enzyme methylate’s position N-6 on 
the adenine within the recognition sequence preventing cleavage of the DNA by the 
endonuclease. 
During the study conducted by Česnavičienė et al. (2003) the nucleotide sequence of 
the entire pEsp1396 plasmid was determined.  This showed the gene organisation of the 
Esp1396I RM system and also the locations of putative binding sites for the C.Esp1396I 
C-protein relative to the C/R and M genes (Figure 1.19 B and C).  C.Esp1396I was 
observed to have the double binding site upstream of the C and R genes common to 
Motif 2 C-proteins such as C.PvuII and C.AhdI (these two sites are termed OL and OR) 
(Figure 1.9 and 1.19 C), however, a third single C-protein binding site was also 
observed upstream of the M gene, termed OM (Figure 1.19 B).  It was confirmed that 
C.Esp1396I affected the expression of the C/R genes, both increasing and then 
subsequently decreasing the levels of expression (Bogdanova et al., 2009).  For the OM 
operator site it was observed that C-protein expression (and presumed binding to this 
site) significantly reduced methyltransferase expression (Bogdanova et al., 2009). 
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Figure 1.20 C-protein mediated temporal control in the 
Esp1396I RM system.  A:  Upon establishment of the pEsp1396I 
plasmid within a bacterium, the methytransferase gene (blue) is 
strongly expressed and the C-protein gene (green) weakly 
expressed.  B:  Once C-protein concentration builds up, the dimer 
binds to the OM site and represses expression of the 
methyltransferase.  C:  Further increase in C-protein results in 
binding to the OL site, greatly increasing C-protein and 
endonuclease  gene (red) expression by recruiting the sigma 
subunit of RNAP (purple).  D:  Eventually C-protein 
concentration builds up enough and the OR site is occupied, 
repressing C-protein and endonuclease expression. 
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Bogdanova et al. (2009) were able to confirm the binding sites through foot-printing 
analysis as well as using in vitro transcription to show that the operator sites were 
responsible for transcriptional regulation in the presence of the C-protein (summarised 
in Figure 1.19). 
1.5.2 Esp1396I in vitro 
The Esp1396I RM system has been studied in vitro in order to understand the 
transcriptional regulation properties of the C-protein; C.Esp1396I.  Previous in vitro 
work on the controller protein C.AhdI had shed light on aspects of C-protein-DNA 
interactions in terms of cooperativity (McGeehan et al., 2006), DNA bending 
(Papapanagiotou et al., 2007) and the HTH homodimeric nature of the protein structure 
(McGeehan et al., 2005) however, a C.AhdI nucleoprotein complex has so far eluded 
crystallisation.  McGeehan et al. (2008) solved the X-ray crystal structure of the closely 
related C-protein C.Esp1396I in complex with DNA.  The structure comprised of two 
C.Esp1396I dimers bound to a 35 bp DNA duplex which contained both the operator 
sequences pertaining to the double OL+R binding site.  This structure confirmed details 
such as the overall DNA bend (~50 ° per operator site but reduced overall due to the 
two binding sites being on almost opposite sides of the DNA), the protein-protein 
cooperativity and of course the HTH C-protein structure itself.  As discussed in section 
1.4.4, the dimerisation interface of C.Esp1396I is much larger than C.AhdI and it was 
therefore predicted that C.Esp1396I would have a lower dimerisation constant (Kdim) 
than C.AhdI.  The experimentally determined  Kdim's for C.AhdI was 2.5 μM 
(McGeehan et al., 2004) and for C.Esp1396I was 0.6 μM (Bogdanova et al., 2009).  A 
more stringent method using a mutant version of C.Esp1396I, which had a greater 
extinction coefficient at 280 nm, and analytical ultracentrifugation (AUC) experiments 
using a wider range of protein concentrations, reported a Kdim for C.Esp1396I closer to 
1.6 μM (Ball et al., 2012).  The accurate Kdim allowed for more a more accurate 
determination of the dissociation constants (KD) of C.Esp1396I and its binding sites as 
the actual amounts of biological dimer (which is required for DNA binding) can be 
calculated during DNA binding experiments.  OM was shown to have the highest 
binding affinity of the three operators, followed by OL and then OR with KDs of 0.61, 5.6 
and 121 nM respectively (Bogdanova et al., 2009, Ball et al., 2012). 
The tetrameric OL+R structure of C.Esp1396I also showed the role of the conserved 
residues discussed in section 1.4.4 (McGeehan et al., 2008).  Unfortunately symmetry 
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related averaging and the low resolution (2.8 Å) of the structure prevented the 
visualisation of DNA binding residues that were likely to be in alternative 
conformations in each binding site due to averaging of the electron density or solvent 
mediated interactions. 
A structure of C.Esp1396I in a free, unbound state was subsequently solved and 
revealed structural differences when compared to the bound state (Ball et al., 2009).  
The primary observation by Ball et al. (2009) was that the protein was flexible at the 
loop between helices 3 and 4.  This loop contains residues that, from the DNA bound 
structure, are known to interact with the DNA and are also highly conserved between 
the members of the Motif 2 family of C-proteins.  It was postulated that this flexible 
loop allows the protein to recognise the three subtly different operator sites in the 
Esp1396I RM system (Figure 1.19).  This was confirmed when subsequent C-protein-
DNA structures were published on the single operator sites OL (McGeehan et al., 2012) 
and OM (Ball et al., 2012).  The OL operator site which, unlike the other two (OM and 
OR) has a longer spacer between the binding sites (three bases compared to two), was 
unexpectedly shown to have a non-symmetrical C.Esp1396I dimer bound (McGeehan et 
al., 2012).  The flexible loop in each monomer had adopted different conformations in 
the OL structure however the C.Esp1396I dimer in the more perfectly symmetrical OM 
operator site bound structure was symmetrically bound with the loops in the same 
conformation (Ball et al., 2012).  These OL and OM structures showed the DNA binding 
residues in greater detail than the tetrameric OL+R complex due to higher resolution and 
the ability to determine DNA directionality due to designed overhanging, 
complementary bases.  The C.Esp1396I-OL complex at 2.1 Å resolution was especially 
informative as solvent molecules were visible in the electron density which were 
involved in bridging protein-DNA contacts. 
1.6 Project aims 
The primary aim of this project was to elucidate the role of amino acid side chains from 
the controller protein C.Esp1396I with respect to DNA binding.  The majority of 
biochemical, biophysical and structural data published prior to the outset of this project 
involved the use of the native sequence of C.Esp1396I, or mutants that did not affect 
DNA binding.  These experiments provided the background that allowed for further 
experiments to be conducted using C.Esp1396I as a model.  A series of point mutations 
were introduced into the primary amino acid sequence of C.Esp1396I through specific 
alteration of the protein encoding gene, esp1396IC.  These mutant proteins were then 
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used in DNA binding experiments, alongside the wild type protein, in order to 
understand the effects of these subtle amino acid alterations, and to therefore give 
information on the role of these residues in the formation and stability of protein-DNA 
complexes. 
Based on the published protein-DNA co-crystal structures, which showed a combination 
of both base binding and phosphate binding residues at the protein-DNA interface, two 
classes of residues have been selected for mutagenesis (Figure 1.20).  The mutations to 
base binding residues were designed to understand the importance of sequence 
recognition and mutations to phosphate binding residues were designed to probe the 
importance of induced DNA bending as it is believed that both DNA bending as well as 
DNA base recognition are important for complex formation and stability. 
Detailed structural analyses are also to be carried on the mutant C.Esp1396I proteins in 
order to ascertain if the mutations have had any small structural effects on the protein.  
To judge this accurately a new, higher resolution, free protein structure of C.Esp1396I 
is to be determined by X-ray crystallography.  As well as free protein structures, any 
C.Esp1396I mutants that retain DNA binding are to undergo crystallogenesis trials in 
the presence of DNA duplexes containing the sequences of single operator sites to 
hopefully understand the effects of the mutation in terms of DNA structure. 
Furthermore, a C-protein-OR co-crystal structure is yet to be determined due to the 
inherently weak nature of the interaction.  Therefore C.Esp1396I will undergo extensive 
co-crystallisation trials with various DNA oligonucleotides which contain part or all of 
the OR site in order to gain structural information on this relatively weak protein-DNA 
interaction. 
  
R35 
T36 
R46 
Y37 
T49 
S52 
Figure 1.21  Mutagenesis targets in C.Esp1396I.  The six key 
DNA binding residues of C.Esp1396I are shown as sticks and 
labelled.  As R35 was mutated in a previous study (Figure 1.18) 
this residue was not mutated.  The remaining five residues were 
selected for mutagenesis due to their clear role in DNA binding.  
T36 and R46 bind to the DNA bases and Y37, T49 and S52 all 
bind to the same phosphate group. 
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Chapter 2: Designing, constructing, purifying and 
analysing the C.Esp1396I mutants 
2.1 Introduction 
Mutagenesis has been commonly used to determine the role and/or importance of 
individual amino acids in a protein.  Previously, McGeehan et al. (2008) mutated 
residues in C.Esp1396I that were involved in protein-protein cooperativity in the 
tetrameric repression complex (Figure 1.17 B).  However, no C.Esp1396I mutants were 
designed to study the role of individual amino acids involved in DNA binding. 
Analysis of C.Esp1396I-DNA co-crystal structures identified the residues that bind to 
the DNA and bioinformatic analysis showed the high degree of conservation of these 
residues (Figure 1.11 and 1.12) (McGeehan et al., 2008, Ball et al., 2012, McGeehan et 
al., 2012, Martin et al., 2013).  Identified key residues were mutated to determine their 
role in DNA binding using either site-directed mutagenesis or gene synthesis to 
introduce point mutations into the primary sequence of C.Esp1396I. 
Mutated proteins, as confirmed by DNA sequencing, were purified as previously 
described (McGeehan et al., 2008), and detailed in section 2.5.  All purified proteins 
were subjected to dynamic light scattering to determine whether they had formed dimers 
and to judge their polydispersity and levels of protein aggregation prior to 
crystallisation trials and biophysical & biochemical experiments. 
2.2 Methods 
2.2.1 Agarose gel electrophoresis of DNA 
DNA molecules were separated based upon their size using agarose gel electrophoresis.  
The pore size of the gel matrix was varied depending upon the percentage of agarose 
used; the higher the percentage the smaller the average pore size.  Agarose was 
dissolved in 1 × TAE through heating and allowed to cool to ~50 °C at which point 
EtBr was added to a concentration of 1 μg/20mL.  The liquid solution was then poured 
into a gel sled whereupon a comb was added to create wells for sample loading.  DNA 
samples were mixed with 5 × Orange G at a ratio of 4:1 prior to loading on the gel.  
Once the gel had set it was placed in an electrophoresis tank and submerged in 1 × TAE 
buffer.  Prepared DNA samples were loaded into the wells upon removal of the comb.  
An electric current was then passed through the gel at 60 – 120 V for a desired duration 
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to ensure separation of heterogeneous samples.  Gels were imaged using UV light 
which causes intercalated EtBr to fluoresce.  The sizes of DNA fragments were 
estimated by comparing them to a standard (Figure A2.1) 
2.2.2 Denaturing polyacrylamide gel electrophoresis 
In order to ascertain the molecular weight and purity of a protein sample, denaturing 
polyacrylamide gel electrophoresis (PAGE) was used.  As sodium dodecyl sulphate was 
using as the denaturant, the technique is referred to as SDS-PAGE.  Due to the low 
molecular weight, of approximately 10 kDa, of C.Esp1396I tris-tricine SDS-PAGE was 
used throughout this thesis as this method results in better resolution of low molecular 
weight proteins (Schägger and von Jagow, 1987). 
Tris-tricine SDS-PAGE resolving gel was made as described in section 2.1.2 and 
poured between two sealed mini-gel plates, leaving enough volume for 1.5 – 2 cm of 
stacking gel.  A layer of water-saturated butanol was used to ensure a smooth interface 
between the resolving and stacking gels.  This layer was removed once the resolving gel 
had set and before application of the stacking gel.  The stacking gel was made as 
described in section 2.1.2 and poured on top of the resolving gel to fill the space 
between the plates.  A comb was then placed into the gel in order to create wells for 
sample loading.  Protein samples were prepared by mixing aliquots with 5 × SDS 
sample loading buffer and heating to 100 °C for two minutes.  Once the stacking gel had 
set, the gaskets sealing the gel plates were removed and the gel was placed vertically in 
an electrophoresis tank.  Cathode and anode buffers were added to the correct chambers 
and the comb was removed in order to prepare the gel for sample loading.  Once 
samples were loaded onto the gel, a constant electric current was passed through at 150 
V for ~90 minutes or until the dye front had reached the bottom of the gel.  In order to 
determine the molecular weight, a set of protein standards were also electrophoresed for 
direct comparisons (Figure A2.1). 
The gel was then removed from the plates, washed in dH2O with a heating step prior to 
staining with Simply Blue Safe Stain (Invitrogen).  This involved removing as much 
excess dH2O from the gel and then flooding the gel with the stain, heating and then 
agitating for ~15 minutes.  Gels were then washed and destained in dH2O through steps 
of heating and agitation.  Gels were visualised by eye and digitally recorded. 
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2.2.3 Site-directed mutagenesis 
Mutagenesis has been used to alter proteins in order to better understand the function of 
individual amino acids relevant to substrate binding, complex formation, enzymatic 
function and so on.  Site-directed mutagenesis involves altering the protein encoding 
portion of a DNA molecule in order to alter the sequence of the transcribed mRNA and 
therefore the translated amino acid sequence (Hutchison et al., 1978).  This method 
utilises the well characterised polymerase chain reaction (PCR) to introduce controlled 
mutations within the gene that encodes for the protein (Figure 2.4).  These mutations are 
often substitutions to one or two DNA bases that result in the alteration of one amino 
acid within the primary protein sequence.  These proteins can then be studied side-by-
side with the wild type protein in order to ascertain the role or significance of that single 
amino acid 
Mutagenic primers for the site-directed mutagenesis PCR (SDM-PCR) were designed to 
possess melting temperatures of >60 °C (Figure 2.4).  The PCR was set up using 125 ng 
of each primer, 20 ng of pET-28-esp1396IC, 500 μM dNTP mix, 4 mM MgSO4 and 2 
units of vent-exo
-
 DNA polymerase.  An initial melting step at 95 °C for five minutes 
preceded the cycling of the following steps: 
1. Melting: 1 minute at 95 °C 
2. Annealing: 2 minutes at 55 °C 
3. Extension: 10 minutes at 72 °C 
These cycles were repeated 20 times with a final 15 minute extension step.  The 
template plasmid was then digested with 10 units of DpnI prior to transformation of the 
PCR product into competent E. coli cells (section 2.2.6).  This removed the methylated, 
non-mutated template plasmids.  Mutagenesis was confirmed using DNA sequencing  
supplied by GATC Biotech using their T7 primer which corresponds to the promoter 
site on the pET28 plasmid upstream of the esp1396IC gene. 
2.2.4 Preparation of plasmid DNA from E. coli 
Individual colonies of E. coli that were grown on LB agar were used to inoculate 5 mL 
of LB broth and left to shake at 225 rpm at 37 °C overnight.  The plasmid DNA from 
these E. coli cells was purified using the Macherey-Nagel NucleoSpin® Plasmid 
purification kit.  In brief; the E. coli cells were removed from solution by centrifugation 
for 30 seconds at 11000 × g.  The cells are then resuspended in Buffer A1, mixed and 
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incubated for five minutes at room temperature in Buffer A2 and finally Buffer A3 is 
added.  This process lyses the cells and digests the RNA through the RNAaseA added to 
Buffer A1.  The lysate is then removed through centrifugation at 11000 × g for five 
minutes.  The supernatant is then loaded onto a NucleoSpin® Plasmid Column above a 
collection tube and then centrifuged for one minute at 11000 × g, after which the flow-
through is discarded.  The membrane is then washed using Buffer A4 and centrifugation 
for one minute at 11000 × g.  After the flow-through is discarded, the membrane is then 
dried through further centrifugation for two minutes at 11000 × g.  The DNA is then 
eluted from the column using Buffer AE, which has been cooled to 4 °C, and after a one 
minute incubation is centrifuged for one minute at 11000 × g.  The concentration of 
plasmid DNA was determined using absorbance at 260 nm. 
2.2.5 pUC-57 to pET-28 cloning 
esp1396IC mutant genes which had been synthesised by GenScript (USA) were stored 
and maintained in the pUC57 cloning vector.  In order to express the mutant 
C.Esp1396I proteins the gene was sub-cloned into the expression vector pET-28.  An 
NdeI site was included as part of the synthesis construct at the N-terminus to create an 
in-frame ATG start codon which allows specific directional ligation into the pET-28 
vector, which included an N-terminal 6-His tag for affinity purification.  The C-
terminus of the gene had a HindIII restriction site downstream of the stop codon and a 
redundant stop codon.  As pUC57 contains another NdeI site approximately 210 bp (the 
esp1396IC constructs were ~250 bp) away from the NdeI site in the gene construct a 
two-step digestion and purification method was required. 
The first step was to digest the pUC57-esp1396ICmutant plasmid with NdeI to excise 
the ~210 bp fragment.  This required 10 units of NdeI (NEB) being incubated with 1000 
ng of the plasmid for one hour at 37 °C in 1 ×NEBuffer (NEB).  The enzyme was heat 
inactivated at 65 °C for 20 minutes.  The digested plasmid was electrophoresed through 
a 0.8 % agarose gel and the larger fragment (~2700 bp) was excised from the gel and 
the DNA was purified using the Macherey-Nagel Gel Extraction Kit.  In brief: the gel 
fragment containing the DNA fragment of interest was melted at 50 °C in Buffer-NT.  
The melted solution was then passed through a NucleoSpin® Extract II Column using 
centrifugation.  The DNA was then eluted using Buffer-NE following centrifugation of 
the column. 
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Plasmid pUC57-esp1396Ic-M is cleaved using NdeI 
Digested pUC57 plasmid is electrophoresed to separate 
the undesired fragment (~250 bp).  Larger fragment 
(linearised pUC57-esp1396Ic-M) is purified from the gel. 
Truncated pUC57-esp1396Ic-M is cleaved using HindIII 
Digested pUC57 plasmid is electrophoresed to separate 
the desired fragment (~250 bp) which is then purified. 
Purified esp1396Ic-M is incubated with pET28 (which as 
been linearised by a double digest using NdeI and 
HindIII and been gel purified) and T4 DNA ligase. 
Ligated plasmid in heat-shock transformed into 
competent E. coli and grown on LB agar with 50 mg/mL 
kanamycin 
Figure 2.3 pUC57 to pET28 cloning strategy.  Flow diagram 
showing the method for transferring mutant esp1396Ic genes 
(esp1396Ic-M) synthesised by GenScript (USA) from the pUC57 
cloning vector to the pET28 protein expression vector. 
47 
 48 
 
The purified, linear pUC57-esp1396IC mutant vector was then incubated with 10 units 
of HindIII (NEB) for one hour at 37 °C in NEBuffer-2.1.  HindIII was then heat 
inactivated at 80 °C for 20 minutes.  The digested plasmid was electrophoresed through 
a 0.8 % agarose gel, the smaller fragment (~250 bp) was excised from the gel and the 
DNA was purified using the Macherey-Nagel Gel Extraction Kit.  The pET-28 plasmid 
was double digested with 10 units of NdeI and 10 units of HindIII for one hour at 37 °C 
in NEBuffer-2.  The digested plasmid was electrophoresed through a 0.8 % agarose gel, 
the larger fragment (~5400 bp) was excised from the gel and the DNA was purified 
using the Macherey-Nagel Gel Extraction Kit. 
The purified esp1396IC-mutant and cleaved pET-28 were then incubated with 5 units of 
T4 DNA ligase (NEB) for one hour at 16 °C in Ligation Buffer (NEB).  Plasmids were 
then transformed into competent cells and successful gene insertions were confirmed by 
agarose gel electrophoresis and DNA sequencing (GATC BioTech).  A summary of the 
cloning strategy is shown in Figure 2.3. 
2.2.6 Heat shock transformation of Escherichia coli 
Plasmids carrying the esp1396IC native and mutant genes were transformed into 
competent E. coli cells using the heat shock method.  Approximately 50 μL of 
competent cells were incubated with purified plasmid DNA on ice for 10 minutes before 
heating them to 42 °C for between 30 – 90 seconds.  The shocked cells were incubated 
at 37 °C in 500 μL of LB media for an hour.  The cells were pelleted using 
centrifugation and resuspended in 100 μL of LB before being spread onto the surface of 
an LB agar plate containing the relevant antibiotic.  The strains used for the work 
presented in this thesis were E. coli DH5α (for cloning and maintaining plasmid stocks) 
and E. coli BL21 (DE3) pLysS (for protein expression). 
2.2.7 Protein expression using the pET-28 vector 
To produce large quantities of proteins for biophysical analysis, the proteins are often 
produced in non-native organisms that have been designed and modified for this exact 
purpose.  As C.Esp1396I is a bacterial protein, the E. coli based expression system was 
used to produce all proteins presented in this thesis.  DNA plasmids that carry a gene of 
interest and a suitable promoter can be placed into the cytosol of E. coli cells with 
relative ease and without damaging the protein production machinery of the cell.  All 
the work described in this thesis used the bacteriophage T7 transcription promoter 
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(Figure 2.1).  This promoter has evolved to be an extremely potent promoter as a part of 
the T7 bacteriophage lifecycle and is therefore very useful for expressing large 
quantities of recombinant proteins.  The particular E. coli cells used in the work 
presented in this thesis also carry the pLysS plasmid which carries the gene for the T7 
lysozyme protein.  This protein will inhibit the T7 polymerase which is encoded by the 
DE3 lysogen, and in theory prevent any expression prior to desired induction.  Induction 
in this system is based around the lac operon, which responds to the presence of 
allolactose or structurally similar molecules (section 1.1, Figure 1.1 and 1.2).  In nature 
this operon governs the expression of a series of enzymes required for the breakdown of 
lactose into glucose and galactose (section 1.1).  When allolactose, a lactose metabolite, 
is present in the cytosol, the lac repressor protein undergoes a conformational change 
and can no longer bind to DNA, therefore allowing RNA polymerase to transcribe any 
genes upstream of this repression site.  In molecular biology a non-digestible lactose 
analogue, such as IPTG (Figure 1.2 E), can be used to inhibit the lac repressor’s DNA 
binding ability and therefore induce the transcription of mRNA and subsequent protein 
production. 
Transformed cells were spread on LB agar containing 50μg/mL kanamycin and 
incubated at 37 °C overnight.  Individual colonies were used to seed 30 mL of 2 × YT 
media with 50 μg/mL kanamycin and were incubated overnight.  Culture growth was 
confirmed by observing the turbidity of the 30 mL media compared to a negative 
control.  Starter cultures were added to 1 L of 2 × YT media and kanamycin with 1 % 
glucose added to reduce undesired basal expression.  Once the culture had reached an 
OD600 reading of 0.6, IPTG was added to a final concentration of 1 mM in order to 
promote gene expression from the lac promoter (section 1.1.2).  Cultures were then 
pelleted by centrifugation at 4000 × g for 30 minutes at 4 °C.  The supernatant was 
removed and pellets could be frozen for later or used immediately for purification.  A 
small fraction of the culture was removed prior to centrifugation and used to confirm 
recombinant protein production using SDS-PAGE. 
2.2.8 Purification of soluble C.Esp1396I 
Once a source of a protein of interest has been either found or engineered, the protein 
needs to be purified for further biophysical study to remove the potential of 
contaminants affecting the results.  Proteins that are produced recombinantly can be 
engineered in various ways to aid purification such as the addition of other polypeptide 
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sequences that bind to known surfaces or ligands.  The vast majority of proteins for 
biophysical study are purified using chromatographic methods as a wide variety of 
chromatography columns exist that can separate molecules, such as proteins, by size, 
charge, hydrophobicity or the ability to bind to another molecule.  All the proteins 
produced for the work in this thesis were engineered with a hexahistidine “tag” to aid in 
purification.  This sequential row of histidines can chelate metal ions such as Ni
2+
 and 
Co
2+
 effectively binding them to the protein (Figure 2.7).  Chromatography columns can 
be made using matrices that bind and retain these metal ions and can then subsequently 
be used to isolate hexahistidine fusion proteins from a mixture of cellular proteins and 
molecules. 
Frozen pellets from 1 L bacterial cultures were resuspended in 30 mL lysis buffer and 
lysed using sonic disruption.  The sonication protocol involved bursts of 10 second 
sonic pulses followed by 10 second pauses for cooling, the sample was placed on ice.  
This was repeated 15-20 times until the cells had been fully lysed as judged by 
viscosity.  The lysed cells were then centrifuged at 40,000 × g for 32 minutes at 4 °C in 
order to remove large and insoluble components.  The supernatant was then filtered 
through a 0.2 μm filter prior to FPLC purification. 
As all produced proteins contained an N-terminal 6-His tag, initial purification was 
carried out using a 1 mL HisTrap HP nickel affinity column (GE Life Sciences).  After 
samples were dialysed using a 3350 Da membrane into the HisTrap loading buffer, the 
sample was injected onto the column and then washed through with 5 column volumes 
(cv) of the loading buffer.  A gradient over 45 cv of 0 – 100 % HisTrap elution buffer 
was used to elute retained proteins from the column, which were then collected in 1 mL 
fractions for SDS-PAGE analysis.  Fractions containing C.Esp1396I were dialysed 
against 5 L of cleavage buffer over night at 4 °C. 
Dialysed samples were then incubated with 0.1 units of thrombin (Sigma) per 0.1 mg of 
protein at room temperature for 4 hours.  Phenylmethanesulfonylfluoride (PMSF) was 
added to the reaction to a final concentration of 1 mM to inhibit the thrombin activity.  
The cleaved sample was then loaded onto a 26/60 Sephacryl S-200 gel filtration column 
(GE LifeSciences).  The column was run isocratically using the gel filtration buffer for 
1.5 cv whilst the UV absorbance at 220, 260 and 280 nm was recorded.  Fractions of 2 
mL were collected for SDS-PAGE analysis.  The purified C.Esp1396I was then either 
dialysed into the storage buffer or into Heparin loading buffer.  Those proteins that were 
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dialysed into the Heparin loading buffer were loaded onto a 1 mL HiTrap Heparin 
column (GE LifeSciences) and eluted using a step gradient of 0 – 100 % Heparin 
elution buffer.  This had the effect of concentrating the protein into 1 – 3 mL of buffer.  
The samples were then dialysed into storage buffer. 
2.2.9 Purification of insoluble C.Esp1396I 
Frozen pellets from 1 L bacterial cultures were resuspended in 30 mL lysis buffer and 
lysed using sonic disruption.  The lysed cells were then centrifuged at 40,000 ×  g for 32 
minutes at 4 °C in order to remove large and insoluble components.  For preparing the 
insoluble protein fraction the pelleted material was then resuspended in 20 mL wash 
buffer I and centrifuged at 20,000 × g for 16 minutes at 4°C.  This was repeated once 
more in wash buffer I and twice in wash buffer II.  The final pellet was then 
resuspended in 5 mL denaturing buffer before any remaining cell debris was removed 
using centrifugation (20,000 × g for 16 minutes at 4 °C).  The supernatant was then 
loaded onto a 1 mL HisTrap column (GE LifeSciences) where the denatured 
C.Esp1396I was retained.  The protein was then refolded using a linear gradient of 0 – 
100 % HisTrap loading buffer over 45 cv.  The folded C.Esp1396I was eluted using the 
HisTrap elution buffer and purified as described for the soluble fraction in section 2.5.1. 
2.2.10 Dynamic Light Scattering 
Dynamic light scattering is often used to elucidate the basic shape of a macromolecule 
in terms of its hydrodynamic radius and in the case of proteins this can often reveal the 
oligomeric state and purity of a protein or complex of interest.  The molecular weight of 
a globular sample can be determined using the empirical formula: 
               
     
(Equation 2.1) 
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2.3 Analysis for mutational targets. 
2.3.1 Bioinformatic analysis 
Previous bioinformatic analysis conducted by Sorokin et al. (2009) analysed several 
confirmed and putative C-proteins and subsequently separated them into classes based 
upon their amino acid sequence and binding sites.  C.Esp1396I falls into the Motif 2 
class along with the C-proteins C.AhdI and C.BclI which have also been structurally 
characterised (Sawaya et al., 2005, McGeehan et al., 2005).  A review of the amino acid 
sequences of the Motif-2 C-proteins revealed some very highly conserved amino acids 
and sequences.  Firstly there was the 
 
 
QE sequence, with the threonine only present in 
C.Esp1396I.  The glutamate residue has been shown previously to play a role in protein-
protein cooperativity (McGeehan et al., 2008) and the glutamine is involved in maintain 
the structure of the C-protein, therefore neither were altered in this study .  The other 
highly conserved sequence is the 
 
 
RTY group.  The final three residues in this sequence 
are known to bind DNA and will therefore be discussed in section 2.3.2.  Two other 
highly conserved amino acid residues are arginines 43 and 46 which are shown to 
interact with the DNA in the co-crystal structures.  A full review of the bioinformatic 
analysis of the amino acid sequence of Motif 2 C-proteins is described in section 1.4.4. 
2.3.2 Structural analysis 
Multiple published crystal structures of C.Esp1396I, both as a free protein and in 
complex with DNA, are available in the Protein Data Bank (PDB).  The three 
previously published C.Esp1396I DNA-protein complexes revealed in atomic detail the 
DNA binding interface and the residues involved in this interaction.  Residues R35, T36 
and R46 were identified as being DNA base-specific and interacted with the DNA in all 
three of the published operator site co-crystal structures (Ball et al., 2012, McGeehan et 
al., 2012, McGeehan et al., 2008).  Several other residues that interacted with the 
phosphate backbone were identified in these structures including Y37, T49 and S52 
which are close to the dimerisation interface and interact with the minor groove 
phosphate.  Together with the corresponding residues in the other monomer of the 
C.Esp1396I dimer, they appear to be responsible for the minor groove compression and 
subsequent major groove opening required for C.Esp1396I binding.  Due to the clear 
conservation observed by bioinformatic analysis, and the obvious interactions in the 
crystal structures, these six residues are ideal mutagenesis targets.  However, the residue 
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R35 was mutated to an alanine in a previous study (McGeehan et al., 2008) and shown 
to abolish all DNA binding (Figure 1.17 B). 
2.4 Generating the C.Esp1396I mutant constructs 
2.4.1 Site-directed mutagenesis and gene synthesis 
Site-directed mutagenesis was used to introduce mutations into the C.Esp1396I 
expression construct supplied by K. Severinov and E. Bogdanova (Rutgers University, 
USA).  The mutagenic primers were designed to have an optimal melting temperature 
(Tm) of ≤78 and >60 °C as recommended by the Agilent Technologies manual relating 
to the kit used for the reactions (Figure 2.4).  The mutagenesis reaction was carried out 
using the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies) as 
described in section 2.3.1.  Poor mutagenic efficiency was observed with the 
C.Esp1396I mutagenic primers compared to the control plasmid and primers which are 
supplied as part of the kit.  Very few (<10)  E. coli colonies formed after transformation 
with mutated plasmids and only three were confirmed to have the R46A mutation and 
only one colony for the Y37A mutant compared to more than 80 colonies for the control 
mutagenesis reaction with an mutation efficiency of 75 % (Figure 2.5).  The poor 
mutagenic efficiency was most likely due to the size of the mutagenic primers which, in 
order to achieve the desired Tm, had to be ~60 bases in length due to the high AT 
content of the C.Esp1396I gene.  Therefore, future C.Esp1396I mutants were generated 
by de novo synthesis at GenScript (USA).  These mutants genes were excised from the 
synthesis cloning vector pUC57 (Figure 2.2) and ligated into the pET-28b expression 
vector (Figure 2.1) to match the existing C.Esp1396I expression construct.   
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Figure 2.5 Sequencing of the site directed mutagenesis.  A: 
Example ABI trace from DNA sequencing (supplied by GATC 
Biotech) B:  The DNA and translated protein sequence from the 
R46A mutagenesis clones.  The blue box highlights the N-
terminal methionine, the green box the native start methionine 
and the red box the mutagenesis site. C:  The DNA and translated 
protein sequence from the Y37A mutagenesis clones.  The blue 
box highlights the N-terminal methionine, the green box the 
native start methionine and the red box the mutagenesis site. 
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2.5 Mutant protein production and purification 
All the mutant C.Esp1396I proteins were produced as described in section 2.4 and 
purified as previously described (McGeehan et al., 2008) and detailed in section 2.5.  
The yields of the wild type and mutant proteins varied between 10 mg/L and 70 mg/L of 
soluble protein.  The R46H mutant was entirely insoluble in the conditions used for all 
other mutants and was therefore purified using the insoluble protein purification 
protocol detailed in section 2.5.2.  A loss of soluble protein was always observed at the 
thrombin cleavage stage used to remove the hexahistidine tag which is known to 
improve protein solubility in some cases (Woestenenk et al., 2004).  Despite previous 
results showing that the hexahistidine tag had no effect on DNA binding (Ball, 2010) it 
was decided that the tag should be removed prior to crystallisation trials, and therefore 
the DNA binding studies, in order to maintain consistency.  This resulted in an average 
final yield of 3-30 mg/L of purified, cleaved, soluble protein.  Heparin affinity columns 
have been used previously to increase the concentration of C.Esp1396I prior to 
crystallisation as well as increasing the purity of the protein, however, during this stage 
of the purification of the R46A mutant it was observed that the protein did not bind to 
the heparin matrix of the column.  Due to this all of the mutants were concentrated 
using centrifugation through a membrane with a molecular weight cut-off of 3350 Da 
prior to crystallisation trials.  The final concentration of the C.Esp1396I constructs was 
determined using UV absorbance spectroscopy (see Table 2.1). 
2.5.1 Bacterial cell culture 
Production of C.Esp1396I in E. coli strain BL21 (DE3) pLysS had previously been 
optimised to produce the maximum amount of soluble protein (Ball, 2010).  The only 
further optimisation carried out for this study was the addition of glucose to a final 
concentration of 1 % at the stage of 1 L bacterial cell cultures which greatly increased 
the yields of soluble C.Esp1396I at the point of bacterial cell lysis.  Details of the 
bacterial protein production methods can be found in section 2.4.  The production of 
C.Esp1396I constructs was confirmed using whole cell lysate SDS-PAGE prior to 
attempted purification (Figure 2.6). 
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Figure 2.6 Mutant expression tests.  Example gel testing the 
expression of four different C.Esp1396I constructs..  All four of 
these constructs showed over-production of a protein 
approximately the molecular mass of His-tagged C.Esp1396I, 
11.4 kDa.  50 kDa standard highlighted on the gel.  The ~11 kDa 
arrow is based on confirmed C-protein molecular weight. 
M: Marker (Benchmark, Figure A2.1), U: Uninduced, I: Induced 
using IPTG. 
~11 kDa 
58 
50 kDa 
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2.5.2 Chromatography 
All the proteins produced in this study included an N-terminal hexahistidine tag 
designed to aid purification through metal ion affinity (Figure 2.7).  This hexahistidine 
tag binds to metal ions, including Ni
2+
 and Co
2+
, which can be immobilised onto a 
matrix contained within an HPLC column.  Native C.Esp1396I and the mutants were 
initially purified using a Ni
2+
 column (Figure 2.8).  This hexahistidine tag was 
subsequently removed using the serine protease thrombin which left the tripeptide 
remnant GSH before the starting methionine of C.Esp1396I (Figure 2.1).  The removal 
of the hexahistidine tag resulted in a loss of up to two-thirds of the protein yield due to 
precipitation/aggregation of the protein.  The hexahistidine tag is known to affect 
protein solubility and it is possible that this is the cause of the loss of protein.  It is also 
known that this precipitation is crystalline in nature so could be resolubilised (Ball et 
al., 2009).  The samples were then filtered using a 0.2 μm filter to remove the 
precipitant prior to being subjected to size exclusion chromatography to separate the 
cleaved C.Esp1396I from the purification tag and the thrombin (Figure 2.9).  The wild 
type C.Esp1396I construct was further purified and concentrated using heparin affinity 
chromatography.  Heparan sulphate is a DNA mimic molecule which can be used to 
purify DNA binding proteins (Figure 2.10).  The heparin column gave highly 
concentrated protein with a purity >95 % (as judged by SDS-PAGE Figure 2.11) but it 
was observed that the mutant R46A did not bind to the heparin matrix and as such, none 
of the C.Esp1396I mutants were subjected to heparin affinity chromatography. 
2.5.3 Dynamic Light Scattering 
In order to confirm that all the purified proteins were dimerised, Dynamic Light 
Scattering (DLS) was used to estimate molecular weight from the hydrodynamic radius.  
This technique also provides an indication as to the purity and polydispersity of the 
sample; both of which are important factors when it comes to biophysical analyses and 
crystallisation trials.  The DLS experiments were carried out using the DynaPro 
MSTC800 (Protein Solutions) with the proteins at a concentration of 2 mg/mL in a 
volume of approximately 300 μL.  The radius in nm, the polydispersity (in % and nm) 
and the molecular weight were recorded for each sample (Table 2.2).  None of the 
C.Esp1396I constructs showed monomer present in solution during the DLS 
experiments but the mutants T49A and R46H has estimated molecular weights well 
above that of dimeric C.Esp1396I. 
Figure 2.7 Nickel affinity to histidine.  A:  Ni2+ ions are bound 
to a resin that can be used to fill an HPLC column for purification 
of poly-His-tagged proteins.  B:  The molecular arrangement of 
the amino acid side chain histidine.  R refers to the polypeptide 
chain.  C)  The small molecule imidazole which is used to elute 
bound proteins from Ni affinity columns during purification 
N
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Figure 2.8 Nickel affinity chromatography of C.Esp1396I.  A:  
Example chromatograph of Ni affinity chromatography based 
purification of wild-type C.Esp1396I with a zoom of the protein 
peaks during imidazole elution (B).  The red line represents 
absorbance at 260 nm and the blue at 280 nm.  The green line 
represents the relative concentration of elution buffer (Appendix 
A1).  The two peaks observed during elution, P1 & P2, were 
electrophoresed using denaturing SDS-PAGE (C) to confirm the 
presence of C.Esp1396I.  M: Marker (Benchmark, Figure A1.2). 
P1 
P2 
P1 
M 
P2 
B 
A 
C 
10 kDa 
50 kDa 
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Figure 2.9 Gel filtration of C.Esp1396I.  Gel filtration 
chromatograph of C.Esp1396I using a Sephacryl S200 gel 
filtration column.  The red line represents absorbance at 260 nm 
and the blue line at 280 nm.  The peak “P” was analysed using 
SDS-PAGE to confirm the presence of cleaved C.Esp1396I.  
Additional peaks were confirmed not contain protein. (B).  
Fractions from across the peak were loaded onto the gel so each 
lane contained the same concentration of protein.  The C-protein 
has been successfully cleaved by thrombin due to the clear loss in 
molecular weight compared to Figure 2.9. M: Marker 
(Benchmark, Figure A2.1). 
P 
M M 
P 
B 
A 
10 kDa 
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Figure 2.10 Structure of heparan sulphate.  Heparan sulphate 
(A) closely resembles DNA (B).  The helical structure and surface 
charge of heparin sulphate are ideal for the purification of DNA 
binding proteins as there is both a charge-charge interaction (like 
ion exchange) and the recognition of a structural element (like 
affinity chromatography). 
B 
A 
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Figure 2.11 Heparin affinity chromatography of C.Esp1396I.  
A:  Chromatogram of C.Esp1396I wild-type purified using a 
heparin affinity column.  The red line represents absorbance at 
260 nm and the blue at 280 nm.  The green line represents the 
concentration of Heparin elution buffer (section 1.1).  The peak, 
“P”, was tested for the presence of C.Esp1396I using SDS-PAGE 
(B).  Fractions of the same volume were loaded from across the 
peak (P).  The presence of a contaminant was shown at high 
concentrations (red circle).  M: Marker (Benchmark, Figure A2.1) 
B 
A 
M 
P 
P 
10 kDa 
50 kDa 
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2.6 Discussion 
The wild-type C.Esp1396I proteins and all of the mutants were successfully produced in 
E. coli and purified to a level suitable for biophysical analyses and crystallisation trials.  
The dynamic light scattering confirmed the presence of dimeric species in solution and 
all of the mutants except T49A and R46H displayed properties similar to that of the 
wild type C.Esp1396I.  The R46H mutant was the only construct that produced solely 
insoluble protein.  The histidine mutation at this position was designed to preserve a 
charged surface and to also mimic the C-protein C.Csp231I which has a histidine at the 
same relative position as the arginine in C.Esp1396I (McGeehan et al. 2011).  The 
T49A mutant although produced as a soluble protein had a hydrodynamic radius 
indicating the presence of a species much larger than a dimer.  Both R46H and T49A 
produced the lowest yields of purified recombinant protein at 5 and 3 mg/L 
respectively.  Interestingly, R46H and T49A were the only C.Esp1396I mutants not to 
crystallise in this study and T49A displayed no ability to interact with DNA (Chapter 3).  
The R46H mutant was unsuitable for the DNA binding studies conducted in Chapter 3 
as it was unstable and insoluble in the SPR and EMSA running buffer. 
The poor mutagenic efficiency observed during the site-directed mutagenesis was likely 
down to the high AT content of the C.Esp1396I gene and the therefore long mutagenic 
primers.  An increase in the annealing time was required in-order to achieve any 
successful mutagenesis reactions and even then the efficiency was extremely poor.  The 
direct gene synthesis route had significant benefits, most notably the avoidance of 
unintended base alterations as a result of the PCR used to introduce mutants in site-
directed mutagenesis.  As the gene synthesis was quicker, cheaper and more efficient it 
was a much more logical approach to generating proteins with altered amino acid 
sequences.  The decreased cost was due to the small size of the gene (~240 bp) however 
introducing mutations during chemical gene synthesis, regardless of gene size, is still 
very cost effective and efficient compared to site-directed mutagenesis. 
All of the proteins produced were used for DNA binding studies to elucidate the role of 
the altered side chains (Chapter 3) as well as crystallisation trials to determine the 
structures of the mutant proteins (Chapters 4, 5 and 6).  The majority of the mutant 
proteins yielded high resolution X-ray crystal structures, further confirming the 
successful mutations, biological dimerisation and overall structure. 
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Chapter 3: DNA-binding analysis of the C.Esp1396I 
mutant proteins 
3.1 Introduction 
In order to determine the effects of the altered amino acid sequence of C.Esp1396I on 
its ability to bind to DNA, both Electrophoretic Mobility Shift Assays (EMSA) and 
Surface Plasmon Resonance (SPR) experiments were undertaken on single operator 
sites.  The purpose of these experiments was to elucidate the importance of the amino 
acid sequence of C.Esp1396I at the DNA binding interface observed in the co-crystal 
structures. 
3.2 Methods 
3.2.1 Native polyacrylamide gel electrophoresis for EMSA 
EMSAs can be used to determine whether one protein molecule or complex interacts 
with another molecule such as DNA.  This has been a common technique when it comes 
to studying protein-nucleic acid interactions due to the inherently high charge on a DNA 
molecule and its very predictable movement through a gel matrix.  Garner and Revzin 
(1981) described the use of the technique to elucidate interactions between transcription 
factors and DNA elements in the E. coli lac operon (Garner and Revzin, 1981).  The 
assay works by using standard nucleic acid in-gel electrophoresis but with a potential 
DNA binding protein added to each lane at varying but specific concentrations (Figure 
3.1).  The DNA’s progress through the gel matrix will be retarded if a protein has bound 
to the DNA due its increased mass and normally decreased charge to mass ratio. 
EMSAs can provide both qualitative and quantitative information about protein-DNA 
interactions.  The potential of more complex species then 1:1 can be much more easily 
observed with EMSAs than with techniques such as SPR and Isothermal Titration 
Calorimetry (ITC).  This is because EMSAs rely on the retardation (or lack thereof) of 
the DNA through a gel matrix, and not just amount or rate of complex formation, which 
can be visualised and measured with different species forming giving different band 
positions on the gel.  A more quantitative approach to EMSAs requires modified DNA 
duplexes that have either been labelled radioactively or fluorescently as this is much 
more sensitive than post-staining with DNA intercolators such as Ethidium Bromide 
(EtBr).  The fluorophore 4, 7, 2', 4', 5', 7'-Hexachloro-6-carboxyfluorescein (HEX) 
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(Figure 3.2) can be covalently linked to DNA and absorbs light at 537 nm and emits 
light at a frequency of 556 nm, which can be visualised on a fluorescence imager.  HEX 
was used in this thesis to allow analysis of the binding of C.Esp1396I and the mutant 
proteins to various DNA operator sites at concentrations lower than those that could be 
visualised with EtBr. 
The program Scientist (MicroMath Scientific Software) was used to fit the EMSA data 
to a model for 1:1 binding which takes into account the dimerisation of C.Esp1396I; 
Kdim of 1.6 μM.  This constant is then fixed and the KD can be calculated using the 
formula: 
    
      
    
 
(Equation 3.1) 
where [N] is the concentration of nucleic acid, [D] the concentration of protein (as a 
dimer) and [ND] the concentration of complex. 
8 % native polyacrylamide gels were made as described in Appendix A1 and poured 
into sealed mini-gel plates until full, at which point a comb was inserted in order to 
create wells for sample loading.  Once the gel was set it was placed in a vertical 
electrophoresis tank and submerged in running buffer.  The comb was then removed 
and the gel was pre-run at 100 V for 60 minutes at 4 °C.  For protein-DNA complexes, 
the purified protein and DNA duplexes were incubated at room temperature at varying 
molar ratios for 30 minutes and then mixed with 90 % (v/v) glycerol to give a final 
concentration of 9 % (v/v) glycerol in order to retain the sample within the well.  Once 
samples were loaded into the gel they were electrophoresed for 100 minutes at 100 V or 
until the samples had separated. 
3.2.2 DNA Duplex formation and purification 
Synthetic complementary single stranded DNA oligonucleotides were mixed in equal 
ratios in 10 mM Tris-HCl pH 7.5 and 100 mM NaCl and then heated to between 80 and 
95 °C and allowed to cool to room temperature overnight.  The samples were then 
mixed with glycerol to a final concentration of 9 % (v/v) and loaded onto an 8 % non-
denaturing polyacrylamide gel and subjected to electrophoresis. 
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The DNA bands were visualized using EtBr, excised from the gel and then crushed.  
The crushed bands were then immersed in 500 mM sodium acetate pH 8 and 1 mM 
EDTA (elution buffer) and left to agitate overnight.  Following overnight agitation, the 
samples were centrifuged at 48000 g for 30 minutes at 4 °C and the eluent was aspirated 
and stored at 4 °C. The fragments were covered in fresh elution buffer and shaken as 
before for 4 hours. The centrifugation/aspiration step was repeated and the fragments 
were then placed in a small volume of absolute ethanol and shaken for 1 hour (or until 
the fragments became opaque). The sample was then placed in a 0.45 µm Spin-X 
microcentrifuge tube (Costar) and the eluent was recovered by centrifugation at 13000 g 
at 4 °C for 10 minutes. 
To the combined eluent from the gel extraction procedure was added 0.1 volumes of 3 
M sodium acetate (pH 5.2) and 3 volumes of cold absolute ethanol. The samples were 
then incubated at -70 °C for 1 hour. Following incubation the solution was centrifuged 
at 27000 g for 30 minutes at 4 °C, after which the supernatant was aspirated and 
discarded. The pelleted material was washed with 70 % ethanol and centrifuged at 
16000 g for 30 minutes at 4 °C. The supernatant was aspirated and discarded and the 
samples were dried by inversion at room temperature. The DNA was then resuspended 
in a small volume of annealing buffer and stored in small aliquots at -20 °C. 
3.2.3 Surface Plasmon Resonance 
SPR has become a common method of determining the binding affinities of one 
molecule or complex for another. SPR aims to measure the change in reflected light 
from a metallic surface based upon the change of a plasmon wave resulting from the 
oscillations of the electrons within the metal.  In practise, more specifically molecular 
biology, this can be applied to mass changes on a surface as when the mass changes, the 
electron oscillation also changes resulting in a change of resonance angle of the 
reflected light.  This change in the resonance angle is measured in response units (RU).  
In the case of biological interactions, say proteins and DNA, this can provide sensitive, 
qualitative and quantitative results about association and dissociation rates (ka and kd 
respectively) of an interaction. 
A common experimental set-up, and the one used throughout this thesis, is to 
immobilise a DNA duplex containing the protein binding site to the surface of a chip 
where the uncoated side is composed of a gold film used to measure the change in 
surface plasmon resonance (Figure 3.3). 
Figure 3.1 Electrophoretic Mobility Shift Assay.  
Electrophoretic mobility shift assay (EMSA).  The DNA (red) is 
electrophoresed though a gel matrix (grey).  Typically a protein 
concentration gradient is run across the gel.  If the protein (green) 
interacts with the DNA then a shift in the DNA position relative 
to the free DNA is observed.  Most often the DNA shifts towards 
the negative electrode as the DNA is less mobile through the gel.  
Aggregation can occur resulting in a “supershift” in the DNA.  
Smears often occur due to complex dissociation during the 
electrophoreses of the gel as well as the fluorophore separating 
from the DNA molecule. 
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Figure 3.2 The chemical structure of Hexachloro-6-
carboxyfluorescein. 4, 7, 2', 4', 5', 7'-Hexachloro-6-
carboxyfluorescein (HEX) is a fluorophore which has a maximal 
absorbance at 537 nm and emits light at 556 nm.  In high 
concentrations the solutions appear bright pink. 
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Figure 3.5 An SPR curve. The association phase (A, red arrow) 
is when the analyte is being flowed over the chip’s surface.  The 
phase, despite its name, is recording both association and 
dissociation of the complex being studied.  B (green arrow) 
shows when the injection of sample has ended..  The dissociation 
phase (C, black arrow) only measures dissociation of the 
complex. 
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3.2.4 Preparation and immobilisation of DNA ligands 
DNA duplexes formed from single stranded DNA (ssDNA) oligonucleotides were 
prepared as described in section 3.2.2.  For SPR experiments one of the ssDNA 
oligonucleotides was covalently linking at the 5’ end to a biotin molecule.  The biotin 
allows for immobilisation on the surface of an SPR chip pre-coated in streptavidin (SA).  
The SA-biotin interaction is extremely tight and behaves as if covalently linked.  This 
means that ligand immobilisation is essentially permanent for all SPR experiments 
described in this thesis. 
Purified DNA duplexes were diluted in SPR running buffer to a final concentration of 
20 nM.  The DNA duplexes, which contained either the OL, OR or OM operator sites 
were passed over the surface of flow cells two, three and four at a flow-rate of 30 
μL/minute until a total response units (RU) reading of ~200 was achieved (Figure 3.4).  
Flow cell one was intentionally left blank as a negative control and for baseline 
correction. 
3.2. 5 Protein preparation and data collection 
Purified samples of wild type C.Esp1396I and the mutant constructs were dialysed 
overnight at 4 °C against SPR running buffer using a 3350 Da molecular weight cut-off 
membrane. Dialysed samples were serially diluted to create concentration ranges for 
SPR experiments.  Typical concentration ranges covered a 10 fold molar range e.g. 20 – 
200 μM total protein or 100 – 1000 μM.  The data were collected on the BIACore T-100 
using the BiaControl software.  All experiments were conducted at 30 μL/minute to 
reduce mass transport, a known issue with C.Esp1396I DNA interactions studied using 
SPR (Ball, 2010, Ball et al., 2012).  The experiments consisted of a 30 second 
association phase and a 300 second dissociation phase.  This experimental set up was 
designed for subsequent kinetic analysis as equilibrium is unlikely to be reached after 
30 seconds.  After 300 seconds any remaining protein was flushed out using 3 M NaCl. 
In order to determine a binding constant (KD) for the protein-DNA interaction both the 
ka and kd need to be determined.  KD is related to ka and kd by the following formula: 
    
  
  
 
(Equation 3.2) 
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The kd can be determined as a change in RU during the dissociation phase (Figure 3.5).  
This is not as simple for ka as the association phase comprises both complex 
dissociation as well as association.  For a 1:1 complex, the rate of complex formation 
(ka) can be described as the increase in complex concentration [AB] over time relative 
to the product of the concentrations of the components [A] and [B]: 
     
  
            
(Equation 3.3) 
where t is the measurement of time.  Similarly the kd can be described by the decrease in 
complex concentration over time relative to the concentration of the complex: 
     
  
          
(Equation 3.4) 
Combining these two equations gives us the net rate of complex formation during the 
association phase of the experiment: 
     
  
                   
(Equation 3.5) 
During an SPR experiment one of the complex partners, the analyte, is kept at a known 
concentration throughout [A] and the concentration of free surface bound ligand (DNA 
in the case of the work presented in this thesis) [B] can be measured indirectly as a 
function of Rmax (the maximum analyte binding capacity) minus R (the RU at a given 
time).  The concentration of complex [AB] can be described by R.  If we substitute 
these into the net complex formation equation (Equation 4.5) we get: 
  
  
                     
(Equation 3.6) 
During the dissociation phase of the experiment, the analyte concentration [A] is zero: 
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(Equation 3.7) 
Therefore both the ka and kd can be determined using SPR which means that the KD for 
an interaction can also be determined. All data were processed using the BiaEval 
(version 2.0.2) software with the reference channel signal subtracted from the 
experimental channel.   
3.3 Electrophoretic Mobility Shift Assays 
Wild type C.Esp1396I and the mutant proteins were analysed for their DNA binding 
capacity using EMSAs and two different DNA duplexes which contained either the OM 
operator site or the OL operator site (Figure 3.6).  Both of the duplexes were labelled 
with HEX so the DNA could be visualised using fluorescence.  Quantitative analyses 
were carried out using the programs ImageJ (http://rsbweb.nih.gov/ij/) for densitometry 
and Scientist (MicroMath Scientific Software) for quantitative modelling of the binding 
(Figure 3.11). 
3.3.1 EMSA analysis of phosphate binding mutants. 
The C.Esp1396I mutants Y37A, Y37F, T49A and S52A were analysed for DNA 
binding potential against the OM and OL operator sites using EMSAs (Figure 3.8).  Total 
protein concentrations were used and calculated using UV absorbance at 280 nm with 
the extinction coefficient values shown in Table 2.1.  The C.Esp1396I-T49A mutant 
showed no interaction with either of the operator sequences even at a molar ratio of 8:1 
protein:DNA and only free, unbound DNA was observed on the gels.  Analysis of the 
free DNA bands showed no reduction in the overall fluorescence that might have 
indicated extremely weak binding. 
The S52A mutant protein formed stable dimeric (one protein dimer bound to one DNA 
duplex) complexes with both the OM & OL operators.   This species was confirmed to be 
the dimeric species as clear bands were visible on the gel which had shifted to an 
identical degree as that of the wild type run in tandem on the same gel. 
 
 
OM :  5’-Biotin-TGCCATGTAGACTATAGTCGACGAGC 
 
                 ACGGTACATCTGATATCAGCTGCTCG
             5’-GCTCGTCGACTATAGTCTACATGGCA 
 
OL :  5’-Biotin-TGCCATGTGACTTATAGTCCGTGAGC 
 
                 ACGGTACACTGAATATCAGGCACTCG
             5’-GCTCACGGACTATAAGTCACATGGCA 
 
OR :  5’-Biotin-TGCCGTGTGATTATAGTCAACATAGC 
 
                 ACGGCACACTAATATCAGTTGTATCG
              5’-GCTATGTTGACTATAATCACACGGCA
 
OM:  5' - HEX-GCTATGTAGACTATAGTCGACG 
 
OL:  5' - HEX-GCTATGTGACTTATAGTCCGTG 
 
OL+R: 5' – HEX-ATGTGACTTATAGTCCGTGTGATTATA  GTCAACAT
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These complexes only form at higher ratios of protein to DNA and only a partial shift 
was observed with the OL operator site at a ratio of 8:1 protein:DNA.  Analysis using 
ImageJ for both the OL and OM operator complexes showed that the S52A mutant 
protein never reaching 100 % bound in both cases at a protein concentration of 7200 nM 
(8:1) (Figure 3.11).  Data were fitted using the program Scientist (MicroMath Scientific 
Software) to obtain the KD for the interaction of S52A and the two operator sites using a 
one-to-one binding model.  The dimerisation constant of C.Esp1396I was fixed at 1.6 
μM for all analyses as determined by Ball et al. (2012).  This analysis gave KD values of 
0.61 (±0.2) and 1.8 (±0.2) μM for OM and OL respectively (Table 3.1).  Compared to the 
wild type values of 0.22 (±0.03) and 0.52 (±0.04) μM, for OM and OL respectively, this 
is a notably weaker binding mutant.  However, the ratio between the two KDs is similar 
for both the S52A mutant and the wild type. 
The C.Esp1396I-Y37A mutant was prone to super-shifting, the formation of higher 
order structures.  The lack of defined complexes (i.e. smeared bands on the gel) was 
also common with this mutant indicating that the complexes were much less stable than 
the wild type C.Esp1396I-DNA complexes.  No clear dimeric complexes could be seen 
in the OL or OM operator site EMSAs.  Measurements of the total bound and unbound 
DNA showed that the degree of complex formation for both tested operator sites was 
similar to that of wild type C.Esp1396I.  Therefore it is likely that the Y37A mutant 
forms less stable complexes than the wild type which resulted in the lack of observable 
complexes on the gels.  Due to the absence of discrete bands, analysis using Scientist 
was not sufficient to determine accurate KD values. 
Unlike the Y37A mutant, the Y37F mutant produced more distinct bands relating to the 
correct protein-DNA complexes.  The Y37F mutant appears to bind more readily to the 
OM site than even the wild type as greater than 90 % of the DNA was in the bound state 
at a ratio of 2:1 protein:DNA which relates to a protein concentration of 1800 nM.  This 
was not observed until a molar ratio of 8:1 for the wild-type (7200 nM protein 
concentration).  For the OL site a distinct Y37F-DNA complex was not observed and 
instead produced non-specific smearing of the DNA on the gel.  A maximum shift of 
~40 % of the DNA was observed by 8:1 protein:DNA, much lower than the 
corresponding wild type and even the Y37A and S52A mutants.  Although the Y37F 
mutant formed discrete complexes with the OM operator, the lack of complexes for the 
OL operator meant that an accurate ratio between the KDs for these two sites could not 
be accurately determined using Scientist. 
Figure 3.7 EMSA analysis of wild-type C.Esp1396I. Wild-type 
C.Esp1396I was used for EMSA’s against the operator sites OM 
and OL.  The protein:DNA (molar concentration of protein-
momomer:DNA-duplex) ratio increases from left to right; 0:1, 
1:1, 2:1, 4:1 and 8:1. The final DNA concentration in each well 
was 900 nM. 
D: DNA-Protein Complex (Dimer) 
F:Free DNA 
OM OL 
F 
D 
F 
D 
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Figure 3.8 EMSA analysis of the phosphate binding mutants.  
The four C.Esp1396I mutants Y37F, Y37A, S52A and T49A were 
used for EMSA’s against the operator sites OM and OL.  The 
protein:DNA (molar concentration of protein-monomer:DNA-
duplex) ratio increases from left to right; 0:1, 1:1, 2:1, 4:1 and 
8:1. The final DNA concentration in each well was 900 nM. 
D: DNA-Protein Complex (Dimer) 
F:Free DNA 
Y37A 
Y37F 
S52A 
T49A 
OM OL 
F 
D 
F 
D 
F 
D 
F 
F 
D 
F 
D 
F 
D 
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Figure 3.9 EMSA analysis of the base binding mutants.  The 
two C.Esp1396I mutants R46A and T36A were used for EMSA’s 
against the operator sites OM and OL. The protein:DNA (molar 
concentration of protein-monomer:DNA-duplex) ratio increases 
from left to right; 0:1, 1:1, 2:1, 4:1 and 8:1. The final DNA 
concentration in each well was 900 nM. 
D: DNA-Protein Complex (Dimer) 
F:Free DNA 
OM OL 
R46A 
T36A 
F F 
F F 
D 
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Figure 3.10 Quantitative analysis of EMSAs.  Using the 
program ImageJ the gel images were split into individual lanes 
and then the resulting graphs were split into different complexes 
or bound and unbound DNA.  D: Dimer complex, F: Free DNA, 
SS: Supershifted DNA, UB: unbound DNA, B: Bound DNA 
83 
Figure 3.11 Quantitative analysis of EMSAs.  The EMSA’s for 
the wild type (orange) and S52A (green) mutants against the OM 
operator (A) and OL operator (B) were analysed for the fraction 
of bound DNA and binding curves were fitted using a single site 
binding model in the program Scientist (MicroMath Scientific 
Software).  The DNA concentration was fixed at 900 nM and the 
total protein concentration was used with the dimerisation 
constant fixed at 1.6 μM. 
A 
B 
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Protein 
OM OL 
KD 
(μM) 
Error 
(μM) 
KD 
(μM) 
Error 
(μM) 
Wild 
type 
0.22 ±0.03 0.52 ±0.04 
S52A 0.61 ±0.20 1.8 ±0.2 
Table 3.1 Experimental KDs from single site EMSA’s.  Values 
were obtained by least squares fitting to the data shown in Figure 
4.10  using Scientist (MicroMath Scientific Software) with a 
fixed protein dimerisation constant of 1.6 μM (as determined by 
Ball et al. (2012)).  Errors are calculated as standard deviation 
from the fitted curve to the data which give a maximum and 
minimum value. 
85 
 86 
 
3.3.2 EMSA analysis of base binding mutants 
The C.Esp1396I mutants R46A, R46H and T46A were analysed for DNA binding 
potential against the OM and OL operator sites (Figure 3.9).  Due to its insoluble and 
unstable nature, R46H proved to be unsuitable for EMSAs.  The R46A mutant, although 
stable and soluble to concentrations in excess of the maximum 7200 nM used here, 
showed no interaction with DNA at all tested concentrations and conditions.  The free 
DNA band remained constant even at a ratio of 8:1 protein:DNA.  This would indicate 
that R46 is vital for complex. 
The T36A mutant displayed a limited ability to interact with both of the operator sites 
tested here.  No clear dimeric complex was observable with the OM operator until a 
protein:DNA ratio of 8:1 where there was a 100 % shift in the DNA away from the free 
state.  An approximately 50 % reduction in free DNA was observed at 3600 nM protein 
(4:1 protein:DNA).  In the OL EMSAs a very slight reduction in the free DNA can be 
observed (~40 % bound DNA at 8:1 protein:DNA) but no clear complex species were 
visible on the gel. 
All of the KD values obtained from the EMSA experiments were an order of magnitude 
higher than those reported by Ball et al. (2012), which were obtained using SPR 
experiments.  Also, only the S52A mutant proved to be reliable in EMSA analysis for 
both the OM and OL operator sites.  Therefore SPR was used to determine more accurate 
KD values as much lower protein concentrations can be used due to the greater degree of 
sensitivity. 
3.4 Surface Plasmon Resonance 
In order to characterise the C.Esp1396I interactions more quantifiably and precisely, 
SPR on the single operator sites OR, OL and OM was employed (Figure 3.12).  
Modelling a two site ligand (two C.Esp1396I dimers per DNA duplex) using SPR is less 
reliable than single sites and the mutants presented in this thesis are not designed to 
probe the nature of the cooperativity in the OL+R repression complex.  As with the 
EMSAs, the R46H mutant was insoluble in the SPR running buffer even at the 
relatively low concentrations used for SPR (Appendix A1).  
 
 
Figure 3.12 Biotinylated DNA  for SPR experiments.  The 
three individual operator sites OM, OL and OR were synthesised 
with a 5’-Biotin molecule attached to one of the complementary 
strands.  The conserved GT is shown in cyan, the GAC/GTC “C-
box” in yellow and the conserved TATA in bold. 
OM:  5’-Biotin-TGCCATGTAGACTATAGTCGACAAGC 
               ACGGTACATCTGATATCAGCTGTTCG 
 
OL:  5’-Biotin-TGCCATGTGACTTATAGTCCGTGAGC 
               ACGGTACACTGAATATCAGGCACTCG 
 
OR:  5’-Biotin-TGCCGTGTGATTATAGTCAACATAGC 
               ACGGCACACTAATATCAGTTGTATCG 
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3.4.1 Determining the binding constants for the C.Esp1396I mutant proteins 
In order to determine the binding constants (KD) the total protein concentrations used 
for the SPR experiments had to be corrected to account for the dimerisation constant 
(Kdim) of C.Esp1396I.  The Kdim was found by Ball et al. (2012) to be 1.6 μM and this 
value was used throughout for both the wild type and mutant proteins.  Total dimer 
concentration [D] can be calculated as a function of total protein concentration [T] as 
determined by UV spectroscopy and the monomer extinction coefficient (Table 2.1, 
Chapter 2): 
[ ]   
( [ ]          √    (      [ ]))
 
 
(Equation 3.8) 
Description of the derivation of the equation is shown in Appendix A1. 
The binding constants were calculated using the BiaEval software (V 2.0.2, Agilent) 
using a 1:1 steady state model: 
       (
[ ]
[ ]     
) 
(Equation 3.9) 
where [A] is the analyte concentration (the independent variable), Rmax is the theoretical 
maximum RU (all possible ligand sites occupied by analyte) and R is the offset of RU.  
Multiple analyte concentrations can be used to generate a binding curve from which the 
KD can be calculated. 
Due to the inherently weak binding of the mutant proteins, only interactions with the 
OM operator site produced reliable, reproducible data and as such will be the only 
operator site discussed in this section.  Wild type C.Esp1396I was used as a control in 
these experiments and compared to the values reported by Ball et al. (2012).  The wild 
type gave very similar values for the KD (0.51 nM reported here and 0.61 nM for Ball et 
al. (2012)) and therefore the DNA duplexes used for the SPR experiments were deemed 
to be comparable (Figure 3.12). 
 
Figure 3.13 Example SPR data.  Graphical display of four SPR 
curves from experiments using C.Esp1396I mutants and the OM 
operator site.  The proteins were injected at a total protein 
concentration of 200 nM for 30 seconds (association phase).  The 
protein then dissociates (dissociation phase) for the remainder of 
the sensogram.   
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The range of dimer concentrations used for the SPR experiments ranged from 0.2 nM to 
17 nM (20-200 nM total protein) and all except two of the mutant proteins, T36A & 
T49A, were shown to interact with the OM operator site within this concentration range.  
Further experiments increased the maximum dimer concentration to 210 nM (1000 nM 
total protein) but still no interactions were observed with those mutants.  The Y37F 
mutant showed the strongest interaction with the OM site after the wild type followed by 
S52A, Y37A and then R46A (Figure 3.14 and Table 3.2): 
Wild type > Y37F > S52A > Y37A > R46A > T36A = T49A 
The KD for the R46A mutant was ~30 fold greater than that of the wild type suggesting 
a relatively weak complex with the OM operator site.  The KD for the S52A-OM 
interaction was 5 fold higher than the wild type suggesting a complex that is much more 
readily formed compared to the R46A mutant.  They Y37A and Y37F mutants had KDs 
that were 11 and 3.5 fold higher than the wild type respectively.  The 3 fold difference 
between these two mutants indicates that the structure of the phenyl group is also 
important for complex formation and/or stability.  This is discussed in greater detail in 
the context of protein-DNA crystal structures in Chapter 5. 
The KDs determined by SPR can be used to calculate the Gibbs free energy (ΔG) of the 
interaction using the equation: 
          
(Equation 3.10) 
where R is the ideal gas constant (8.314 J/mol
-1
) and T is the temperature in Kelvin (298 
K for the SPR experiments).  The ΔG values are summarised in Table 4.2.  All of the 
values were negative indicating that the reactions were spontaneous.  The ΔΔG values 
can be calculated as the difference between two interactions.  These values give an 
indication of the free energy contribution of the missing amino acid side chains.  Two of 
these mutants, Y37F and Y37A, and their respective ΔΔG values, are discussed in 
Chapter 5. 
3.4.2 Kinetic analysis 
From the EMSA analysis (section 4.2) several residues were implicated in protein-DNA 
complex stability.  The SPR experiments allowed for observation of the dissociation 
phase of the complexes which directly relates to the stability of the complex (Figure 
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3.15).  Therefore, the 17 nM dimer concentration experiments (200 nM total protein) 
were analysed using the BiaEval software kinetics mode employing a 1:1 binding model 
to determine the dissociation rate (kd) for each mutant protein.  Kinetic analysis could 
only be performed during the dissociation phase of the SPR experiments as the ka 
(association rate) was outside of the instrument’s measurement limits for all the 
mutants; i.e. the association rate was too quick.  The detection limits of the BIAcore T-
100 are 10
3
 – 107 M-1s-1 for ka and 10
-5
 – 0.5 s-1 for kd, as described in the BIAcore T-
100 user manual.  The curve fitting including the association phase produced small Chi
2
 
values (<5) and errors in the ka up to 1000 fold lower than the predicted values but the 
errors in the KD were greater than those determined using the equilibrium analysis. 
The analysis (summarised in Table 3.3) showed a vast range of dissociation rates for the 
mutant proteins.  The kd of wild type C.Esp1396I was shown to be 0.063 s
-1
 and the 
only complex which appeared more stable than that was the R46A-OM complex which 
had a kd of 0.012 s
-1
.  As an R46A protein-DNA complex was not observed during the 
EMSA experiments (which were conducted at much higher concentrations), the Rmax 
was very small (~20 RU) and the due to the rate measurement limits of the BIAcore T-
100 this value may be inaccurate.  However if all of the R46A-OM SPR data is used (the 
full range of protein concentrations) for the analysis, the kd remains the same with a 
much lower Chi
2
 value of 0.18 indicating that this value is accurate.  The errors for the 
kd of R46A-OM were also 10 fold smaller than the value given. 
The other three C.Esp1396I mutants, Y37A, Y37F & S52A, all showed dissociation 
rates much quicker than that of the wild type.  The S52A mutant had a kd of 0.283 s
-1
 
with the OM operator site which would suggest that the S52A-OM complex dissociates 
~4.5 fold faster than the WT-OM complex.  The kd value for the Y37F mutant was 
similar to that of the S52A mutant at 0.248 s
-1
.  This is unsurprising as both of these 
residues interact with the same phosphate group on the DNA backbone of the operator 
site and are therefore likely to affect the complex in a similar manner.  However, the 
Y37A mutant had an ever greater kd at 0.578 s
-1
 which suggests that the phenyl group 
structure of the tyrosine at position 37 also affects the stability of the protein-DNA 
complex and not just the hydrogen bond between the hydroxyl group and the phosphate 
oxygen.  Together the KD and kd values allow for calculation of the kas (Table 3.3). 
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Protein KD (nM) 
Error 
(nM) 
Chi2 
ΔG (kJ 
mol-1) 
Wild 
type 
0.51 ±0.04 1.9 -53.0 
Y37F 1.8 ±0.26 7.2 -49.9 
S52A 2.6 ±0.45 4.8 -49.0 
Y37A 5.5 ±1.7 0.16 -47.1 
R46A 15.8 ±4.7 0.18 -44.5 
T36A N/D N/D N/D N/D 
T49A N/D N/D N/D N/D 
Table 3.2 Equilibrium SPR analysis of the C.Esp1396I mutant 
proteins against the OM operator.  Analysis of the SPR data 
using the 1:1 affinity model from the BiaEval software with the 
dimerisation constant of C.Esp1396I fixed at 1.6 μM to estimate 
the dimer concentration from the total protein concentration. 
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Protein kd (s
-1) Chi2 
Calculated 
ka (M
-1 s-1) 
Wild type 0.063 3.4 1.24 x 108 
R46A 0.012 1.1 7.59 x 105 
Y37F 0.248 2.8 1.38 x 108 
S52A 0.283 3.3 1.09 x 108 
Y37A 0.578* 1.0 1.05 x 108 
T36A N/D N/D N/A 
T49A N/D N/D N/A 
Table 3.3 Analysis of the dissociation and association rates of 
C.Esp1396I mutants interacting with the OM operator site.  
Analysis of the SPR data using the 1:1 kinetic model from the 
BiaEval software with the dimerisation constant of C.Esp1396I 
fixed at 1.6 μM.  From the experimental KD and kd values the ka 
can be calulated (ka = kd /KD).  * this value exceeds the maximum 
kd reliably detectable by the BiaCore T-100 of 0.5 s
-1.  The kd 
value for R46A is likely to be an error due to the shape of the 
sensogram resulting in a poor fit for the curve. 
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3.5 Discussion 
Although the experimental set up for the SPR experiments was not ideal for equilibrium 
analysis, meaningful values for the KD were able to be determined.  The mutant versions 
of C.Esp1396I clearly showed a reduced affinity for the native C.Esp1396I single 
operator sites as expected.  Aside from the T49A mutant, the mutations to those side 
chains involved in binding to the phosphate backbone at the compressed minor groove 
had a lesser effect on overall DNA binding than those mutations to base binding 
residues.  One of these mutants, Y37F, is discussed in more detail in Chapter 5 in terms 
of its structural properties when interacting with DNA. 
For the SPR experiments and the quantitative analysis of the EMSAs, the dimerisation 
constant (Kdim) was fixed at 1.6 μM as determined for the wild type protein by Ball et al. 
(2012).  The values for the mutant proteins could have differed from this value which 
would significantly also the calculated KDs.  However, the subsequent structural 
analysis described in Chapter 5 showed that the structure and hydrogen bonding 
network of the mutant proteins was identical to that of the wild type and all had very 
low (less than 1 Å) Root Mean Square Deviation (RMSD) values when compared to the 
wild type.  This would suggest that the Kdim would be very similar if not identical and 
therefore the values were not determined experimentally. 
The base binding mutant, T36A, showed no interaction with DNA during SPR 
experiments but a very slight shift could be seen in the EMSAs with OM.  This is likely 
due to the protein concentrations used during the EMSA analysis being much greater 
then used in the SPR experiments, indicating that T36A forms an extremely weak 
complex with DNA.  These higher concentrations could not be used for SPR as the 
proteins were far less soluble in the SPR running buffer. 
Contrary to T36A, the R46A mutant was shown not to interact with the DNA in the 
EMSAs but when the much more sensitive SPR technique was applied, R46A was 
shown to interact with the OM operator site, albeit weakly.  It was previously observed 
that an R35A mutant version of C.Esp1396I did not interact with the OL+R operator in 
EMSA experiments (McGeehan et al., 2008) (Figure 1.17 B).  Also when the wild type 
protein was subjected to EMSA analysis on the OR operator site alone, no shift in the 
DNA was observed but SPR did yield good data and a KD for the interaction.  This 
could be due to SPR detecting non-specific protein-DNA complexes (as observed in the 
19OR co-crystal structure discussed in Chapter 6) as well as fast, transient complexes.  
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The R46A mutant was observed to have a very fast kd, approximately 5-fold higher than 
the wild type, indicating that the complex was very unstable which could have resulted 
in the appearance of only free DNA in EMSAs as the protein readily dissociated thus 
giving the appearance of no binding. 
The three residues that were mutated which interact with the phosphate groups retained 
the ability to bind to the DNA operator sites, except for T49A which showed no 
interaction by either EMSA or SPR.  The T49A mutant was prone to aggregation and 
was the only mutant (besides the insoluble R46H mutant) not to form protein crystals 
(Chapter 3).  The S52A mutant showed clear binding in both the EMSA and the SPR 
experiments and the SPR gave a KD of 2.6 nM for the OM site.  This is approximately 
five fold weaker than the wild type KD of 0.51 nM.  Despite observing a clear shift in 
the EMSAs with the OL site in isolation, S52A was not shown to bind to OL up to 210 
nM dimer.  When a shift was observed in the S52A-OL EMSAs, the dimer concentration 
was in excess of 1000 nM (3600 nM total protein) and analysis of the EMSA gave a KD 
of 610 nM, implying a weak complex.  Due to all C.Esp1396I mutant proteins being 
less soluble in the SPR running buffer (than buffers used for other biophysical analyses: 
section 1.1) it was not possible to test these concentrations to determine a KD for this 
interaction using SPR. 
The two Y37 mutants, Y37A and Y37F both showed reduced DNA binding in both the 
EMSA and SPR experiments.  The Y37A-OM interaction was clearly much weaker than 
the Y37F-OM interaction as they had KDs of 5.5 and 1.8 nM respectively (SPR results).  
The Y37F mutant appears to form much more stable complexes than the Y37A mutant 
as very few clear complexes were visible for the Y37A mutant compared to the Y37F 
mutant in the EMSA experiments.  This was verified by comparing the dissociation 
rates for the Y37A- and Y37F-OM complexes using SPR which showed that Y37A 
dissociated from the DNA at more than twice the rate of Y37F.  Together these two 
mutants suggest that for Y37 the phenyl group of the side chain is also important for 
stable DNA binding and not just the hydrogen bond formed between the hydroxyl and 
the phosphate group.  The structural bases of this can be seen in the Y37F-19OM co-
crystal structure discussed in Chapter 5 
The calculated ka values presented in Table 3.3 were all very similar.  As all of the 
proteins were run at the same speed and temperature, the only affects on ka would be 
due to the mutations themselves.  These vales would indicate that complex formation 
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has been unaffected by the mutations, something that is observed in the mutant co-
crystal structure presented in Chapter 5. 
The two techniques used in this chapter to investigate the DNA binding of the mutants, 
EMSA & SPR, gave both quantitative and qualitative results regarding the protein-DNA 
interactions, although the degree of accuracy varied greatly.  The EMSA experiments 
could be performed at much higher concentrations due to increased protein solubility in 
the buffers used.  The complexes were also formed in solution prior to electrophoresis 
which is a much more biological representation of the interactions than those observed 
in SPR where the DNA is fixed onto a surface which could affect the flexibility of the 
DNA or cause steric hindrance if the loading of DNA on the chip is too high.  However, 
SPR is an extremely sensitive technique which can give quantitative values for 
inherently weak complexes that cannot be resolved using an EMSA; i.e. a “smeary” gel.  
Also, due to EMSA relying on the fluorescence of a fluorophore covalently attached to 
the DNA, the concentration of DNA had to be relatively high to be visible 
(approximately 100 nM DNA determined by a dilution series of HEX-labelled DNA run 
on an 8 % polyacrylamide gel).  Of course SPR also has its limitations as the BIAcore 
T-100 has a limited range for accurate measurements for the association and 
dissociation rates.  The association phase of the C-protein-DNA experiments was 
several orders of magnitude faster than the instrument could reliably detect which 
means that the interactions were not suitable for full kinetic analysis and the equilibrium 
method had to be used. 
Although the KD for the wild type OM interaction determined by SPR was similar to that 
reported by Ball et al. (2012) the kd was markedly different.  This is likely to be a result 
of the DNA constructs used for the SPR experiments as those used by Ball et al. were  
longer (35 bp compared to 26 bp used in this study) and simply contained mutated sites; 
such as a 35 bp OL with a randomised OR site. 
These results significantly add to the understanding of the overall mechanism for 
C.Esp1396I-DNA binding by elucidating the importance of individual residues involved 
in complex formation and stability.  Although distortion of the DNA is necessary for the 
formation of a stable C-protein-DNA complex, those residues that are involved in 
inducing or stabilising this distortion appear to be of less importance to the complex 
formation then the residues which interact directly with the DNA bases that constitute 
the C-box. 
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Chapter 4: Structural analysis of C.Esp1396I wild 
type and mutant proteins 
4.1 Introduction 
The native free protein structure of C.Esp1396I was previously determined by X-ray 
crystallography to a resolution of 2.8 Å (Ball et al., 2009).  This model revealed a high 
degree of flexibility in the loop between helices 3 and 4, which contains several key 
DNA binding residues that have been mutated in this study.  In order to ascertain the 
effects of the mutations on the overall structure of the protein, and more specifically the 
flexible loop, several of the mutant proteins were crystallised in order to obtain high 
resolution structural data.  These were then compared to the published wild type 
C.Esp1396I structure as well as a new, high resolution wild type structure described in 
this chapter.  
Despite the mutations all being alterations to single amino acids, mostly alanine 
substitutions, each mutant protein behaved uniquely during crystallogenesis and as such 
presented a wide array of space groups, unit cells and crystal packing interactions.  The 
new wild type crystal structure showed a clear dependence upon a sulphate ion for 
crystal packing interactions between the dimers.  Therefore all further crystal trials were 
conducted in the presence of sulphate.  This yielded seven free protein crystal structures 
for analysis in the resolution range between 1.4 and 2.0 Å. 
All refined structures presented in this thesis were deposited in the Protein Data Bank 
(PDB, http://www.rcsb.org/pdb/home/home.do) with the accession codes: 
 4I6R – C.Esp1396I    wild-type free protein(triclinic) 
 4I6T – C.Esp1396I-T36A   free protein 
 4IA8 – C.Esp1396I-Y37A             free protein 
 4I6U – C.Esp1396I-Y37F   free protein 
 4F8D – C.Esp1396I-R46A   free protein (cubic space group) 
 4FBI – C.Esp1396I-R46A   free protein (trigonal space group) 
 4FN3 – C.Esp1396I-S52A   free protein 
 4IWR – C.Esp1396I-25OL  nucleoprotein complex 
 4I8T – C.Esp1396I-19OR   nucleoprotein complex 
 4IVZ – C.Esp1396I-Y37F-19OM  nucleoprotein complex 
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4.2 Crystallography theory 
In order to determine the 3-dimensional (3D) atomic structures of macromolecules the 
X-ray portion of the electromagnetic spectrum is utilised.  The wavelengths at this end 
of the spectrum are approximately the distances between covalently bound atoms, 0.9 - 
1.5 Å.  Atoms are composed of nuclei, containing protons and neutrons (except 
hydrogen which only contains a single proton) and orbiting electrons.  The X-rays 
interact with the electrons within the molecules and are subsequently diffracted in very 
specific directions as described by Bragg’s law (section 5.2.3).  In order to amplify the 
diffraction from a molecule, the molecule can be crystallised. The process of 
crystallisation forces multiple, identical molecules into a regular, repeating lattice.  The 
process of diffraction, as opposed to refraction, removes the phase information from the 
diffracted light.  Once the phases of the diffracted X-rays can be determined then an 
electron density map can be generated through a Fourier transform of the diffraction 
data.  Limits on X-ray power and the detection of diffraction require crystals to be 
grown as the signal from a single molecule would be insufficient but free-electron lasers 
with high-speed detectors are opening up the possibility of using micro-crystals 
4.2.1 Macromolecular crystallisation 
The process of crystal growth can be described in three steps: nucleation, growth and 
the cessation of growth (Figure 4.1).  The most common method of achieving 
crystallisation of macromolecules, and the method used in this thesis, is vapour 
diffusion (Figure 4.2).  Vapour diffusion allows for the continuous but controlled 
increase in protein concentration in an environment containing other components 
conducive to nucleation and/or crystal growth.  Proteins, being biological in origin, 
must maintain their biological fold during the crystallisation process otherwise the data 
collected would be of limited or no scientific value.  Therefore protein crystallisation 
conditions are often buffered to maintain a specific pH in which the protein of interest is 
stable. The buffers used for macromolecular crystallisation also often contain salts 
and/or precipitant molecules that do not affect the protein fold directly but are necessary 
for crystallisation. 
The process of vapour diffusion for protein crystallisation involves mixing a highly 
concentrated, stable and pure protein solution with a crystallisation buffer and then 
creating a sealed micro-environment which also contains a separate reservoir of 
undiluted crystallisation buffer. 
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Undersaturated 
Metastable 
Labile 
(Nucleation) 
Precipitation 
Figure 4.1  Crystallisation phase diagram.  The red arrows 
show the progress of crystallogenesis and crystal growth in a 
vapour diffusion experiment.  Initially the protein and precipitant 
concentrations increase as the crystallisation drop reaches 
equilibrium with the reservoir.  This leads to a nucleation event.  
Protein concentration in the solution then dramatically drops as 
the crystal grows. 
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Hanging-drop 
Vapour 
diffusion 
Sitting-drop 
Vapour 
diffusion 
Micro-
batch 
under oil 
Micro-
dialysis 
Free 
interface 
diffusion 
Figure 4.2  Methods of growing protein crystals.  A & B:  Both 
vapour diffusion methods rely on gradually increasing the protein 
concentration in a favourable solution.  C: Micro-batch 
experiments can either rely upon the diffusion of water through 
the oil to increase protein concentration similar to vapour 
diffusion or simply rely upon the buffer conditions used to form 
crystals without the concentrating step.  D:  Micro-dialysis results 
in a change of buffer conditions that the protein is stored in 
without altering the protein concentration.  A change in 
conditions can lead to crystallogenesis.  E:  Free interface 
diffusion creates a gradient of protein concentration and 
precipitant concentration along a micro capillary.  (Adapted from 
Rupp, 2009) 
B A D C E 
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Over time, the water vapour diffuses from the lower concentration solution in the 
protein-buffer drop until, at equilibrium, the concentration of the buffer and precipitant 
components are equal, while the protein concentration in the drop has increased, 
hopefully yielding crystals.  In practical terms this is often carried out using specially 
made plastic trays that contain multiple wells which can be individually sealed.  The 
protein-buffer solution is either placed on a platform above the reservoir (sitting drop) 
or on the cap/coverslip used to seal the well (hanging drop) (Figure 4.2 A and B). 
Currently successful crystallisation conditions for a protein cannot be predicted.  
Therefore sparse matrix screening is employed in order to cover as much of 
crystallisation space as possible.  Crystallisation space can be seen as a 
multidimensional space where all possible crystallisation conditions (variations of 
buffer, pH and salt) are covered.  In practical terms a novel protein could potentially be 
screened for crystallisation in hundreds, or even thousands, of buffer conditions as well 
as varying temperatures and protein concentrations.  A logical approach can be applied 
to this method of screening based upon the properties of the protein undergoing 
crystallisation trials.  Once a condition has been found using sparse matrix screening, a 
focus screen is often employed which varies specific conditions systematically in order 
to optimise the crystallisation and possibly promote the formation of larger or more 
stable crystals.  Small molecule “additives” can also be used to increase the X-ray 
diffraction potential of protein crystals.  These additives are often small molecules that 
interact with the protein surface.  This can be especially relevant in the case of enzymes 
where substrates, products, co-factors or inhibitors can be used. 
4.2.2 Macromolecular crystal properties 
Crystalline material consists of repeating units arranged into 3D lattices.  These 3D 
lattices are formed from individual unit cells, repeated in three dimensional space. The 
unit cell can (and usually does) contain more than one asymmetric unit (ASU), the basic 
structural unit that contains no (crystallographic) symmetry elements (Figure 4.3).  In 
3D space there are 14 possible Bravais lattices which, when combined with the 32 point 
groups, result in all the possible 230 crystallographic space groups (Figure 4.4).  Space 
groups describe the symmetry of a crystal and derive their notation from a series of 
properties including (where present) the centring of the Bravais lattice, screw axes, 
rotation axes and (for chiral molecules), mirror planes and glide planes.  For example, 
the space group P21 is a primitive lattice with one screw axis (the “21”) and no rotation 
 104 
 
axes.  The 21 screw axis describes the rotation of the asymmetric unit 180 ° around an 
axis and translation of half a unit cell along the same axis.  Protein, DNA or 
nucleoprotein complex crystals can only form in 65 out of the possible 230 space 
groups due to their inherent chirality.  Each unit cell is defined by six numerical 
parameters: the lengths of the three cell edges (a, b and c) and the angles of the three 
vertices (α, β and γ).  Each unit cell vertex describes a point of the crystal lattice.  An 
infinite number of regularly spaced planes can be drawn through these lattice points and 
are described using the Miller Indices hkl (Figure 4.5).  Bragg’s Law is a description of 
how these planes can be thought of as reflective planes for X-rays and can be used to 
understand the patterns of X-ray diffraction from a crystal (section 4.2.3). 
  
A 
B 
Figure 4.3  The crystallographic unit cell and asymmetric 
unit.  A:  The crystallographic unit cell can be described using 
six parameters; a, b & c are used to describe the length of the cell 
edges and α, β & γ are used to describe the internal angle of the 
vertices.  B:  Each unit cell can be composed of multiple 
asymmetric units.  (Adapted from Rupp, 2009) 
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Figure 4.4  Crystallographic symmetries.  Names of the 
different possible crystal symmetries and their unit cell 
characteristics based on Bravias lattices. (Adapted from Rupp, 
2009) 
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Figure 4.5 Miller indices.  Miller indices are the basis of Bragg 
planes within a crystal.  Each Miller index can be described by 
three integers; h, k & l. (Adapted from Rupp, 2009) 
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Twinning can occur in protein crystals when two individual parameters, unit cell, space 
group etc., associate in the same crystalline phase.  The twinning fraction, α, can be 
described as: 
   , untwinned 
     
 
 
, partially twinned 
   
 
 
, a perfect twin 
The “Twin Law” of the crystal can be used to “de-twin” the data prior to refinement.  
Partially twinned crystals can be de-twinned by taking two intensities (I) related by the 
twin law and solving them as simultaneous equations.  Perfect twins have to be de-
twinned using the calculated intensities (Icalc) instead.  However, these only work when 
dealing with hemihedral twins.   Epitaxial twins can be more simply separated as the 
lattices cannot be superimposed. 
4.2.3 Bragg’s Law 
William Lawrence Bragg was able to calculate the geometry of X-ray diffraction from a 
crystal in terms of X-ray “reflections” from the previously described planes within a 
crystal lattice (Figure 4.6).  Bragg’s Law describes X-ray diffraction from equivalent 
parallel planes within the crystal and how each of these planes must be separated by an 
integral number of wavelengths to produce a diffracted beam of X-rays.  The inter-plane 
spacing, described as dhkl, will only produce a diffracted beam at a specific angle of 
incidence (θ) where the path length difference (2d sin  ) of the diffracted X-rays from 
successive planes is equal to an integer (n) multiplied by the wavelength (λ). 
             
(Equation 4.1) 
Each diffracted beam of X-ray has an intensity related to that of the electron density of 
the set of planes that produced it.  Therefore each spot, or “reflection”, within a 
diffraction pattern contains information about each of the atoms within the unit cell.  
Each reflection can be designated an index corresponding to the planes that produced it. 
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1/λ 
Figure 4.7 The Ewald Sphere.  The Ewald sphere is a geometric 
construction of a sphere with radius 1/λ.   The crystal (grey cube) 
is at the centre of the sphere. (0,0,0) is the lattice origin which 
will give rise to the reflections on the detector at points along the 
surface of the Ewald sphere 
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4.2.4 Reciprocal space 
Reciprocal space or the Reciprocal lattice is a term used when describing the Fourier 
transform of the real space crystal lattice.  As these lattices are perpendicular to the real 
space lattices within the crystal they have an inter-plane spacing of 1/dhkl.  The unit cell 
edges of the reciprocal lattice are also described as reciprocals of the unit cell of the 
crystal (1/a, 1/b etc.).  Therefore a small unit cell in reciprocal space means a large unit 
cell in real space and vice versa.  If we apply Bragg’s Law in reciprocal space and 
construct the Ewald sphere, the direction of a diffracted beam can be predicted.  The 
Ewald sphere describes the vector of the incident & diffracted X-ray beams and the 
diffraction angle for a given reflection (Figure 4.7).  When a reciprocal lattice point 
intersects the Ewald, sphere a reflection is produced.  This reflection occurs at the angle 
between the incident wave and the line between the centre of the sphere and the 
intersecting lattice point.  Therefore the resulting positions of the reflections within a 
diffraction pattern are directly related to the unit cell dimensions. 
4.2.5 Electron density 
Electron density describes the probability of an electron being present at a specific 
location.  In X-ray crystallography, electron density maps are calculated as a Fourier 
transform of the structure factors (Fhkl) obtained from the X-ray diffraction data. 
However, it is only the intensities Ihkl that are observed (where Ihkl = |Fhkl|
2
) and the 
phases cannot be measured. Electron density, or ρ, can be described as a 3D wave 
consisting of three frequencies (h, k and l) in the x, y and z directions with a structure 
factor, Fhkl and a phase Φhkl.  At any specific point, ρ(x, y, z) the electron density can be 
described as the Fourier sum: 
          
 
 
          
                      
   
 
(Equation 4.2) 
4.2.6 Macromolecular X-ray diffraction data collection 
X-ray diffraction data collected from crystals requires highly focused monochromatic 
X-ray beams with a high flux.  Biological molecules often suffer from radiation-induced 
damage due to the high X-ray flux from sources such as synchrotrons.  The radiation 
damage results in a loss of diffraction, which reduces the resolution of the final 
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structure. As a consequence of radiation damage, there is often a reduced lifetime of the 
crystal in the beam.  One way of mitigating radiation damage is to cool the crystals to 
100 K prior to data collection using nitrogen gas.  Hydroxyl radicals are a common 
source of secondary radiation damage to protein crystals but they are not mobile at 
temperatures <100 K.  However, due to protein crystals containing large percentages of 
water (25 - 75 %) the cooling process can result in the formation of water ice which 
diffracts X-rays strongly and can contaminate the diffraction pattern.  The formation of 
the water ice crystals can also physically damage the protein crystal causing it to crack 
and possibly shatter.  Therefore the crystals must be grown in, or transferred to, a 
solution that prevents the formation of water ice.  A common molecule used for cryo-
protection is glycerol, which prevents the formation of water ice by competing with 
other water molecules for hydrogen (H) bonds. All the X-ray diffraction data presented 
in this thesis was collected at ~100 K and therefore a wide range of cryo-protectants 
were used. 
4.2.7 Measuring diffraction data quality 
Several metrics can be applied to the collected X-ray diffraction data to assess the 
quality of the data in different resolution shells.  One very simple metric is the 
completeness of the resolution shell in question, which can be affected by diffraction 
properties such as anisotropy.  Another metric compares the mean signal-to-noise ratio 
of resolution shells, I/σ(I).  This is an arbitrary measure as no standard has yet to be 
devised but a value greater than 2 in the highest resolution is considered to be 
acceptable.  Currently the most common metric for judging data quality is the R-factor;  
Rmerge.  The formula for Rmerge is: 
        
              
        
 
(Equation 4.3) 
where Ihi refers to an individual observation (after scaling) and h is the weighted 
average of symmetry-related or replicate observations of a single reflection.    Rmerge can 
be used as a general term to describe Rint; merging identical intensities, Rsym; for 
merging of symmetry-related reflections, Rcryst; for merging between different crystals 
and Ranom; for merging Friedel pairs with anomalous signal.  However, these R-factors 
are affected by the redundancy, or multiplicity, of the dataset where data with lower 
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multiplicity appear better in quality then those with a high multiplicity.  The multiplicity 
describes how many times a single unique reflection is measured during the data 
collection and has therefore been scaled.  Therefore the formula is altered and this R-
factor is given the name Rmeas or Rr.i.m (redundancy independent merging): 
            
  
  
    
 
 
  
           
 
    
      
 
(Equation 4.4) 
where n is the multiplicity of the data.  Recently Karplus and Diederichs assessed the 
use of R-factors for measuring data quality and stated that a potentially large portion of 
higher resolution data was being disregarded to meet the criteria of these formulae and 
that a new metric should be introduced based on the Pearson correlation coefficient 
(CC) (Karplus and Diederichs, 2012).  Their method essentially splits the data set 
arbitrarily in half (CC1/2) and derives a relationship between this measure and the CCtrue, 
the true level of signal at a given resolution shell.  The relation between CCtrue and CC1/2 
is 
      
    
  
      
  
 
(Equation 4.5) 
where CC* is an estimate of CCtrue based on a finite sized sample.  Both Rmerge and 
CC1/2 values are reported in this thesis where calculated. 
4.2.8 The phase problem 
In order to solve the structure of a molecule by X-ray crystallography the phases of the 
diffracted X-rays need to be determined.  The two most common methods currently 
used for phase determination in macromolecular crystallography are anomalous 
dispersion experiments and more often molecular replacement.  All the structures 
presented in this thesis were solved by molecular replacement and as such only this 
method will be discussed in detail. 
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Molecular replacement relies upon the existence of a “search model” which consists of 
structural coordinates from a molecule with a similar 3D structure.  In protein 
crystallography, this is often a homologue or variation of the “target model”, the novel 
structure needing to be solved, which has often been identified through primary amino 
acid sequence similarity.  The search models for molecular replacement can be 
individual structures, ensembles of homologue structures or a library of different 
structures or components that might form the asymmetric unit of the target model.  
Isomorphous molecular replacement relies upon the target model and search model both 
being in identical orientations within the same unit cell.  As this is rarely the case then 
non-isomorphous molecular replacement can be carried out where in the first step is 
reorientating the search model to match the unit cell composition of the target model.  
This is achieved through a six dimensional search involving three angles of rotation and 
three axes of translation.  There are two methods for obtaining a molecular replacement 
solution: the Patterson function or a maximum-likelihood approach.  The programme 
PHASER (McCoy et al., 2005) uses the maximum-likelihood method to determine the 
phases for X-ray diffraction data and was used for all the structures presented in this 
thesis. 
Maximum-likelihood is essentially a statistical method used for estimating the 
parameters of a statistical model.  In X-ray crystallography and phase determination, 
maximum-likelihood is used to model the differences between observed and calculated 
reciprocal space structure factors as Gaussian distributions using the central limit 
theorem.  The most likely rotation and translation functions are selected by calculating 
the probability that the calculated structure factor (Fc) gives rise to the observed 
structure factor (Fo).  When the search model and target models are not identical, then 
the phases determined by molecular replacement act as an estimate which can be 
improved through iterative refinement. 
4.2.9 Refinement and validation 
The estimated phases from molecular replacement and the intensities of the reflections 
provide a starting point for the calculation of an accurate real space electron density 
map.  The electron density map can be interpreted in real space and the coordinates of 
the atoms within the asymmetric unit can be refined manually using computer 
programmes such as COOT (Emsley and Cowtan, 2004).  The phases are improved by 
refining the position of each visible atom within the electron density map of the 
 115 
 
asymmetric unit.  The structure factor equation can be solved by summing the 
contribution of every atom within the unit cell to each reflection.  The structure factor 
equation is defined as:  
         
                
 
   
 
(Equation 4.6) 
where fj is the atomic scattering factor of the jth atom that has coordinates xj, yj, zj 
measured as a fraction of the unit cell edge constants.  Accurate and unbiased 
refinement of an electron density map requires the removal of bias introduced by over-
interpretation.  One way to achieve this is using a difference density map where the 
observed and calculated structure factor amplitudes are used as coefficients in the 
Fourier transform.  The most used difference map, the 2Fo – Fc is described by: 
          
 
 
                 
                     
   
 
(Equation 4.7) 
where the calculated phases, α, are provided either through phasing experiments or 
molecular replacement.  This produces a map with positive and negative electron 
density peaks.  Positive peaks indicate a lack of electron density in a given area and 
negative peaks indicate too much.  The practical interpretation of this map is that there 
should be an atom or multiple atoms in the positive density peaks and atoms need to be 
removed from any negative density peaks. 
As the model undergoes refinement, the measured and calculated structure factor 
amplitudes should converge.  The degree of convergence is measured using the R-
factor, Rwork.  An Rwork of zero would imply that the model matches the “real” structure 
perfectly, although this situation is never observed with genuine X-ray diffraction data.  
Another method to remove over-interpretation of the maps is to use a different R-factor 
called the “Rfree”.  The Rfree compares the refined model to a subset of unrefined data.  
Comparing the Rwork and Rfree factors gives an unbiased value of the interpretation of the 
electron density maps.  The formula for both Rwork and Rfree is: 
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(Equation 4.8) 
Validation of the model is important to avoid over-interpretation and remove the 
template model bias.  Several aspects of a structure can be analysed including: 
molecular geometries, interatomic bond angles/distances and overly large difference 
map peaks.  However, higher resolution protein structures often contain standard 
geometry outliers as the detail in the electron density map allows much more accurate 
placing of protein side chains and the backbone which can be under strain.   
4.3 Crystallography of the C.Esp1396I proteins 
4.3.1 Crystallisation and structure solution of wild type C.Esp1396I 
The previous free protein C.Esp1396I structure was solved using crystals that formed 
during a dialysis step of the purification and yielded relatively low resolution structures 
(2.8 Å).  In order to observe any structural alterations that might occur due to the amino 
acid mutations, a higher resolution free protein wild type structure needed to be 
determined. 
Unlike previous crystallogenesis using dialysis, all crystalline precipitant was removed 
and the wild type GSH-C.Esp1396I was concentrated to ~7 mg/mL and subjected to 
sparse matrix screening using the Cartesian Honeybee X8 crystallisation robot (Cronus 
Technologies).  The wild type crystallised in 0.2 M lithium chloride, 0.1 M Tris-HCl pH 
8, 20 % (w/v) PEG 6000 and 0.1 M sodium sulphate and formed cubic crystals with 
edges between 50 and 100 µm in length.  Crystals were transferred to a cryo-protectant 
solution of 33 % (v/v) glycerol prior to flash cooling in liquid nitrogen.  Diffraction 
experiments were performed on beamline I04-1 of the Diamond light source at 100 K.  
Complete data were collected on a Pilatus 2M pixel area detector to a resolution of 1.4 
Å.  The data were processed using MOSFLM (Leslie, 1992) and AIMLESS (Evans, 
2006, Evans, 2011) in the triclinic space group P1.  Molecular replacement was carried 
out using PHASER (McCoy et al., 2005, McCoy et al., 2007) with the published wild 
type structure (Ball et al., 2009)(3G5G) as a search model to reveal two monomers in 
the asymmetric unit.  Refinement was carried out using iterative cycles of refinement in 
Refmac5 (Murshudov et al., 1997) and model building 
Protein Crystallisation condition Cryo-protectant 
C.Esp1396I 
wild type 
0.2 M lithium chloride, 0.1 
M Tris-HCl pH 8, 20 % w/v 
PEG 6000 and 0.1 M sodium 
sulphate 
33 % v/v Glycerol 
C.Esp1396I 
T36A 
2.4 M sodium malonate pH 7 
and 0.1 M sodium sulphate 
12.5 % di-
ethylene glycol, 
12.5 % glycerol 
and 12.5 % 1,2-
propanediol 
C.Esp1396I 
Y37A 
0.2 M lithium sulphate, 0.1 
M sodium acetate pH 4.5 
and 50 % v/v PEG 400 
N/A 
C.Esp1396I 
Y37F 
0.2 M sodium acetate 0.1 M 
Bis Tris propane pH 8.5, 20 
% w/v PEG 3350 and 0.1 M 
sodium sulphate 
12.5 % di-
ethylene glycol, 
12.5 % glycerol 
and 12.5 % 1,2-
propanediol 
C.Esp1396I 
R46A 
(monoclinic) 
0.2 M sodium sulphate, 20 % 
w/v PEG 3350 
33 % v/v glycerol 
C.Esp1396I 
R46A 
(trigonal) 
0.1 M MIB buffer pH 9 and 
25 % w/v PEG 1500 
33 % v/v Glycerol 
C.Esp1396I 
S52A 
0.2 M sodium sulphate, 20 % 
w/v PEG 3350 
 
6.25 % di-
ethylene glycol, 
12.5 % ethylene 
glycol, 6.25 % 
MPD, 6.25 % 1,2-
propanediol, 6.25 
% glycerol and 
6.25 mM NDSB 
201 
Table 4.1  Crystallisation conditions and cryo-protectant 
buffers for C.Esp1396I and mutant free protein crystals.  
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WT T36A 
Y37A Y37F 
R46A S52A 
Figure 4.8  Crystals of C.Esp1396I and mutants.  Crystals 
grown in conditions described in Table 5.1.  The R46A crystal 
show here is that of the trigonal space group. 
200 μm 
200 μm 
200 μm 
200 μm 
200 μm 
200 μm 
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Figure 4.9 X-ray diffraction images from C.Esp1396I free 
protein crystals.  A:  A diffraction image from a C.Esp1396I 
wild type crystal in a triclinic space group.  Image taken at 
beamline I04-1 of the Diamond light source on a Pilatus 2M 
detector.  The edge of the detector is at 1.38 Å resolution.  B:  A 
diffraction image from a C.Esp1396I-R46A crystal in a 
monoclinic space group.  Image taken at beamline I02 of the 
Diamond light source on an ADSC Q 315r CCD detector.  The 
edge of the detector is at 1.5 Å resolution 
A 
B 
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in COOT (Emsley and Cowtan, 2004) to yield a final Rwork/Rfree of 14.9/18.2 %.  Data 
processing and refinement statistics are summarised in Tables 4.2 and 4.3 respectively. 
4.3.2 Crystallisation of the C.Esp1396I mutants 
Despite the mutant proteins precipitating as crystalline material during dialysis and/or 
cleavage of the hexahistidine purification tag, the purified proteins were filtered and 
then concentrated using a spin concentrator with a molecular weight cut off of 3350 Da 
until they began to show precipitation.  The concentration limit for each mutant was 
different, between ~6 and 14 mg/mL.  Each mutant protein was subjected to sparse 
matrix screening using the Cartesian HoneyBee X8 crystallisation robot (Cronus 
Instruments) and the crystallisation screens PACT Premier and JCSG
+
 (Molecular 
Dimensions Ltd.).  To improve the crystallisation of all the mutants, 100 mM sodium 
sulphate was added to the protein stocks prior to sparse matrix crystallisation trials in an 
attempt to replicate the observed sulphate dependent crystallisation with the high 
resolution wild type protein (section 4.3.1).  This resulted in protein crystallisation 
occurring in ~50 % of the conditions in both PACT and JCSG
+
 for all but one of the 
mutants, T49A (Figure 4.8).  The crystallisation conditions for each of the mutant 
proteins is summarised in Table 4.1. 
4.3.3 X-ray diffraction data collection and structure solution 
All of the free protein mutant crystals were transferred into cryo-protectant solutions 
(Table 5.1) prior to cryo-cooling in liquid nitrogen.  The diffraction data for each of the 
crystals were collected on the various macromolecular crystallography (MX) beamlines 
at the Diamond Light Source, Oxfordshire at 100 K (Figure 4.9).  All of the free protein 
crystals diffracted to beyond 2 Å resolution and the final structures ranged in resolution 
from 1.5 to 2 Å.  The data were either indexed & scaled with MOSFLM (Leslie, 1992) 
and SCALA or AIMLESS (Evans, 2006, Evans, 2011), or XDS and XSCALE (Kabsch, 
2010).  The structures of T36A and Y37A both presented high Rmerge values (>100 %) 
for the outer resolution shell during scaling.  However, when the higher resolution 
reflections were included, the electron density maps clearly improved.  Therefore, the 
CC1/2 metric was used to determine the highest resolution shell for these structures.  
Molecular replacement was carried out on all of the structures presented here using the 
original free protein wild type crystal structure (Ball et al., 2009)(3G5G) as the search 
model using the programme PHASER (McCoy et al., 2005).  Refinement was carried 
out using iterative cycles of model building in COOT 
Protein Wild 
Type 
T36A Y37A Y37F R46A R46A S52A 
PDB code 4I6R 4I6T 4IA8 4I6U 4F8D 4FBI 4FN3 
Space Group P1 P65 P1 P212121 C2 P32 C2 
Cell Dimensions: 
a, b, c (Å) 34.76, 
34.78, 
41.86 
65.45, 
65.45, 
72.29 
34.26, 
34.28, 
41.12 
48.61, 
81.85, 
135.08 
46.4, 51, 
74.6 
65.33, 
65.33, 
71.38 
46.59, 
51.32, 
74.38 
α, β, γ (°) 110.47,
105.6, 
96 
90, 90, 
120 
104.44, 
108.92, 
97.42 
90, 90, 90 90, 96.6, 
90 
90, 90, 
120 
90, 95.46, 
90 
Solvent 
content (%) 
37.2 40.1 37.2 37.5 36.1 36.33 36.51 
Monomers in 
ASU 
2 2 2 6 2 4 2 
Data Collection: 
Beamline DLS-
I04-1 
DLS-I04-
1 
DLS-I04-
1 
DLS-I04-
1 
DLS-I02 DLS-I04-
1 
DLS-I02 
Wavelength 
(Å) 
0.92 0.92 0.92 0.92 0.98 0.92 0.98 
Resolution (Å) 1.38 2 1.85 1.97 1.5 1.5 1.79 
No. measured 
reflections 
112030 130244 44469 527601 81886 128533 96678 
No. unique 
reflections 
29528 12474 11313 38881 27204 53279 30869 
Completeness 83.5 
(83.8) 
99.6 
(100) 
79.4 
(82.6) 
99.8 
(100) 
97.8 
(94.9) 
95.1 (97) 95.2 
(94.3) 
<I/(I)> 14.3 (4) 4.2 (1.1) 5.8 (1.5) 22.6 (6.7) 15.3 (3) 15.3 (3.9) 10.2 (3.2) 
Multiplicity 3.8 
(3.8) 
10.4 
(10.7) 
3.9 (4) 13.6 
(13.7) 
3.2 2.4 (2.4) 3.1 (3.2) 
Rmerge
† 4.3 (31) 41.8 
(238.9) 
11 (103) 8 (40.8) 4 (40) 3.4 (24.6) 6.5 (39) 
CC1/2
* 0.998 
(0.881) 
0.933 
(0.549) 
0.994 
(0.705) 
0.999 
(0.963) 
N/A 0.999 
(0.881) 
0.998 
(0.895) 
Table 4.2  Data collection and statistics from the C.Esp1396I 
and mutant free protein crystals.  Values in parenthesis are for 
the highest resolution shell. † Equation 5.5, * Equation 5.7. 
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Protein Wild 
Type 
T36A Y37A Y37F R46A R46A S52A 
Refinement Parameters: 
Rwork/ 
Rfree 
14.9/18.2 18.4/24.5 21.3/27.7 17.1/21.7 17.7/20 15.8/19.6 17.9/20.7 
No. atoms/B-factors (Å2) 
Protein 
1300/7.47 1312/28.3 1276/28.3 3797/23.2 1384/17 2750/15.4 1368/17.5 
Water 79/28.8 88/33.9 36/36.6 157/29.8 131/32.7 271/23.4 34/35.3 
Ligands 45/27.8 7/56.9 5/24.2 37/38.8 22/37.7 12/22.9 15/32.3 
R.m.s. Deviations from standard*: 
Bond 
lengths 
(Å) 
0.03 0.019 0.018 0.018 0.033 0.026 0.027 
Bond 
angles (°) 2.7 1.88 1.83 1.86 2.63 2.88 2.17 
Table 4.3  Refinement statistics from the C.Esp1396I and 
mutant free protein crystals.  * Standards from Engh & Huber 
1991. 
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(Emsley and Cowtan, 2004) and refinement in Refmac5 (Murshudov et al., 1997).  
Statistics for the data collection and refinement are presented in Table 4.2 and 4.3 
respectively.  
4.4 Analysis of the C.Esp1396I  Free Protein Structures 
Overall the new triclinic wild type and mutant free protein structures closely correlate to 
the original free protein structures presented by Ball et al. (2009).  The root mean 
square deviations (RMSD) between the main chain atoms of the structures presented 
here and the previous structures were <1 Å in all cases.  One obvious feature of these 
higher resolution structures was the presence of several water molecules that were seen 
to be interacting with the surface of the proteins (Figure 4.10).  The side-chain positions 
could also be placed with a higher degree of confidence and quite often more of the 
residues and polypeptide backbone were visible (Figure 4.11). Due to the mutants 
crystallising in multiple space groups and unit cell configurations the crystal contacts 
were mostly unique to each structure.  One key crystallisation contact in the majority of 
the structures in this chapter relied upon an SO4 molecule contacting symmetry related 
chains.  Despite other crystals only forming in the presence of SO4, the ion was not 
visible in the electron density maps (Figure 4.10).  The B-factors across the mutant 
structures are all fairly consistent with the C-terminus having the highest B-factors 
(Table 4.3). 
4.4.1 Analysis of the high resolution wild type C.Esp1396I structure 
The high resolution triclinic wild type structure presented in this thesis differs greatly in 
crystal contacts when compared to the previously described wild type structure 3G5G 
(Ball et al., 2009).  Tyrosine 29 (Y29) in either monomer in the asymmetric unit is not 
interacting with a symmetry related Y29 residue in manner observed in several 
C.Esp1396I crystal structures.  Instead the majority of the contacts are direct hydrogen 
bonds between side chains.  A large number of crystal contacts occur through the C-
terminal tail of C.Esp1396I and symmetry related chains.  This gives that normally 
flexible region a high degree of stability allowing the complete C-terminus up to the 
terminal carboxyl oxygen atoms (OXT) of both monomers in the asymmetric unit to be 
modelled.  The other primary crystallisation interface is centred on one of the SO4 ions.  
The SO4 ion essentially bridges the gap between symmetry related chains as in this 
region no direct protein-protein interactions occur (Figure 4.12). 
 
A 
E 
C 
F 
D 
B 
G 
Figure 4.10 Free C.Esp1396I and mutant crystal structures.  
A:  High resolution C.Esp1396I wild type, 4I6R.  B:  
C.Esp1396I-R46A, monoclinic space group, 4F8D.  C:  
C.Esp1396I-R46A, trigonal space group, 4FBI.  D:  C.Esp1396I-
S52A, 4FN3.  E:  C.Esp1396I-T36A, 4I6T.  F:  C.Esp1396I-
Y37A, 4IA8.  G:  C.Esp1396I-Y37F, 4I6U.  Mutation sites re 
indicated by red arrows, waters are shown as dark blue spheres, 
ligands as yellow spheres and crystallographically important 
sulphate groups as pink spheres.  Some ligand are labelled 
including glycerol (GOL), sulphates (SO4), sodiums (NA) and 
malonate (MLI).  Full lists of co-crystallised ligands can be found 
in the PDB. 
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N47 
Figure 4.11 Representative electron density map for 
C.Esp1396I.  A:  1.5σ, 2F0-Fc electron density map for residues 
R43 - N47 of the 1.4 Å resolution C.Esp1396I wild type crystal 
structure (4I6R).  B:  1.5σ, 2F0-Fc electron density map for 
residues R43 - N47 of the 1.5 Å resolution C.Esp1396I-R46A 
crystal structure (4F8D).  The arrows point to position 46, the 
mutation site 
A B 
R43 
A46 
N47 
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Figure 4.12 Coordination of the sulphate ion required for 
crystallogenesis.  Top  panel shows the asymmetric unit of the 
C.Esp1396I high resolution wild type X-ray crystal structure 
(4I6R) in orange with a symmetry related dimer in light orange.  
The sulphate ion is shown as pink spheres.  The zoom shows 
atoms hydrogen bonding directly to the sulphate including water 
molecules (dark blue spheres). Hydrogen bonds are shown as 
grey dashed lines. 
Q24 
R17 Q24 
R35 
E25 
126 
Figure 4.13 Position of the flexible loop of C.Esp1396I 
between helices 3 and 4.  A:  The three observed loop positions 
of free (not bound to DNA) wild type C.Esp1396I.  The low 
resolution C.Esp1396I loop positions from 3G5G are shown in 
light blue (major conformation, A) and light green (minor 
conformation, B) and the high resolution wild type loop position 
from 4I6R is shown in orange (C).  B:  The side chains of S45, 
R46 and N47 are displayed as sticks.  The helix shown in the 
figure is Helix the; the recognition helix. 
A 
B 
90° 
A 
C 
B 
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The flexible loop region identified by Ball et al. (2009) was not observed to be in either 
of the previously described conformations for the free protein.  Instead, the loop had 
adopted another, geometrically favourable position with an ~8 Å shift in the Cα of S45 
(Figure 4.13).  For clarity and later discussion the three know loop positions of free 
C.Esp1396I will be referred to as A (the major conformation from Ball et al. (2009)), B 
(the minor conformation from Ball et al. (2009)) and C (the newly described position). 
4.4.2 Mutant protein crystallisation contacts 
The SO4 based interaction observed in the high resolution wild type structure is also 
observed in the Y37A, S52A and monoclinic R46A mutant structures.  In fact, the 
Y37A crystal contacts are identical to those of the triclinic wild type structure.  This is 
not surprising as they have very similar unit cells and identical space groups, despite the 
differing crystallisation conditions.  Both the monoclinic R46A and S52A structures 
again show identical crystal contacts to that of the triclinic wild type but the space group 
and unit cell are different. 
The other three mutant structures are all unique in space group, unit cell and crystal 
contacts.  The Y37F structure shows the most similarity in terms of crystal contacts with 
the original free protein structures as Y29 in 4 of the monomers in the ASU stacks with 
a symmetry related Y29.  Despite Y37F and T36A only crystallising in the presence of 
SO4, neither of them appeared to require the molecule to mediate protein-protein 
contacts.  As with the high resolution wild type structure, the C-terminal tail is also 
involved in several crystal contacts with multiple monomers in the T36A, trigonal 
R46A and Y37F structures.  These structures also contain crystallisation contacts that 
include residues 46 and 47.  These residues are in the flexible loop region of 
C.Esp1396I and will therefore be mentioned in section 5.4.2. 
4.4.3 Comparisons of the flexible loop of C.Esp1396I 
One key observation from the original wild type C.Esp1396I structure and the multiple 
DNA bound structures is the ability of the loop between helices 3 and 4 (E42 – T49) to 
alter its conformation in both the free and DNA bound states.  As this loop contains 
multiple DNA base and backbone binding residues, its conformation is of interest with 
respect to the DNA binding potential of the mutant C.Esp1396I proteins.  The published 
C.Esp1396I wild type free protein structure (Ball et al., 2009)(3G5G) showed two loop 
conformations called the “major” (loop conformation A) and “minor” (loop 
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conformation B) conformations based upon their relative frequencies within the 
asymmetric unit of the crystal structure.  With the acquisition of the high resolution wild 
type data, this loop position was expected to be confirmed and refined.  However, this 
new data revealed a novel loop position, which will now be referred to as conformation 
C.  The movement of the Cα of residue 46 between loop conformations A and C is ~6 
Å, with the side chain moving in a much more exaggerated way but still in the allowed 
region of the Ramachandran plot (Figure 4.13).  This loop position also involves 
altering the hydrogen bonding network at the dimerisation interface by displacing the 
side chain of N47 with the backbone carbonyl oxygen of R46 (Figure 4.14).   
The T36A mutant structure was observed to adopt both loop conformations A and C 
within the asymmetric unit in equal proportions (Figure 4.15 A).  Position 36 is not part 
of the flexible loop region as is in fact near the N-terminal end of helix 3 and therefore 
the likelihood of a mutation at this position altering the loop conformation is minimal.  
Although the T36A crystal structure does make crystal contacts involving the flexible 
loop, the fact that the loop is adopting conformations observed in wild type structures 
indicates that the loop conformations observed in the T36A structure are not a 
crystallographic packing artefact.  In terms of crystal packing interactions, the Y37A 
crystal structure is identical to the triclinic wild type structure but clearly adopts loop 
conformation A in both monomers in the asymmetric unit (Figure 4.15 B).  The Y37F 
crystal structure has six monomers (three biological dimers) in the asymmetric unit 
(Figure 4.10 G).  Five of the monomers in the asymmetric unit are observed to be in 
loop conformation A but the sixth more closely resembles that of conformation B 
(Figure 4.13 E).  When compared to the DNA bound loop conformations, this minor 
position in Y37F is almost identical to that of the 19OM (Ball et al., 2012)(3UFD) bound 
protein and very close to one of the loop positions in the 19OL (McGeehan et al., 
2012)(3S8Q) bound protein (Figure 4.19).  Both of the R46A crystal structures and the 
S52A crystal structure have all adopted loop conformation C, despite the varying 
collections of conditions and crystallographic interactions in those three structures 
(Figure 4.13 C&D). 
  
Figure 4.14 Dimerisation contacts in the alternate loop 
conformations.  The high resolution wild type crystal structure 
(4I6R) is shown in orange (one monomer dark and one light) and 
the low resolution wild type is shown in silver (one monomer 
dark and one light).  The hydrogen bond is shown as a grey 
dashed line. 
R46 
N47 
R46 
N47 
K51 
K51 
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Figure 4.15 Position of the flexible 
loop of C.Esp1396I in the mutant 
crystal structures.  The three wild 
type loop conformations observed in 
3G5G and 4I6R are shown in the 
same colours as in Figure 5.13 and 
are translucent. A:  T36A loop 
positions shown in green.  B:  Y37A 
loop position shown in dark red.  C:  
Loops positions in both R46A 
structures shown in red (monoclinic 
space group) and purple (trigonal 
space group).  D:  Loop position of 
S52A shown in light green.  E:  
Observed loop positions in Y37F. 
C 
A B 
D 
E 
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Figure 4.16 Comparison of the loops in Y37F and DNA bound 
structures.  The two loop conformations observed in the Y37F 
free protein crystal structure (4I6U) are shown in blue.  The loop 
conformation from the 19OM (3UFD) co-crystal structure is 
shown in light grey and the two conformations observed in the 
19OL (3S8Q) co-crystal are shown in dark grey. 
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4.5 Discussion 
The high resolution wild type C.Esp1396I structure presented here gives a much more 
detailed structural view of C.Esp1396I when not bound to DNA.  The improved 
resolution allowed for the placing of much more of the amino acid sequence as well as 
observations of alternative side chain conformations.  A large number of waters (79) 
were also clearly visible in the electron density, showing the hydration state of the DNA 
binding interface.  This is relevant as water displacement is a key step in DNA binding. 
Crystallisation of the mutant structures was originally intended to simply confirm the 
detailed structural integrity of the mutant proteins compared to that of the wild type.  
However, it was revealed that the flexible loop region of the protein is much more 
flexible than previously thought.  It is possible that the R46A mutation might lock the 
loop into a particular conformation (C) (Figure 4.13 C).  As the R46A mutant 
crystallised in two different space groups, six different monomers could be compared 
with varying packing interactions reducing crystallisation bias.  As the carbonyl 
backbone oxygen of residue 46 is involved in the alteration of the dimerisation 
interface, it is possible that the alanine mutation causes that novel position to be more 
favourable.  This loop position (C) contains side chain conformations that would be 
highly unfavourable for DNA binding.  If the R46A mutant does only exist in 
conformation C, then this would contribute towards the highly reduced DNA binding 
shown in Chapter 3.  High resolution solution NMR data may be able to shed more light 
on this structural alteration.  The only other loop position of note was that of the minor-
Y37F loop position which resembled a DNA bound conformation.  All together these 
free protein structures show the high degree of flexibility within the loop between 
helices 3 and 4 of C.Esp1396I.  They also show that despite the mutations the protein is 
intact and behaves in a very similar if not identical way to the wild type protein with the 
same dimerisation interface.  This is an important observation as an alteration to the 
dimerisation interface would likely alter the dimerisation constant (Kdim) which is a 
required factor when calculating the binding constants elucidated in Chapter 3. 
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Chapter 5: Structural analysis of C.Esp1396I-Y37F 
in complex with DNA 
5.1 Introduction 
The OM operator site is known to be the highest affinity sequence for binding of 
C.Esp1396I (Bogdanova et al., 2009, Ball et al., 2012).  A crystal structure of wild type 
C.Esp1396I in complex with an 18 bp DNA duplex containing the entire OM operator 
site with over hanging complementary bases was crystallised by Ball et al. (2012).  This 
structure, from here on referred to as WT-19OM, revealed the intricate nature of the 
protein-DNA interactions in this highly stable, high affinity repression complex as well 
as the distortion to the DNA pertaining to the operator site.  This distortion has been 
observed in all of the C.Esp1396I DNA-protein co-crystal structures to an almost 
identical degree including the 19OL and 35OL+R complexes (Ball et al., 2012, 
McGeehan et al., 2012, McGeehan et al., 2008).  Circular dichroism experiments and 
in-gel assays of C-proteins interacting with their DNA operator sites showed that DNA 
distortion and bending occurs in solution and is therefore not a result of crystal packing 
interactions (Bogdanova et al., 2009, Papapanagiotou et al., 2007).  Chapter 6 of this 
thesis discusses the nature of the DNA bending in greater detail. 
In order to determine whether the C.Esp1396I mutants generated in this study could still 
bind to and distort DNA in the manner previously observed, crystal trials were 
performed with the mutant proteins in combination with operator site DNA duplexes 
that had previously co-crystallised.  The Y37F mutant was successfully crystallised with 
the same DNA oligonucleotides used for the WT-19OM crystal structure.  This mutant 
was previously determined to have the highest binding affinity of all the mutant proteins 
tested (Chapter 3).  Analysis of this structure, from here on referred to as Y37F-19OM, 
allowed us to assess the role of this residue in DNA distortion and investigate the 
presence of subtle changes to the protein-DNA binding interface. 
5.2 Crystallisation, data collection and refinement 
5.2.1 Crystallisation and data collection 
Complementary DNA oligonucleotides containing the entire OM binding site as well as 
complementary overhanging bases to promote crystallisation, supplied by Eurogentec, 
were annealed at 80 °C, allowed to cool and duplexes were purified using PAGE. 
500 μm 
A 
B 
Figure 5.1 Crystallogenesis of C.Esp1396I-Y37F and the OM 
operator site.  A:  Co-crystal of the Y37F mutant of C.Esp1396I 
and the 18 base pair OM duplex with A-T overhanging bases to 
promote crystallisation (B).  C-boxes are underlined and the 
conserved central TATA in bold. 
5’-ATGTAGACTATAGTCGACA--3’ 
3’--ACATCTGATATCAGCTGTT-5’ 
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A 
B 
Figure 5.2 X-ray diffraction data collection of C.Esp1396I-
Y37F-19OM crystals.  A:  Crystal of Y37F-19OM mounted on 
beamline I04 of the Diamond Light Source at 100 K (scale bars 
100 μm).  B:  Diffraction image captured on an ADSC Q 315r 
CCD detector, 0.5 ° oscillation, 0.5 s exposure.  Detector edge at 
3 Å. 
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 (Figure 5.1 B) (section 2.6).  The Y37F mutant of C.Esp1396I was purified as 
described in Chapter 2 prior to protein-DNA complex formation.  The mutant protein 
was then incubated with the OM DNA duplex for one hour at a molar ratio of 2:1 
(protein to DNA duplex) at room temperature before being subjected to sparse matrix 
screening using the HoneyBeeX8 crystallisation robot (Cronus Technologies) and 
commercially available screens (Molecular Dimensions Ltd.).  As was previously 
observed with the WT-19OM co-crystallisation, the addition of spermidine improved the 
solubility of the complexes during crystallisation, reducing precipitation and resulting in 
larger crystals.  Initial sparse matrix crystallisation conditions were optimised by 
varying the ratio of the complex to crystallisation buffer as well as the pH and PEG 
concentrations.  The optimised crystallisation buffer was 0.1 M SPG buffer pH 8, 25 % 
(w/v) PEG 1500 and 10 μM spermidine with a ratio of 2:1 complex to crystallisation 
buffer and the crystals reached a maximum length of ~800 μm (Figure 5.1 A).  Crystals 
of Y37F-19OM were transferred to a cryoprotectant containing 33 % (v/v) glycerol prior 
to flash cooling in liquid nitrogen. 
Cryo-cooled crystals of Y37F-19OM were mounted at beamline I04 of the Diamond 
Light Source, Oxfordshire, UK, for X-ray diffraction experiments.  A total of 360 
images of 0.5 ° oscillation were collected at a wavelength of 0.98 Å on an ADSC Q 
315r CCD detector at 100 K.  Isotropic diffraction data extended to a resolution of ~ 3 Å 
(Figure 5.2). 
5.2.2 Structure solution and refinement 
The data were processed in space group P21 using MOSFLM (Leslie, 1992) and scaled 
using AIMLESS (Evans, 2006, Evans, 2011) to a resolution of 3.1 Å with an overall 
Rmerge of 9.8 % (full crystal statistics are shown in Table 5.1).  A molecular replacement 
solution was found using PHASER (McCoy et al., 2005, McCoy et al., 2007) with one 
complex from the published WT-19OM structure as a search model (Ball et al., 
2012)(3UFD) . Two complexes were found in the asymmetric unit in an identical 
orientation to those in the WT-19OM structure (Figure 5.3).  Iterative cycles of 
refinement in Refmac5 (Murshudov et al., 1997) and model building in COOT (Emsley 
and Cowtan, 2004) yielded a complete structure with an Rwork/Rfree of 17.7/22.9 %.  All 
19 DNA bases on each DNA strand were visible within the electron density as were 
residues 2-77 of each protein chain.  The orientation of the DNA could be determined 
though inspection of non-symmetric purine/pyrimidine bases  
Figure 5.3 The asymmetric unit of the C.Esp1396I-Y37F-
19OM co-crystal structure.  The asymmetric unit of the Y37F-
19OM co-crystal structure is composed of 4 peptide chains and 4 
DNA chains composing two biological complexes; (purple and 
pink) one C-protein dimer bound to one DNA duplex. 
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PDB code 4IVZ 
Space Group P21 
Cell Dimensions: 
a, b, c (Å) 47.5, 146.7, 47.8 
α, β, γ (°) 90, 93.21, 90  
Solvent content (%) 45 
Complexes in ASU 2 
Data Collection: 
Beamline DLS-I04 
Wavelength (Å) 0.98 
Resolution (Å) 3.1 
No. measured reflections 41888 
No. unique reflections 11810 
Completeness 99.5 (99.6) 
<I/(I)> 12.7 (1.8) 
Multiplicity 3.8 (3.8) 
Rmerge
† (%) 9.8 (55.4) 
CC1/2
* 0.996 (0.701) 
Refinement Parameters: 
Rwork/Rfree (%) 17.7/22.9 
No. atoms/B-factors (Å2) 
Protein 2482/70.6 
Water 2/40.8 
DNA 1546/77.2 
R.m.s Deviations from ideal1: 
Bond lengths (Å) 0.011 
Bond angles (°) 1.716 
Table 5.1  Data collection and refinement statistics for the 
C.Esp1396I-Y37F-19OM co-crystal structure. Values in 
parenthesis are for the highest resolution shell.  † See Equation 
5.5, * See Equation 5.7. 1 Ideals from Engh & Huber 1991. 
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T2 
C18 
A19 
G3 
Chain C 
Chain D 
Figure 5.4 Representative electron density maps for the 
C.Esp1396I-Y37F-19OM co-crystal structure.  Base pairs A19-
T2 and C18-G3 from Chains C and D respectively.  The 2Fo-Fc 
maps are shown in grey and contoured to 2σ.  Base pairing 
hydrogen bonds are shown as grey dashed lines. 
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90° 
A 
B 
Figure 6.5  The formation of pseudo continuous DNA double 
helices in the C.Esp1396I-Y37F-19OM co-crystal structure.  A:  
Intra-ASU duplex-duplex contacts between Chains C-D (purple) 
and Chains G-H (pink).  The overhanging adenine of Chain C in 
forming a hydrogen bond (red line) with the overhanging thymine 
of Chain H.  B:  Inter-ASU duplex-duplex contacts between 
Chains C-D (purple) and symmetry related Chains G-H (light 
pink).  The overhanging thymine from Chain D is forming 
hydrogen bonds (red lines) with the overhanging thymine from 
symmetry Chain G .  C:  Diagrammatic view of the inter-chain 
base pairing.  
A 
A 
T 
A 
T T 
G 
C 
G 
C 
C 
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(Figure 5.4).  The adenine/thymine overhanging bases that encourage the DNA to form 
a pseudo continuous DNA double helix provided additional confidence in the DNA 
directionality (Figure 4.5).   
Despite the lack of DNA interactions of the Y37F mutation due to the missing hydroxyl 
group, the position of the F37 side chain was clear and could be placed with high 
confidence.  The large area normally taken up by the tyrosine ring is filled with the 
phenylalanine. 
5.3 Comparison with the wild type Om complex structure 
5.3.1 Crystallisation contacts 
The design of the DNA duplex allowed for overhanging A-T bases that in the crystal 
formed a pseudo-continuous DNA double helix (Figure 4.5).  The contacts were 
observed both within the asymmetric unit and between symmetry related DNA chains.  
The geometry of the overhanging DNA bases within the asymmetric unit were less ideal 
than those between asymmetric units and subsequently appeared to only form a single 
hydrogen bond compared to the two at the inter-asymmetric unit contacts.  These DNA-
DNA contacts were identical to those observed in the WT-19OM co-crystal structure 
which is unsurprising as the crystals formed in the same conditions and in the same 
space-group.. 
The same can be said for the protein-protein crystal contacts as they were identical 
between the Y37F-19OM and WT-19OM structures.  Very few dimer-dimer contacts 
were observed in the Y37F-19OM crystal structure both within the asymmetric unit and 
between asymmetric units; however, one key contact occurs between Chain A/E and the 
symmetry related chain B/F respectively.  This contact involves Y29 of one chain 
stacking with Y29 of the symmetry-related chain, and additionally forms a stabilising 
hydrogen bond with D26 (Figure 5.6).  This contact is observed in the majority of 
C.Esp1396I crystal structures both previously published and discussed here in this 
thesis (Ball et al., 2009, Ball et al., 2012, Martin et al., 2013).  There appeared to be no 
protein-DNA interactions other than those that are considered to be biological at the 
protein-DNA interface but the low resolution (3.1 Å) of the Y37F-19OM structure does 
not allow for reliable visualisation of solvent molecules. 
 
 
T36 
R35 
C 
A B 
Figure 5.6 Inter-molecular 
contacts in the Y37F-19OM 
co-crystal structure.  A:  
Helix 2 containing Y29 and 
D26 from Chains A/E are 
shown in purple and the 
corresponding Y29 and D26 
from symmetry related 
Chains B/F are shown in 
light pink.  Chain A interacts 
with symmetry Chain B and 
Chain E with symmetry 
Chain F.  Hydrogen bonds 
are shown as grey lines 
B-D:  The Y37F-19OM co-
crystal structure is shown in 
purple and the WT-19OM 
shown in silver.  B:  The 
critical DNA binding side 
chain R35 as remained in an 
almost identical position, as 
has T36 (C) and R46 (D).  
The red circle in D indicates 
the position of a theoretical 
water observed from the 
19OL crystal structure (Ball 
et al. 2012). 
R46 
D 
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5.3.2 Protein-DNA interactions and flexible loop positions 
Complex 1, formed from Chains A, B, C & D, and Complex 2, formed from Chains E, 
F, G & H, had an overall RMSD of 0.4 Å for all comparable main chain atoms and the 
18 DNA base pairs, therefore only Complex 1 has been described in all analyses.  This 
complex of the Y37F-19OM structure had an RMSD of 0.5 Å for the main chain protein 
atoms when compared to the WT-19OM structure and 0.6 Å for the DNA.  As with the 
WT-19OM co-crystal structure, the flexible loop of C.Esp1396I-Y37F was identical in 
both monomers of the complex.  The three major DNA base-binding residues R35, T36 
and R46 were in almost identical positions to those observed in the WT-19OM co-
crystal structure (Figure 5.7). 
The three residues studied in this thesis relating to protein-phosphate interactions (Y37, 
T49 and S52) were in a very similar orientation to the corresponding residues in the 
WT-19OM structure, however,  the two oxygen’s on the phosphate group that are not 
part of the polymer chain had shifted by ~0.7 Å (Figure 5.8 A).  This movement results 
in the loss of one potential hydrogen bond between T49 and the phosphate.  The most 
obvious difference is the loss of the hydroxyl from the tyrosine and therefore the 
hydrogen bond between position 37 and the phosphate group. 
An analysis of the interface between a single protein monomer and corresponding DNA 
chain was conducted using the PDBe PISA server (Krissinel and Henrick, 2007) for 
both the WT-19OM and Y37F-19OM co-crystal structures.  The results indicated a 
Complex Formation Significance Score (CSS) of 0.177 for the WT-19OM structure and 
0.158 for the Y37F-19OM structure.  The CSS from PISA can range from 0 to 1, with 1 
indicating a highly relevant interface and 0 being extremely irrelevant.  The CSS values 
from PISA indicate that the Y37F-19OM complex is weaker than the wild type complex 
and therefore less likely to form in solution.   
5.3.3 DNA structure 
The DNA duplex in the Y37F-19OM co-crystal structure is almost identical to that in the 
WT-19OM structure with an overall RMSD of 0.6 Å (Figure 5.9 A).  The very similar 
interactions and structure of the DNA termini are most likely due to identical crystal 
packing between the wild type and mutant co-crystal structures.  Crystal packing is 
known to have an effect on DNA structure as observed between the 19OL and 25OL 
crystal structures (McGeehan et al., 2012, Martin et al., 2013)(Chapter 6). 
Figure 5.7  The role of the tyrosine/phenylalanine.  A:  The 
three side chains interacting with the phosphate group of G13 on 
Chain D.  The phosphate in the Y37F-19OM structure (purple) has 
shifted approximately 0.7 Å compared to the WT-19OM structure 
(silver).  Hydrogen bonds are shown as dashed lines, the red bond 
indicates a distance further then 3.5 Å.  B:  The ring group stacks 
against the deoxyribose sugar of G13.  Purple dashed lines 
indicate distances less than 4 Å. 
A 
B 
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Y/F37 
T49 
S52 
Figure 5.8 Comparison of the wild-type and Y37F mutant 
19OM co-crystal structures.  The wild type structure is shown in 
silver and the Y37F mutant structure in purple.  A:  An overlay of 
the two structures shows the high degree of similarity between 
the two.  B:  The DNA “pinching” point in the central TATA 
sequence.  Hydrogen bonds are shown as grey lines. 
A 
B 
Y37 
F37 
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A 
B 
Figure 5.9 DNA bending analysis of the DNA from the 
C.Esp1396I-Y37F-19OM co-crystal structure.  A:  Groove 
width analysis of Chains C and D from the Y37F-19OM crystal 
structure.  The wild-type 19OM co-crystal structure is shown in 
grey and the Y37F mutant co-crystal structure in purple.  Major 
grooves widths are shown with squares and minor groove widths 
with circles.  B:  The DNA duplex from the Y47F-19OM co-
crystal structure shown with the helical axis in grey.  Analysis 
performed using the Curves+ server (Lavery et al. (2009)). 
5’-T G T A G A C T A T A G T C G A C A--3’ 
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The residue Y37 in C.Esp1396I is implicated in DNA bending due to its interaction 
with the phosphate group at the highly compressed minor groove in all the X-ray co-
crystal C-protein-DNA structures (Ball et al., 2012, Martin et al., 2013, McGeehan et 
al., 2012, McGeehan et al., 2008).  However, in the Y37F-19OM structure the DNA 
bend is almost identical to the WT-19OM structure with an overall total bend of 54.7 ° 
compared to the WT-19OM DNA which has a total bend of 56 ° (Ball et al., 2012) 
(Figure 5.10).   This would suggest that the missing hydroxyl from the tyrosine, and 
concomitant loss of what appeared to be a key hydrogen bond interaction, has not had 
an effect on the DNA distortion induced by C.Esp1396I. 
5.4 The role of the Tyrosine/Phenylalanine side chain 
DNA binding analysis conducted in Chapter 3 showed that Y37F formed much more 
stable complexes than Y37A with KDs of 1.8 and 5.5 nM for the OM operator site 
respectively but both were lower than the wild type which had a KD of 0.51 nM 
(Chapter 3).  This indicated that the role of the tyrosine was more than just the 
formation of a hydrogen bond with the DNA backbone, but was perhaps a structural 
role of the phenyl group common to both tyrosine and phenylalanine.  The free protein 
structures of the wild type, Y37F and Y37A mutants showed no major structural 
differences either in the local binding regions in terms of helix or side chain positions, 
or in the overall fold.  The Y37A free protein structure simply had a large gap where the 
tyrosine/phenylalanine would normally be accommodated (Figure 5.11).  In the two 
protein-DNA complex structures the tyrosine and the phenylalanine were equally buried 
and inaccessible to external solvent and in both cases the ring group is stacking against 
the deoxyribose ring in the DNA with a maximum distance of 3.9 Å (Figure 5.9 B).  It 
is therefore likely that this interaction contributes to complex stability and subsequently 
limits the movement of the DNA.  As mentioned above, the phosphate group that the 
tyrosine interacts with in the wild type structure has moved in the mutant structure.  
This shift in the position of the phosphate is a likely consequence of the missing 
hydroxyl group at position 37, as it has moved away from this side chain and towards its 
other two binding partners T49 and S52.  This may contribute towards the DNA 
flexibility and therefore stability of the complex which was severely reduced in the 
Y37A mutant. 
To understand the role of the Y37 side chain in the context of DNA binding the free 
energy contribution from the hydroxyl bond, phenyl group and the tyrosine as a whole 
can be calculated from the DNA binding studies conducted in Chapter 3.  From the 
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Y37F-19OM co-crystal structure, it is clear that the only major alteration to the binding 
interface is the loss of the hydroxyl to phosphate hydrogen bonds; one per monomer.  
The ΔG values for the wild type, Y37F and Y37A mutant interacting with the OM 
operator site are -53.0, -49.9 and -47.1 kJ mol
-1 
respectively (Table 3.2). Therefore the 
ΔG difference (ΔΔG) between the two interactions can be calculated.  For the hydroxyl 
group only, the ΔΔG between the wild type and Y37F mutant was calculated resulting 
in a value of -3.1 kJ mol
-1
, or -1.55 kJ mol
-1
 per hydrogen bond; assuming each 
contributes equally.  The ΔΔG for the phenyl group alone (using the values for Y37F 
and Y37A), is -2.8 kJ mol
-1
, or -1.4 kJ mol
-1
 per monomer.  As these two values are 
very similar, this indicates that the ring group is of similar importance to the interaction 
as the hydrogen bond.  As a Y37A-DNA co-crystal structure could not be determined it 
cannot be known how this amino acid alteration affected the actual DNA binding 
interface in terms of other hydrogen bonds and protein-DNA interactions.  
Another potential influence on complex formation is the displacement of water 
molecules from the protein surface required for DNA binding.  The free protein 
structures described in Chapter 4 were all of sufficient resolution to identify and 
position a significant number of waters around the proteins.  Analysis of the free protein 
structures showed that Y37 is often found within hydrogen bonding distance to an 
adjacent water molecule (Figure 5.12).  In order for C.Esp1396I to form a complex with 
DNA this water molecule needs to be displaced, and in the case of the Y37F mutant, the 
energy penalty for water displacement would be lower as there are less hydrogen bonds 
holding it in position.  The solvent accessible areas may also have further affects on 
complex formation as water is also observed in the Y37A structure in a position similar 
to that of the tyrosine hydroxyl in the wild type free protein structure.  In theory this 
water would not need to be displaced during complex formation and may remain within 
close proximity to the protein and then subsequently the DNA.  This water is likely to 
affect the position of the DNA and possibly reduce complex stability.  The role of the 
highly conserved tyrosine residue at position 37 in C.Esp1396I is clearly more than just 
the hydrogen bonding potential but also its structural properties.  
Figure 5.10 Position of side chain 37.  The side chain at position 
37 fills a space on the DNA binding surface of C.Esp1396I.  The 
surface of the Y37A mutant (free protein) is shown in red and the 
position 37 side chains from the Y37F-19OM and WT-19OM 
structures are shown in purple and silver respectively.  The DNA 
is shown from the Y37F-19OM co-crystal structure as a surface. 
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5.5 Discussion 
The Y37F-19OM co-crystal structure would appear to indicate that the mechanism of 
DNA binding is identical to that of the wild type C.Esp1396I, despite the mutation.  As 
calculated in Chapter 3, the ka values for the wild type, Y37F and Y37A proteins were 
all very similar (1.05 - 1.24 × 10
8
 M
-1
 s
-1
).  It can therefore be concluded that mutations 
to the Y37 side chain only significantly affect the complex stability and not formation.  
The DNA in the structure is still distorted in a very similar manner to that of the wild 
type structure with an almost identical overall bend.  Distortion of the DNA is a 
necessary part of the binding of C.Esp1396I to its operator sites as an opening of the 
major groove allows access to the DNA bases by the protein side chains for direct 
sequence recognition.  If C.Esp1396I were unable to bend the DNA it is highly unlikely 
that a stable complex would form.  This would severely impact the C-proteins role in 
transcriptional regulation as stable protein-DNA complexes are required for both the 
positive and negative regulation necessary for the temporal control of the RM system.  
The Y37F-19OM co-crystal structure indicates that the increase in KD compared to the 
wild type is primarily due to the loss of a single hydrogen bond per monomer (two 
across the biological dimer) and is not related to an inability to distort the DNA operator 
site.  However, when compared to the Y37A mutant, Y37F has a KD somewhere 
between this and the wild type indicating that there is an additional role for this 
conserved tyrosine side-chain than simply hydrogen bonding to the phosphate.  The 
Y37F-19OM co-crystal structure confirms the structural role of the ring group in the 
protein-DNA complex as the group still stacks with the deoxyribose sugar in the DNA 
backbone.  This mutant-DNA co-crystal structure provides valuable insight into the 
more specific role of the tyrosine side chain which alanine mutagenesis would not have 
revealed.  This additional structural role of the tyrosine, maintained in the phenylalanine 
mutant, could be true for other DNA binding side chains in C.Esp1396I including R35 
which stacks with a DNA base in the bound state.   
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Chapter 6: Structural analysis of wild type 
C.Esp1396I protein-DNA complexes 
6.1 Introduction 
Of the three naturally occurring operator sites for C.Esp1396I, OR shows the weakest 
binding affinity (KD of 121 nM) to the C-protein when studied in isolation compared to 
OL and OM (KDs of 5.6 and 0.61 nM respectively) (Ball et al., 2012, Bogdanova et al., 
2009).  Previous DNA binding studies indicated that the affinity of the OR operator was 
greatly increased when the adjacent OL operator site was occupied by a dimer of 
C.Esp1396I (Ball et al., 2012).  Analysis of the crystal structure of the C.Esp1396I-OL+R 
tetrameric repression complex (McGeehan et al., 2008)(3CLC) revealed protein-protein 
cooperativity in the form of a salt bridge between residues E25 of one dimer and R35 of 
the other.  The importance of this cooperativity was studied using mutagenesis to 
individually alter the residues E25 and R35 to alanine (Figure 1.17 B).  The E25A 
mutant of C.Esp1396I resulted in reduced cooperativity as clear evidence of a dimeric 
species was evident (only OL occupied) in EMSA experiments using the full OL+R 
operator sequence.  When the wild type protein was studied by EMSA using the same 
operator sequence and protein concentrations very little dimeric species was evident and 
the tetrameric complex was most prevalent.  The R35A mutant showed no ability to 
interact with the DNA indicating that the residue was important for DNA binding as 
well as protein-protein cooperativity.  EMSA experiments using the OR site in isolation, 
both with a short DNA duplex or a randomised OL site never showed the formation of a 
protein-DNA complex.  McGeehan et al. (2008) proposed a cooperative mechanism for 
the formation of the tetrameric complex composed of two C.Esp1396I dimers at the 
OL+R operator site that included DNA distortion as well as the described protein-protein 
interactions.  Both C.Esp1396I-OL and -OM co-crystal structures have also been solved 
which revealed details of the protein-DNA interactions in single operator sites as well as 
the nature of the DNA distortion (McGeehan et al., 2012, Ball et al., 2012). 
In this chapter, two C-protein-DNA co-crystal structures are presented that show DNA 
corresponding to the low affinity OR operator site.  The structure termed 19OR contains 
DNA corresponding to the entire OR operator site and the other, termed 25OL, contained 
DNA corresponding to the OL operator site and half the OR.  These two structures add to 
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the overall mechanism of C-protein DNA interactions and the formation of 
nucleoprotein complexes. 
6.2 Crystallisation, data collection and refinement 
6.2.1 Co-crystallisation of C.Esp1396I with DNA 
Two DNA duplexes were designed in order to study the structure of the OR site DNA in 
isolation and in the context of the C-protein occupied OL site.  One DNA duplex 
contained the entire OL site plus half the OR site and the other contained only the OR 
site.  The sequences, termed 25OL and 19OR respectively were used for co-
crystallisation experiments. 
The 25OL DNA was designed by Professor G.G. Kneale and synthesised chemically by 
Eurogentec (Figure 6.1 A).  Drs Streeter and Thresh performed PAGE purification 
(Chapter 2) and crystallisation experiments using sparse matrix screening and 
subsequent optimisation.  The crystals used for diffraction experiments were grown in 
0.1 M PCB buffer pH 4.0, 20 % (w/v) PEG 1500 and 10 mM spermidine at a molar 
protein:DNA ratio of 2:1. 
DNA duplexes were designed containing the entire OR operator site with either an A-T 
overhang (as used in the 19OM and 19OL co-crystal structures) or blunt ends (as with the 
35OL+R and 25OL structures) (Figure 6.1 B).  Despite comprehensive screening, crystals 
only formed with the blunt ended duplex in conditions 0.1 M PCB buffer pH 4.0 and 25 
% (w/v) PEG 3350 at a molar protein:DNA ratio of 1:1.  The presence of both protein 
and DNA components were confirmed by washing and dissolving the crystals followed 
by the collection of a UV absorbance spectrum.  These crystallogenesis conditions were 
optimised using micro-seeding (D'Arcy et al., 2007) and an additive screen to finally 
produce diffraction quality crystals in 0.1 M PCB buffer pH 5.0, 25 % (w/v) PEG 3350 
and 10 mM spermidine. 
6.2.2 Data collection and processing 
Crystals of the C.Esp1396I-25OL complex were transferred to a cryo-protectant solution 
of 20 % (v/v) PEG 400 before flash cooling in liquid nitrogen.  The crystals were 
transported to beamline ID14-4 of the ESRF for X-ray diffraction data collection. A 
total of 120 images of 1 ° oscillation were collected using an ADSC Q4 CCD detector at 
100 K at a wavelength of 0.933 Å by Dr John McGeehan.  Diffraction data extended to 
5’-ATGTGACTTATAGTCGTGTGATTA-3’ 
3’-TACACTGAATATCAGCACACTAAT-5’ 
5’-TGTGTGATTATAGTCAACA-3’ 
3’-ACACACTAATATCAGTTGT-5’ 
 
5’-TGTGTGATTATAGTCAACA-3 
3’--CACACTAATATCAGTTGTA-5’ 
 
B 
A 
Figure 6.1 DNA oligonucleotides for C.Esp1396I co-
crystallisation.  A:  The DNA duplex used for co-crystallisation 
of the 25OL complex.  The C-boxes are underlined and the TATA 
spacers are in bold.  B:  The two duplexes used for co-
crystallisation experiments for the 19OR structure.  Only the first, 
blunt ended, duplex formed crystals.  The C-boxes are underlined 
and the TATA spacers are in bold. 
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Figure 6.2 X-ray diffraction image from the 25OL complex 
crystals.  A one second 1 ° oscillation X-ray diffraction image 
collected at beamline ID-14-4 of the ESRF on an ADSC Q4 CCD 
detector by Dr John McGeehan.  The top edge of the detector is at 
~2.2 Å 
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Figure 6.3 Crystals and X-ray diffraction image of the 19OR 
co-crystals.  A:  Optimised crystals of the C.Esp1396I-19OR 
protein-DNA complex.  B:  One second 1 ° oscillation X-ray 
diffraction image collected at beamline I02 of the Diamond Light 
Source on an ADSC Q315r CCD detector with the top edge of the 
detector at 3 Å. 
B 
A 
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~2.3 Å resolution (Figure 6.2).  The data were processed using XDS and scaled using 
XSCALE (Kabsch, 2010) to 2.4 Å in space group P32 with an overall Rmerge of 4.8 %. 
The crystals of the C.Esp1396I-19OR complex were transferred to a cryo-protectant 
solution of 25 % (v/v) glycerol prior to flash cooling in liquid nitrogen (Figure 6.3 A).  
The crystals were transported to beamline I02 of the Diamond Light Source for X-ray 
diffraction data collection.  180 images of 1 ° oscillation were collected at a wavelength 
of 0.98 Å using an ADSC Quantum r315 CCD detector at 100 K.  Isotropic diffraction 
data extended to ~2.9 Å resolution (Figure 6.3 B).  These data were processed using 
MOSFLM (Leslie, 1992) and scaled using AIMLESS (Evans, 2006, Evans, 2011) to 3 Å 
in space group C2 with an overall Rmerge of 15.8 %.  Despite the Rmerge in the outer shell 
exceeding 100 % these data were included due to the clear improvement of the electron 
density maps.  These data can justifiably be included using Karplus and Diederichs 
(2012) correlation coefficient statistics as described in section 5.2.7 as the CC1/2 value in 
the outer shell was 0.65.  The data collection statistics are summarised in Table 6.1. 
6.2.3 Structure solution and refinement 
The phases for both the 25OL and 19OR complexes were determined using the 
molecular replacement program PHASER (McCoy et al., 2005, McCoy et al., 2007).  
For the 25OL structure, the 19OL (3S8Q) protein and corresponding 18 bp region of the 
DNA was used as a search model.  PHASER identified two copies of the complex in the 
asymmetric unit with a final solvent content of 44 % (Figure 6.4).  The remainder of the 
DNA was built manually using the program COOT (Emsley and Cowtan, 2004) prior to 
iterative cycles of refinement in Refmac5 (Murshudov et al., 1997) and model building 
in COOT resulting in an R/Rfree of 19.7/25.9 %. 
For the 19OR structure, a monomer of the wild type C.Esp1396I structure (3G5G) was 
used as a search model (Ball et al., 2009).  PHASER identified two monomers in the 
asymmetric unit corresponding to a biological dimer (Figure 6.5).  Attempts to use the 
DNA from either the 19OL (McGeehan et al., 2012)(3S8Q) or 19OM (Ball et al., 
2012)(3UFD) co-crystal structures as a search model for the DNA failed,  however, a 19 
bp standard B-form DNA duplex generated in COOT was successfully used to identify 
the position of the DNA relative to the C-protein using PHASER.  The final 19OR DNA 
structure was built manually using the program COOT alongside the molecular 
replacement solution for the dimer only.  Iterative cycles of model building in COOT 
Table 6.1 Data collection and refinement statistics for 25OL 
and 19OR co-crystal complexes. Values in parenthesis are for 
the highest resolution shell.  † See Equation 5.5, * See Equation 
5.7. 1 Ideals from Engh & Huber 1991. 
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90° 
Figure 6.4 The asymmetric unit of the C.Esp1396I-25OL co-
crystal structure.  Two copies of the C.Esp1396I-25OL complex 
were present in the asymmetric unit, coloured cyan and pale cyan 
respectively. 
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Figure 6.5 The asymmetric unit of the C.Esp1396I-19OR co-
crystal structure.  One copy of the C.Esp1396I dimer and one 
copy of the 19OR DNA duplex were present in the asymmetric 
unit. 
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Figure 6.6 Representative electron density maps for the 19OR 
and 25OL C.Esp1396I-DNA co-crystal structures.  A:  2Fo-Fc 
electron density for Chain C T14 and C15 base pairs with G6 and 
A7 of Chain D from the 19OR DNA.  Hydrogen bonds are shown 
as dashed grey lines.  B:  2Fo-Fc electron density for base pairs of 
Chain C C7 and T8 with A18 and G19 of Chain D from the 25OL 
DNA.  Hydrogen bonds are shown as dashed grey lines.  Both 
maps are contoured to 1.5 σ. 
B 
A 
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and refinement in Refmac5 (Murshudov et al., 1997) and phenix.refine (Afonine et al., 
2005) resulted in a final R/Rfree of 23.5/30 %. 
Both the 25OL and 19OR co-crystal structures were deposited into the PDB with the 
accession codes 4IWR and 4I8T respectively. 
6.3 Analysis of the C.Esp1396I-25OL co-crystal structure 
The C.Esp1396I-25OL co-crystal structure presented an opportunity to analyse the OR 
portion of the DNA when the adjacent OL site was occupied by C.Esp1396I.  The vast 
majority of protein-DNA contacts observed were very similar with a few exceptions 
discussed in section 7.3.1.  The unique packing of the crystals allowed for unbiased 
analysis of the OR portion of the DNA duplex and revealed potential mechanisms of 
cooperativity in the OL+R repression complex.  As the two complexes in the asymmetric 
unit of the 25OL structure have an RMSD of 0.12 Å for the C.Esp1396I dimers and 0.4 
Å for the DNA duplex, only the complex formed from Chains A, B, C and D will be 
discussed in all analyses for clarity. 
6.3.1 Protein-DNA contacts 
The previously published C.Esp1396I-19OL co-crystal structure (McGeehan et al., 
2012)(3S8Q) identified a wide array of both DNA base specific and backbone binding 
residues.  The advantages of the 19OL structure over the 35OL+R structure were the 
clearly observed directionality of the DNA due to the A-T overhangs of the duplex and 
the high resolution of the structure (2.1 Å) which allowed visualisation of solvent 
mediated contacts,  however, in the 25OL structure some of the contacts observed were 
different (Figure 6.8).  The majority of these differences were at the OL “end” of the 
DNA (shown in Figure 6.7) where the crystallographic DNA-DNA contacts are found.  
Crystallisation contacts are discussed in detail in section 7.3.2. 
The largest differences were seen in the arginine side chains that interact with the DNA 
(Figure 6.8).  Residue R43, involved in phosphate binding, has rotated though ~180 ° 
resulting in the loss of one hydrogen bond and the phosphate group that remains in 
contact with the guanidyl head of the arginine has shifted by approximately 1 Å due to 
the differing crystal packing interactions between the 25OL and the 19OL structures 
(Figure 6.8 A).  Another important DNA binding residue, R35, is also shown to be 
slightly shifted but still forms the same contacts with the guanidine base (Figure 6.8 B).  
Again, this is most likely due to the crystal packing interactions but is compensated for 
Figure 6.7 Comparison between the 25OL and 19OL 
C.Esp1396I-DNA complexes.  The 25OL complex is shown in 
cyan and the 19OL in silver.  All main-chain protein atoms were 
aligned with an RMSD of  0.5 Å and the comparable 18 bp of 
DNA had an overall RMSD of 0.9 Å. 
OL 
½OR 
164 
Figure 6.8 Comparison between the protein-DNA interactions 
in the 25OL and 19OL C.Esp1396I-DNA complexes.  The 25OL 
complex is shown in cyan and the 19OL in silver, all numbering 
refers to the 25OL structure.  A:  The position of R43 is markedly 
different between the 25OL and 19OL structures.  In the 25OL 
structure the side chain has rotated ~180 ° and now only contacts 
the phosphate group of T4 on Chain C.  B:  R35, a key DNA 
binding residue, has shifted by ~1 Å but still forms similar 
contacts with G3 on Chain C.  C:  R46 is shown to be identical in 
both the 25OL and 19OL co-crystal structures. 
B 
A 
C 
R35 
G3 
R43 
T4 
R46 
T20 
G19 
165 
 166 
 
by arginine’s high degree of flexibility.  The further away from the OL end of the DNA 
the more consistent the protein-DNA interactions become as observed with R46, 
another crucial DNA binding residue, where the interaction between R46 and the DNA 
is shown to be identical in both the 25OL and 19OL structures (Figure 6.8 C). 
6.3.2 Crystallisation contacts 
Due to the elongated and blunt ended DNA component of the crystal, the packing was 
markedly different to the 35OL+R, 19OL, 19OM and Y37F-19OM C.Esp1396I-DNA co-
crystal structures (McGeehan et al., 2008, McGeehan et al., 2012, Ball et al., 2012) 
(Chapter 5).  The only DNA-DNA contacts occur between two duplexes at the OL end 
of two symmetry related complexes (Figure 6.9 A).  These contacts consist solely of 
base pair stacking between the terminal AT base pairings of each duplex (Figure 6.9 B).  
These contacts differ greatly from the previously studied 19OL complex which formed 
triple-helical DNA at the ends due to the single base over-hangs (Figure 6.10).  These 
different packing interactions appear to have altered the protein-DNA interactions 
(section 7.3.1).  
As has been commonly observed with C.Esp1396I crystal structures the 
crystallographic protein-protein contacts involved Y29 and D26 forming hydrogen 
bonds as well as the tyrosines stacking against one another (Figure 6.11).  This 
interaction is extremely common and has been described multiple times in this thesis 
(Chapters 4 and 5). 
Aside from the well characterised biological protein-DNA interactions involved in 
formation of the C-protein-OL operator complex there are very few crystallographic 
protein-DNA interactions.  The only observable interaction is between K20 on Chain 
B/F and the phosphate backbone of a symmetry related DNA duplex.  However, due to 
the low resolution, solvent mediated contacts could not be observed. The extended 
portion of the DNA duplex containing half of the OR operator site contained no 
observable crystallographic contacts and sat within a pocket formed by the various 
symmetry related complexes (Figure 6.12).  This allows for an analysis of the DNA 
structure in a free, unconstrained conformation (section 6.3.3). 
  
A 
A 
T 
T 
A 
A 
T 
T 
Figure 6.9 DNA based crystal contacts in the C.Esp1396I-
25OL co-crystal structure.  A:  Chains A-D that form one of the 
complexes in the asymmetric unit of the 25OL structure are 
shown in cyan with a symmetry related complex shown in pale 
cyan.  The zoom shows how the ends of the DNA interact and 
base-stack.  The protein as been removed for clarity.  B:  
Diagrammatic view of the terminal base pairs of the 25OL DNA 
that form the crystallisation interface. 
90° 
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Figure 6.10 DNA based crystal contacts in the C.Esp1396I-
19OL co-crystal structure.  A:  Chains A-D that form the 
complex in the asymmetric unit of the 19OL structure are shown 
in silver with a symmetry related complex shown in white.  The 
zoom shows how the ends of the DNA interact and base-stack.  
The protein as been removed for clarity.  B:  Diagrammatic view 
of the triple-helical interactions of the 19OL DNA that form the 
crystallisation interface. 
90° 
B 
A 
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Figure 6.11  Protein-protein crystallisation contacts in the 
C.Esp1396I-25OL co-crystal structure.  As with most 
C.Esp1396I crystal structures, Y29 plays a key role by stacking 
with Y29 from another monomer and forming a hydrogen bond 
with D26.  The only notable difference between these contacts 
and those observed in other C.Esp1396I crystal structures is the 
formation of the hydrogen bond to the carbonyl backbone group 
instead of the side chain (red circle).   One asymmetric unit is 
shown in cyan and another in pale cyan. 
90° 
Y29 
Y29 
D26 
D26 
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6.3.3 Analysis of the DNA 
The DNA component of the 25OL co-crystal structure showed clear distortion in both 
the DNA bound and unbound portions compared to standard B-form DNA.  C-protein 
induced DNA distortion has been well characterised by both crystallography and in-
solution methods (Papapanagiotou et al., 2007, Bogdanova et al., 2009, McGeehan et 
al., 2008, McGeehan et al., 2012, Ball et al., 2012).  The OL operator section of the 
25OL structure is strikingly similar to that of the 19OL co-crystal structure showing an 
identical degree of minor groove compression at the TATA spacer in the OL operator 
(Figure 6.14).  The only notable differences in comparable DNA structure between the 
25OL and the 19OL co-crystal structures occur at the first GTC C-box where the minor 
groove widths are reduced in the 19OL structure compared to the 25OL resembling DNA 
closer to that of standard B-form DNA (Figure 6.14).  The triple helical DNA 
interactions in the 19OL co-crystal structure are much less likely to occur within the 
bacterial cell whereas the simple base stacking in the 25OL co-crystal structure more 
closely resembles continuous DNA. 
When compared to the 35OL+R co-crystal structure (McGeehan et al., 2008)(3CLC) an 
identical minor groove compression at the central OL TATA spacer was observed.  Also 
the OR portion of the 25OL co-crystal structure resembles that of the comparable DNA 
in the 35OL+R structure despite not being bound to, and therefore distorted by, 
C.Esp1396I (Figure 6.14).  The major groove width at the highly conserved GT bases 
between the OL and OR operator sites (Figure 1.6) is greater than that of B-form DNA in 
the 25OL co-crystal structure and appears to be closer in conformation to the bound 
DNA in the tetrameric complex. 
  
Figure 7.12  Protein-DNA interactions with the OR portion of 
the 25OL DNA.  The unbound section of the DNA that contains 
half the OR operator site sits within a pocket formed from other 
complexes in the crystal.  One copy of the complex is displayed 
as a cyan cartoon and the other complexes are displayed as pale 
cyan surfaces.  Images on the right have been slabbed for clarity. 
90° 
OR OR 
OR OR 
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10                                                              135 
Figure 6.13 B-factor analysis of the C.Esp1396I-25OL co-
crystal structure.  The complex formed from Chains A-D has 
been coloured according to B-factor using PyMol.  The unbound 
OR portion of the DNA shows B-factors in the range of 130 Å
2 
compared to that the rest of the structure which are about 10-30 
Å2.  The scale bar is in units of Å2. 
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Figure 6.14  Groove width analysis of C-protein bound DNA.  
Groove width analysis performed using the Curves+ server 
(Lavery et al. (2009)) shows the high degree of minor groove 
compression and major groove opening.  The C-boxes are 
underlined and the TATA spacers are in bold for the 31 
comparable base pairs.  All three OL sites show the same degree 
of compression at the TATA site and the 25OL shows opening of 
the major groove in the central GT. 
Major Groove 
Minor Groove 
35bp OL+R (3CLC) 
Major Groove 
Minor Groove 
25bp OL+½R (4IWR) 
Major Groove 
Minor Groove 
19bp OL (3S8Q) 
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6.4 Analysis of the C.Esp1396I-19OR co-crystal structure 
Previous co-crystallisation experiments using C.Esp1396I and single operator sites have 
yielded high resolution structural data for both the OL and OM operators (Ball et al., 
2012, McGeehan et al., 2012).  Attempts to employ the same methodologies with the 
OR site resulted in an unexpected C-protein-DNA interaction, and although this 
structure is considered to be of a ‘non-biological’ nature, it provides new insight into the 
OR operator site DNA. 
6.4.1 C.Esp1396I structure and interactions with the 19OR DNA 
Comparison of the C.Esp1396I protein dimer in the asymmetric unit of the 19OR 
structure and that of the published wild type structure (Ball et al., 2009)(3G5G) revealed 
no significant structural changes;  the loops adopted the most commonly observed 
conformations with an overall RMSD of 0.6 Å for all the comparable main chain atoms 
(Figure 6.15). 
Although crystallisation occurred at a concentration above the identified KD for OR in 
isolation (Ball et al., 2012, Bogdanova et al., 2009), the protein was shown to interact 
with the DNA in a way that is most likely non-biological.  Rather than typical 
interactions via the helix-turn-helix (HTH) motif, the DNA in the asymmetric unit was 
interacting with the C-terminus and N-terminus of helices 1 and 2 respectively on one 
monomer (Figure 6.5).  All observable contacts between the protein and the DNA 
within the asymmetric unit involve the phosphate backbone only.  The only clear 
contacts are between the side chain of R17 & the main chain NH group of Q24 of Chain 
A with the phosphate group of T10 on Chain C (Figure 6.16 A).  The only other protein-
DNA contact occurs between the NH main chain group of N47 on Chain B and the base 
T1 from a symmetry related Chain C (Figure 6.16 B). 
6.4.2 Crystallisation contacts 
Due to the unique interactions between the protein and the DNA in the 19OR co-crystal 
structure there are no DNA-DNA contacts between adjacent asymmetric units.  The 
only observable protein-DNA contacts are described in section 7.4.1 but a symmetry 
related DNA duplex is in close proximity to the dimerisation helix of the C-protein in 
the asymmetric unit though no direct contacts are observed (Figure 6.17).  It is likely 
that solvent mediated contacts are important for crystal formation and stability but 
cannot be analysed due to the low resolution of the data (3 Å).  As with the majority of 
Figure 6.15 Comparison of the C.Esp1396I dimer in the 19OR 
structure and the unbound wild-type protein structure.  The 
asymmetric unit of the 19OR co-crystal structure is shown in 
green and Chains A & B of the wild-type crystal structure (3G5G) 
shown in silver.  The comparable main chain protein atoms had 
an RMSD of 0.6 Å. 
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Figure 6.16 Protein-DNA contacts in the C.Esp1396I-19OR co-
crystal structure.  A:  R17 and Q24 of Chain A interacting with 
the phosphate group of T10 on Chain C.  Hydrogen bonds are 
shown as dashed grey lines.  B:  N47 interacting with T1 from a 
symmetry related DNA chain.  Hydrogen bonds are shown as 
dashed lines. 
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Figure 6.17 Packing of the DNA duplexes in the C.Esp1396I-
19OR co-crystal structure.  The  asymmetric unit is shown in 
bright green with symmetry related DNA duplexes shown in dark 
green. 
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90° 
20° 
Figure 6.18  Protein-protein crystal packing interactions in 
the C.Esp1396I-19OR co-crystal structure.  As with the 
majority C.Esp1396I crystal structures, Y29 stacks against 
another Y29 from a different dimer whilst forming a hydrogen 
bond with D26.  The asymmetric unit is shown in bright green 
with symmetry related C.Esp1396I dimers shown in dark green.  
Hydrogen bonds are shown as dashed grey lines. 
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 C.Esp1396I structures, including those presented in this thesis, Y29 and D26 play a key 
role in protein-protein contacts (Figure 6.18). 
6.4.3 Analysis of the 19OR DNA 
The DNA component of the 19OR co-crystal structure did not conform to a perfect B-
form structure nor did it resemble the C-protein-bound structure.  Analysis using 
Curves
+
 (Lavery et al., 2009) indicated that the DNA has a total bend of 42 ° centred 
around the central TATA spacer region of the OR operator (Figure 6.19).  This bend 
angle is between B-form and the bound DNA which has a total bend angle of 56 ° (Ball 
et al., 2012, McGeehan et al., 2012). 
6.5 Discussion 
The two structures presented in this chapter are the first to show structural information 
about the DNA operator site in an unbound (19OR) and pre-bound (25OL) state as well 
as the OR site in isolation.  McGeehan et al. (2008) proposed a cooperative mechanism 
for the formation of the tetrameric complex of two C.Esp1396I dimers at the OL+R 
operator site that included DNA distortion as well as the described protein-protein 
interactions.  The 25OL structure supports this hypothesis as the OR portion of the DNA 
has an open major groove despite not being bound by C.Esp1396I.  This would indicate 
that the binding of the first dimer to OL affects the downstream adjacent DNA in such a 
way as to prepare the OR site for C-protein binding which is subsequently stabilised by 
protein-protein interactions. 
The DNA from the 19OR structure is not constrained by the HTH motif of C.Esp1396I 
and the only protein-DNA contacts appear to be solely crystallographic.  This structure 
therefore provided a unique opportunity to structurally analyse the operator DNA prior 
to C-protein binding.  The fact that the DNA is notably bent and distorted compared to 
B-form DNA would appear to indicate that this particular DNA sequence is readily 
susceptible to distortion, especially the minor groove at the TATA spacer sequence 
between the C-boxes.  As all known C.Esp1396I operator sequences contain a central 
TATA sequence it can be hypothesised that all of the operator sites behave this way in 
isolation.  DNA sequences that contain poly-TATA are more flexible than other 
nucleotide combinations (reviewed in (Travers, 2004)).  This is clearly observed with 
TATA-binding protein DNA co-crystal structures in the PDB (Juo et al., 1996) as well 
as C.Esp1396I itself.  Other classes of DNA binding proteins are also known to interact 
Figure 6.19 Bending analysis of the OR operator site crystal 
structures.  Bending analysis of the 35OL+R, 19OM and 19OR 
C.Esp1396I-DNA co-crystal structures was performed using the 
Curves+ server (Lavery et al. (2009)).  All three sequences (the 
19OM being different to the bases on the x-axis) were aligned 
using the central TATA (bold) which is conserved in all three 
sequences.  Only the OR portion of the 35OL+R sequence is 
shown.  The 19OM is used for comparison as it has an identical 
length spacer between the C-boxes (underlined).  The analysis 
shows that the minor groove in the 19OR DNA is compressed at 
the TATA sequence. 
Minor Groove 
35bp OL+R (3CLC) 
Minor Groove 
19bp OM (3UFD) 
Minor Groove 
19bp OR (4I8T) 
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Figure 6.20 Construction of the C.Esp1396I repression 
complex.  The 25OL and 19OR structures can be aligned to form a 
reasonable approximation of the tetrameric C.Esp1396I 
repression complex.  The 35OL+R (3CLC) structure is shown in 
magenta, the 25OL in cyan and the 19OR in green.  The positions 
of the C-proteins from the tetrameric structure (3CLC) are shown 
as translucent cartoons. 
Tetramer (3CLC) 
25OL (4IWR) 
19OR (4I8T) 
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 with structural features in the DNA double helix such as distortions and bulges 
(Travers, 2000). 
Combining the downstream conformational changes in the DNA that occur when a 
C.Esp1396I dimer binds to the OL site (observed in the 25OL structure) and the intrinsic 
DNA flexibility (observed in the 19OR structure) a reasonable approximation of the 
DNA from the tetrameric complex is observed (Martin et al., 2013).  This would 
indicate that the energy penalty, in terms of distorting the DNA, for C.Esp1396I binding 
to the OR operator site would be considerably lessened.  This mode of binding has been 
observed in other systems including the HTH DNA binding protein QacR (Schumacher 
et al., 2002).  This adds to the overall mechanism of C.Esp1396I-DNA complex 
formation at the weak, OR operator site.  
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Chapter 7: Final Discussion 
7.1 Conclusions 
The primary research aims of this project were to build on previous biochemical and 
structural studies on the C-protein C.Esp1396I and to further understand the intricate 
DNA binding mechanism.  A rational approach of specific individual amino acid 
mutagenesis was undertaken with the aim of elucidating the importance of residues that 
have been shown to interact with the DNA in high resolution X-ray crystal structures of 
the nucleoprotein complexes.  Bioinformatic analysis, based upon the work of Sorokin 
et al. (2009), revealed that the majority of the DNA binding residues looked at in this 
study were very highly conserved across the Motif 2 C-protein family.  After successful 
generation of seven C.Esp1396I mutant proteins, two approaches were used to 
understand the role of specific amino acids in the protein.  Firstly, DNA binding studies 
were performed to judge the effects of the mutations on protein-DNA complex 
formation (association rate, ka) and stability (dissociation rate, kd).  Secondly, the 
mutant proteins were structurally analysed using high resolution X-ray crystallography 
to ascertain whether the mutations had affected the overall fold of the dimer.  The 
mutational studies were performed in parallel with wild type structural studies using 
DNA duplexes that were designed to probe the mechanism of the DNA distortion 
observed in the published C.Esp1396I-DNA complexes. 
Based upon combined structural and bioinformatic analyses, seven C.Esp1396I mutant 
protein expression constructs were designed and generated.  The point mutations were 
made to two classes of DNA binding residues; phosphate binding residues and residues 
involved in base binding and therefore DNA sequence recognition.  All of the mutant 
proteins were over expressed in E. coli and, following optimisation of the expression 
strategy, resulted in a total of between 3 and 30 mg/L of soluble and pure protein.  
These pure proteins were then used for both electrophoretic mobility shift assays 
(EMSAs) and surface plasmon resonance (SPR).  In order to determine KDs, kas and kds, 
the concentration of the C.Esp1396I dimer had to be calculated based upon the 
monomer concentration.  Ball et al. (2012) calculated the dimerisation constant (Kdim) to 
be 1.6 μM for wild type C.Esp1396I and this value was used throughout for both the 
wild type and the mutant proteins. 
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The mutant proteins were all of sufficient purity and quality for crystallisation trials.  
Five of the mutant proteins formed crystals which diffracted to high resolution along 
with a novel crystal form of the wild type.  The high resolution structural studies of the 
mutants revealed the dimerisation interface of the proteins in great detail. Comparative 
analysis was then performed between these structures, previously published structures 
and the newly determined high-resolution (1.4 Å) wild type structure.  It was observed 
that the dimerisation interfaces of the mutants were identical to the wild type protein, 
complete with the same hydrogen bonding networks and hydrophobic interactions.  In 
the absence of experimentally determined Kdim values, by methods such as AUC, the X-
ray crystal structures support the use of the Kdim value determined by Ball et al. (2012) 
for the wild type protein, for the mutants in the SPR experiments.  
As well as confirming that the mutant proteins were folded correctly, the structural 
studies revealed a more detailed structural picture of C.Esp1396I.  Previously a flexible 
loop in C.Esp1396I had been identified from the wild type structures, where two 
alternative conformations were observed (Ball et al., 2009).  The wild type structure of 
C.Esp1396I presented in this thesis revealed further details including an additional, third 
conformation of the flexible loop region that was subsequently observed in several of 
the mutant protein structures. Between the 16 published and 20 newly determined 
structures of the C.Esp1396I monomer (from nine free protein X-ray crystal structures 
containing multiple monomers) and across seven different crystal forms, only the three 
loop conformations were observed.  The C.Esp1396I-T36A mutant protein crystal 
structure showed both the major conformation from Ball et al. (2009) and the novel 
conformation observed in this study, indicating that both were possible in a single 
biological dimer at the same time.  Flexibility in this loop is very important for DNA 
binding as it has been observed in the nucleoprotein structures to adopt different 
conformations depending on which operator site the protein is bound to, thereby 
presenting the DNA binding residues present in this loop in different orientations to 
accommodate the different sequences in the operator sites.  Despite the alterations to the 
amino acid sequence, the mutant proteins were clearly able to still adopt the various 
loop conformations observed in the wild type structures. 
The DNA backbone binding residues Y37, T49 and S52 all interact with the same 
phosphate group at the highly compressed minor groove of the DNA.  These three 
residues, along with the corresponding three in the other monomer of the biological 
dimer, “pinch” the DNA backbone, reducing the distance between the two phosphate 
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groups at the minor groove to ~1 Å.  In order to investigate the structural basis of the 
DNA distortion, further wild type and DNA co-crystal structures were determined using 
DNA duplexes that contained part or all of the OR binding site, the weakest of the three.  
What was observed was that the DNA distortion is not necessarily induced by the C-
protein but stabilised and enhanced from a naturally distorted state.  This was observed 
in the 19OR co-crystal structure, where the C-protein is not binding to the DNA using 
the HTH motif but DNA distortion is still present in this essentially unbound state 
(Martin et al., 2013)(4I8T).  In the double OL+R operator site it was previously observed 
that there is a high degree of cooperativity between the two C-proteins that is common 
to other dual transcription factor binding events (McGeehan et al., 2008, Grkovic et al., 
2001, Schumacher et al., 2002).  McGeehan et al. (2008) observed a direct dimer-dimer 
interaction in the tetramer structure in the form of a salt bridge between the conserved 
residues E25 and R35.  When these residues were mutated the cooperativity was 
reduced but still present and therefore it was hypothesised that the remaining 
cooperativity could be due to be induced DNA distortion by the first C-protein binding 
to the OL site (McGeehan et al., 2008).  Weight was added to this hypothesis after 
successful co-crystallisation experiments using a DNA duplex that contained the entire 
OL operator site plus half of that pertaining to the OR site yielded diffracting crystals 
(Martin et al., 2013)(4IWR).  In this structure, termed 25OL, the OL site was occupied 
by a C-protein dimer and the ½OR site, 7 bp, remained unbound.  The structure of the 
DNA at the OL site was distorted, as expected, in a manner almost identical to that of 
the 19OL and 35OL+R structures, but the distortion was not limited to the bound portion 
of the DNA.  In fact the major groove adjacent to the OL operator sequence had opened 
up and closely resembled that of the DNA from the fully bound tetrameric OL+R co-
crystal structure (McGeehan et al., 2008) (3CLC).  This lends further support to the 
hypothesis that the C-protein binding to the OL site distorts the downstream DNA, 
preparing it for binding to either another C-protein (as seen in the tetrameric 35OL+R 
structure) or potentially the sigma subunit of RNA polymerase, acting as a 
transcriptional enhancer (McGeehan et al., 2008).   
What was observed in the 19OR co-crystal structure (4I8T), was that the DNA distortion 
is centred at the conserved TATA spacer, which is present in the majority of C-protein 
binding sites and all for C.Esp1396I.  This suggests that this propensity for DNA 
distortion is present in all of the operator sites, reducing the need for induced DNA 
distortion.  In the DNA binding studies, the “backbone-binding” mutants were observed 
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to bind to the DNA with much higher affinity then those mutants with changes to the 
“base-binding” residues.  This could be due to the inherent flexibility of this sequence 
of DNA reducing the energy penalty for induced DNA distortion as supported by this 
novel co-crystal structure, which show significant DNA distortion from standard B-
form in, what can be considered, a free state.  When the DNA from the 25OL and 19OR 
co-crystal structures are aligned to the 35OL+R DNA, they very closely resemble the 
completely bound (two dimers interacting with the DNA) conformation of the DNA.  
This model adds to the understanding of the DNA binding and cooperativity mechanism 
that allows a C-protein to bind at the intrinsically weak OR operator site.  Biologically, it 
is more favourable that the C-protein binds to the correct DNA sequence (containing the 
C-boxes) rather than to any sequence where it can induce DNA distortion.  The relative 
KDs for the wild type and mutant proteins were determined as follows:  
Wild type > Y37F > S52A > Y37A > R46A > T36A = T49A 
where the mutations to the backbone binding residues are underlined.  The ΔG values 
for the mutant C-protein-DNA interactions ranged from -50.0 (for the wild type) to 
 -45.5 kJ mol
-1
 (for the R46A mutant).  These values fit within a range of other HTH 
DNA binding protein-DNA interactions including SinR (-36.7 kJ mol
-1
) (Newman et al., 
2013), the C-protein C.AhdI (-45.7 kJ mol
-1
) (Streeter et al., 2004) and the Cro repressor 
(-64.4 kJ mol
-1
) (Takeda et al., 1992). 
In the highly conserved DRTY sequence, two mutations to the tyrosine were introduced 
in order to study the role of the aromatic side chain as well as the hydrogen bonding 
capacity of the hydroxyl group; Y37F and Y37A.  The KD for Y37A and the OM 
operator site was 5.5 nM (SPR results) compared to 1.8 nM for the Y37F mutant.  The 
kd value was also two-fold higher for Y37A than Y37F, indicating a much less stable 
complex.  However, kas were almost identical for the three proteins indicating that 
complex formation was not affected.  Crystallogenesis trials, using all the mutant 
proteins and a DNA duplex containing the entire OM operator sequence, only yielded 
diffracting crystals with the Y37F mutant, the next tightest binding mutant after the wild 
type.  Given the highly homologous nature of this structure (4IVZ) with the wild type 
(3UFD), in terms of space-group, orientation and crystal packing (RMSD of 0.5 Å for 
the protein and 0.6 Å for the DNA), this provided us with the possibility to characterise 
the structural role of an individual H-bond, with the supporting DNA binding studies. 
What was observed in the Y37F-19OM co-crystal structure was that the DNA was 
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distorted to an identical degree to that in the wild type 19OM co-crystal structure, 
despite the missing hydrogen bonds (one per monomer).  The phenyl group common to 
both tyrosine and phenylalanine was shown in both structures to stack against a ribose 
sugar ring on the DNA backbone.  Calculations of the ΔΔG values between the wild 
type, Y37F and Y37A from binding constants, determined by SPR experiments, showed 
that the phenyl group contributed almost equally to the DNA binding (ΔΔG = -2.8 kJ 
mol
-1
) as the hydrogen bond between the tyrosine hydroxyl and the phosphate group 
(ΔΔG = -3.1 kJ mol-1).  Another study using in depth mutational studies, using tyrosyl-
tRNA synthase as a model, showed that the hydroxyl group of a tyrosine involved in 
substrate binding (as well as the hydroxyl on the phenolic group of the substrate) played 
an important role for substrate specificity (Fersht et al., 1985).  This study included 
looking at the the displacement of water and the relevance of breaking protein-water H-
bonds for protein-substrate H-bonds to form.  As high resolution structures of both the 
free and Y37F mutant proteins have been solved, the positions of water molecules that 
would need to be displaced upon C-protein-DNA binding can be observed.  Also, Fersht 
et al. (1985) calculated the ΔΔG for substrate binding of a tyrosine to phenylalanine 
mutation to be -2.2 kJ mol
-1
, a figure not dissimilar from that obtained in this study for 
the Y37F mutant. 
Over all, this study has significantly added to our understanding of C-protein-DNA 
binding and the interactions involved.  The roles of a number of DNA binding residues 
have been elucidated, as has the impact of DNA sequence and distortion to the 
formation of the protein-DNA complexes. 
7.2 Future work 
X-ray crystallography provides a high resolution snapshot of a protein’s structure at a 
particular time and often in one conformation.  Therefore in-solution structural 
techniques could be employed to understand the dynamics of the flexible loop 
movement observed in the C.Esp1396I crystal structures.  Due to the relatively small 
amount of movement (~10 Å maximum), nuclear magnetic resonance (NMR) 
spectroscopy could be used to understand these movements, due to the potentially high 
resolution obtainable.  Ball (2010) indicated that NMR was a viable approach to 
understanding C.Esp1396I through preliminary 
15
N-labelled experiments.  NMR 
experiments would enable observation of the loop movement and ascertain whether it 
was a fast transition or a slow transition between the two major conformations observed 
through X-ray crystallography. 
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Another potential avenue of research would be mutagenesis of other conserved residues 
in C.Esp1396I.  The residue A28 would be of interest as its function within the C-
protein is not confirmed, yet it is totally conserved across the Motif 2 family.  One 
hypothesis is that it is a structural residue and necessary to maintain the orientation of 
helices 2 and 3.  The position of this alanine is also conserved across other HTH DNA 
binding proteins and has been hypothesised to have a structural role including in the 
well characterised Cro repressor (Mondragon et al., 1989) and SinR proteins (Newman 
et al., 2013), a close homologue of Motif 2 C-proteins.  It would be logical to mutate 
this residue to a glycine (the only smaller amino acid side chain) or a valine (or other 
large hydrophobic) in an attempt to push apart helices 2 and 3.  The other route would 
be to add a charge there with a serine or similar amino acid.  Other mutational targets 
would be E42 as this does not interact with the DNA but is clearly involved in 
maintaining the structure of C.Esp1396I.  Another potential target would be the 
aspartate at position 34, which in approximately half of Motif 2 C-proteins is a histidine 
and therefore swapping the two might elucidate its potential role in differing sequence 
recognition.  Finally mutations to the dimerisation helix could prove to be of interest, 
especially regarding the difference in Kdim between C.AhdI and C.Esp1396I.  Directly 
swapping the helices could be used to elucidate whether the differences in Kdim relate to 
biological function and potentially the time delay in endonuclease expression. 
With approximately 300  other C-proteins from 10 families, including those in Motif 2, 
studying their interactions with their DNA operator sites would be of great general 
interest for protein-DNA interactions as well as specific interest in bacterial 
transcriptional control and even more so for RM systems.  The C-protein C.PvuII would 
be a logical target for biophysical and structural analyses as there is a wealth of 
biochemical and in vivo data for this C-protein.  C-proteins from other families would 
also be of interest, especially C.Csp231I from Motif 8 as it’s free protein structure 
revealed additional helices of unknown function as well as a different array of amino 
acids at the DNA binding interface.  The DNA binding site of C.Csp231I is also very 
different to Motif 2 C-proteins as the two operator sites, OL and OR, are separated by a 
long spacer region.  Understanding this very different system, which essentially controls 
the expression of very similar proteins, would shed further light on the control of 
transcription of RM systems. 
In the long term, the study of C-proteins could lead to the development of novel anti-
bacterial agents as incorrect transcription of RM enzymes can be toxic to the host cell 
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through over methylation or auto-restriction.  Targeting C-proteins could also make 
bacteria vulnerable to phage virus attack as part of a coupled therapy.  As most strains 
of even the same species of bacteria have different RM systems, each bacterium could 
be targeted individually and therefore not affect the native micro-biome of the infected 
organism. 
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Appendices 
A1 Stock solutions and Buffers 
All compounds were purchased from Sigma Aldrich and/or Fisher Scientific. 
A1.1 Stock solutions 
All stock solutions were made using deionised water (dH2O) and filtered through a 0.2 
μm filter prior to use. 
10 % (w/v) Ammonium persulphate (APS) Stored at -20 °C 
10 mg/mL Ethidium bromide (EtBr) Stored in the dark 
1 M Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) 
Stored -20 °C 
100 mg/mL Ampicillin Stored -20 °C 
50 mg/mL Kanamycin Stored -20 °C 
1 M MgCl2  
1 M MgSO4  
1 M KCl  
3 M Tris-HCl pH 7.5-8.5  
100 mM Spermidine Stored 4 °C 
5 M NaCl  
50 × TAE Tris, acetic acid and EDTA  (2 M, 1 M and 
50 mM respectively, pH 8.5). 
 
A1.2 Electrophoresis 
ProtoGel (National Diagnostics) 30 % (w/v) Acrylamide 
0.8 % (w/v) Bis-acrylamide 
19:1 AccuGel (National Diagnostics) 38 % (w/v) Acrylamide 
2 % (w/v) Bis-acrylamide 
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Tris-tricine polyacrylamide gel cathode buffer  100 mM Tris 
100 mM Tricine 
0.1 % (w/v) SDS 
Tris-tricine polyacrylamide gel anode buffer 200 mM Tris-HCl pH 8.9 
4 % Tris-tricine polyacrylamide stacking gel 13.3 % (v/v) ProtoGel1 M Tris-HCl pH 8.45 
0.1 % (w/v) APS 
0.2 % (v/v) TEMED 
12 % Tris-tricine polyacrylamide resolving gel 40 % (v/v) ProtoGel 
1 M Tris-HCl pH 8.45 
10 % (v/v) glycerol 
0.1 % (w/v) APS 
0.2 % (v/v) TEMED 
8 % Native polyacrylamide gel 1 × TAE 
20 % AccuGel 
0.1 % (w/v) APS 
0.2 % (v/v) TEMED 
Native polyacrylamide gel running buffer 0.5× TAE 
Agarose gel Agarose (to desired % (w/v)) 
1 × TAE 
3 % (v/v) EtBr (~300 μg/mL) 
Agarose gel running buffer 1 × TAE 
3 ×Denaturing polyacrylamide gel sample 
loading buffer 
360 mM Tris-HCl pH 6.8 
9 % (w/v) SDS 
15 % (v/v) Glycerol 
15 % (v/v) β-mercaptoethanol 
0.2 % (w/v) Bromophenol Blue 
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5 × Orange G 100 mM Na2-EDTA pH 8 
25 % (w/v) Ficoll 
5 % (w/v) Orange G 
 
A1.3 Cloning and expression 
2 × YT media (1 L) 16 g tryptone 
10 g yeast extract 
5 g NaCl 
pH to 7.2 with NaOH and autoclave 
Ampicillin or Kanamycin added to 100 or 50 
μg/mL respectively 
For pET-28 expression, 1 % (w/v) glucose was 
added 
LB media (1 L) 10 g tryptone 
5 g yeast extract 
5 g NaCl 
pH to 7.2 with NaOH 
12.5 g agar for solid media and autoclaved 
Ampicillin or Kanamycin added to 100 or 50 
μg/mL respectively. 
Plates consisting of 30 mL LB agar were 
poured and stored at 4 °C. 
 
NZY
+
 media (1 L) 10 g NZ amine (casein hydrolysate) 
5 g Yeast extract 
5 g NaCl 
pH to 7.5 with NaOH and autoclave 
12.5 mM MgSO4 
12.5 mM MgCl2 
0.4 % (w/v) glucose 
 
 
A1.4 Site-directed mutagenesis 
10 × Vent DNA polymerase reaction buffer 200 mM Tris-HCl pH 8.8 
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100 mM Ammonium sulphate 
100 mM KCl 
20 mM Magnesium sulphate 
1 % (v/v) Triton X-100 
 
A1.5 Protein purification 
These are the buffers used for the purification of wild type C.Esp1396I in addition to 
the mutant versions described in this thesis. 
 
Lysis buffer 40 mM Tris-HCl pH 8 
500 mM NaCl 
2 mM Imidazole 
HisTrap loading buffer 40 mM Tris-HCl pH 7.5 
500 mM NaCl 
5 % (w/v) Glycerol 
20 mM Imidazole 
HisTrap elution buffer 40 mM Tris-HCl pH 7.5 
500 mM NaCl 
5 % (w/v) Glycerol 
500 mM Imidazole 
Cleavage buffer / gel filtration buffer / heparin 
loading buffer 
40 mM Tris-HCl pH 7.5 
150 mM NaCl 
5 % (w/v) Glycerol 
2.5 mM CaCl2 
Heparin elution buffer 40 mM Tris-HCl pH 7.5 
1 M NaCl 
5 % (w/v) Glycerol 
 
Storage buffer 40 mM Tris-HCl pH 7.5 
150 mM NaCl 
5 % (w/v) Glycerol 
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Wash buffer I 40 mM Tris-HCl pH 8 
500 mM NaCl 
20 mM Imidazole 
1 % (v/v) Triton X-100 
Wash buffer II 40 mM Tris-HCl pH 8 
500 mM NaCl 
20 mM Imidazole 
100 mM Guanidinium hydrochloride 
Denaturing buffer 40 mM Tris-HCl pH 8 
500 mM NaCl 
20 mM Imidazole 
6 M Guanidinium hydrochloride 
 
A1.6 Surface plasmon resonance 
SPR running buffer 10 mM HEPES pH 7.4 
130 mM NaCl 
0.05 % (v/v) Tween-20 
 
  
Figure A2.1 Electrophoresis standards.  A:  Benchmark® 
prestained protein ladder (Invitrogen).  The molecular weights are 
displayed next to the corresponding band.  B:  DNA ladders, from 
left to right: 1 Kbp plus, 100 bp and 10 bp (Invitrogen) 
A 
B 
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A3 Derivation of Equation 3.8 
Equation 3.8 is derived from first principals as described here. 
Monomeric and dimeric species of C.Esp1396I are in dynamic equilibrium: 
         
(Equation A2.1) 
where M is the monomer and D is the dimer.  These two states are related by a binding 
constant (KD).  The KD can be expressed as: 
    
    
   
 
(Equation A2.2) 
where [M] is the monomer concentrations and [D] is the dimer concentration.  The total 
polypeptide concentration [T] is calculated using the molar extinction coefficient for a 
single polypeptide chain.  Therefore 
            
(Equation A2.3) 
The monomer concentration in solution can be described as a fraction (θ) of [T]: 
        
(Equation A2.4) 
where 0 ≤ θ ≥ 1.  Substituting Equation A1.4 into A1.3 and solving for [D] gives: 
     
 
 
       
(Equation A2.5) 
 
KD can be expressed in terms of T by substituting Equations A1.4 and A1.5 into A1.2: 
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(Equation A2.6) 
Equation A1.6 can be expressed as a quadratic and solved for θ using the quadratic 
formula with a = 2T
2
, b = TKD and c = -TKD: 
   
                
  
 
(Equation A2.7) 
Therefore the actual dimer concentration [D] present in a sample of total polypeptide 
concentration [T] is given by substituting Equation A1.7 into A1.5: 
     
                    
 
 
(Equation A2.8) 
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A4 EMSA data analysis using Scientist 
For EMSAs where one C-protein is binding to one DNA binding site, a simple one-to-
one binding model can be used.  However, as C.Esp1396I only binds to DNA as a 
dimer, this adds another variable when it comes to concentration dependent DNA 
binding.  Therefore there are two different constants (K) to take into account, K1 
(protein dimerisation) and K2 (DNA binding).  For all analyses K1 was fixed at 1.6 μM 
as determined by Ball et al. (2012).  K2 is left as unknown and the values from 
densitometry analysis are entered into Scientist as a decimal where the maximum in 
each column can be 1.0. 
    
 [ ]
[ ] 
 
(Equation A4.1) 
where [P] is the concentration of protein as a monomer. 
    
 [ ][ ]
[   ]
 
(Equation A4.2) 
where [D] is the concentration of DNA. 
 
Screenshot from the Scientist software plotting model data.  
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The controller protein of the type II restriction–modification (RM) system
Esp1396I binds to three distinct DNA operator sequences upstream of the
methyltransferase and endonuclease genes in order to regulate their expression.
Previous biophysical and crystallographic studies have shown molecular details
of how the controller protein binds to the operator sites with very different
affinities. Here, two protein–DNA co-crystal structures containing portions of
unbound DNA from native operator sites are reported. The DNA in both
complexes shows significant distortion in the region between the conserved
symmetric sequences, similar to that of a DNA duplex when bound by the
controller protein (C-protein), indicating that the naked DNA has an intrinsic
tendency to bend when not bound to the C-protein. Moreover, the width of the
major groove of the DNA adjacent to a bound C-protein dimer is observed to be
significantly increased, supporting the idea that this DNA distortion contributes
to the substantial cooperativity found when a second C-protein dimer binds to
the operator to form the tetrameric repression complex.
1. Introduction
Bacterial restriction–modification (RM) systems act as a form of
primitive immune system and prevent the establishment of foreign
DNA (such as bacteriophages and plasmids) within bacteria (Wilson
& Murray, 1991). It has been proposed that RM systems play a key
role during the process of horizontal gene transfer between bacteria
(Akiba et al., 1960). An RM system is comprised of two comple-
mentary enzymes: a methyltransferase (M) to label ‘self’ DNA and an
endonuclease (R) to cleave unlabelled (‘non-self’) DNA (Wilson &
Murray, 1991). The plasmid-borne type II RM system Esp1396I has
been well studied both in vitro and in vivo and reveals a temporal
control mechanism that employs a controller protein (C-protein)
encoded within the RM operon (Cesnaviciene et al., 2003; Bogdanova
et al., 2008, 2009). This temporal control is necessary for the correct
function of RM systems and to prevent auto-restriction (i.e. endo-
nucleolytic cleavage of the bacterial chromosome and pEsp1396I
plasmid).
The controller protein C.Esp1396I, and indeed all other C-proteins
studied to date, have been shown to be homodimeric helix–turn–helix
proteins that bind to pseudo-symmetrical DNA operator sequences
(Ball et al., 2009; McGeehan et al., 2005; Streeter et al., 2004; Kita
et al., 2002; Sawaya et al., 2005). In C.Esp1396I and similar systems,
it has been proposed that each DNA operator site comprises
two ‘C-boxes’ having pseudo-dyad symmetry with the consensus
sequence GACT and a short spacer sequence in between them that
is generally comprised of alternating purine–pryrimidine sequences
(Streeter et al., 2004; Knowle et al., 2005; Sorokin et al., 2009).
Subsequently, it was found that the only specific contacts between
C.Esp1396I and the C-boxes are to the GAC bases, so the C-box
is perhaps better described as the trinucleotide GAC (and its
symmetry-related sequence GTC) with the two C-boxes being sepa-
rated by the spacer TATA, at least in the optimal binding site (Ball
et al., 2012). In addition, there are sequence-specific contacts to a
conserved TG motif outside the C-boxes.
C.Esp1396I binds to three subtly different DNA sequences with
vastly different affinities (Kd between 1 and 230 nM) that are located
upstream of the C/R and M genes: OM (which regulates the expres-
sion of the M gene), and OL and OR (which together control the
expression of both the C and R genes) (Bogdanova et al., 2009; Fig. 1).
The X-ray crystal structure of C.Esp1396I has been determined to
high resolution as the free protein (Ball et al., 2009) and as various
protein–DNA complexes (McGeehan et al., 2008, 2012; Ball et al.,
2012). All of the C-protein–DNA complex structures reveal distor-
tion of the DNA helix owing to compression of the minor groove,
which is either induced or stabilized by the bound C-protein. Owing
to symmetry-related averaging of the tetrameric C-protein–DNA
complex in the crystal structure (McGeehan et al., 2008) further
studies employed just single operator sites, to which a single
C-protein dimer bound (Ball et al., 2012; McGeehan et al., 2012). The
OL sequence yielded the highest resolution C-protein–DNA complex
structure to date and showed the binding interface in great detail
(McGeehan et al., 2012). The subsequent OM C-protein–DNA
complex (Ball et al., 2012) revealed conformational flexibility within
the protein structure, enabling the protein to recognize different
sequences but with quite different affinities. In contrast, the DNA was
shown to have an almost identical structure in each case, with the
overall bend angle being very similar to that of OL and closely
resembling that observed in the C/R tetrameric complex.
Here, we present two novel crystal structures that show the
operator DNA structure corresponding to the OR binding site, the
lowest affinity of the three for C.Esp1396I. Each of these two
structures, termed 19OR and 25OL, are nucleoprotein complexes
comprising a C-protein dimer and a DNA duplex. The 19OR structure
includes the entire OR C-protein binding site. The 25OL DNA
sequence includes the OL sequence plus half of the OR C-protein
binding site. The 25OL complex allows the observation of part of the
free (unbound) OR sequence, unlike the previously published 35OL+R
complex that has the complete OR sequence. In the latter complex,
owing to the high cooperativity between sites, the C-protein forms
a tetramer (i.e. two dimers) on the 35OL+R DNA (McGeehan et al.,
2008).
2. Materials and methods
2.1. Crystallization
Expression and purification of native C.Esp1396I was carried out
as described previously (McGeehan et al., 2008). In brief, C.Esp1396I
was overexpressed in Escherichia coli strain BL21 (DE3) pLysS using
the pET-28b vector to introduce an N-terminal six-histidine sequence.
C.Esp1396I was purified using nickel-affinity chromatography and
size-exclusion chromatography. Prior to the crystallization trials,
the six-histidine tag was removed using thrombin. The DNA oligo-
nucleotides for crystallization of the 19OR complex (5
0-TGTGT-
GATTATAGTCAACA-30 and its complementary strand) and the
25OL complex (5
0-ATGTGACTTATAGTCGTGTGATTA-30 and its
complementary strand) were synthesized by ATDBio and Euro-
gentec, respectively, and were purified by RP-HPLC. The comple-
mentary oligonucleotides were annealed by heating to 353 K
followed by cooling and the duplexes were further purified using
gel electrophoresis. Initial cocrystallization was carried out using
a HoneyBee X8 crystallization robot (Cronus Technologies) and
sparse-matrix screening using the PACT Premier and JCSG+ screens
(Molecular Dimensions Ltd) at varying molar ratios of C.Esp1396I
to DNA duplex. Crystals of the 19OR complex formed by vapour
diffusion in 0.1 M propionic acid, sodium cacodylate and bis-tris
propane (PCB) buffer pH 4.0 with 25%(w/v) PEG 3350 at a molar
protein:DNA ratio of 1:1. However, these crystals were of insufficient
size for diffraction experiments, so a microseeding approach was
employed (D’Arcy et al., 2007). This produced much larger crystals in
0.1 M PCB buffer pH 5.0, 25%(w/v) PEG 3350, 10 mM spermidine.
The crystals were confirmed to contain both protein and DNA by
washing them and subsequently dissolving them in dH2O before
taking a UV absorbance spectrum. Crystals of the 25OL complex
formed in 0.1 M PCB buffer pH 4.0, 20%(w/v) PEG 1500, 10 mM
spermidine at a molar protein:DNA ratio of 2:1.
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Figure 1
Organization of genes in the Esp1396I RM system. (a) The C-protein binding sites
are coloured orange. The C-protein gene (C) is coloured green, the endonuclease
gene (R) is coloured red and the methyltransferase gene (M) is coloured blue
(adapted from Bogdanova et al., 2009). (b) The OL+R C-protein binding sites. The
conserved GAC binding sites are underlined and the central TATA sequences are
shown in bold. The TATA of the OR binding site forms part of the ‘35 box’ for the
C/R genes
Figure 2
C-protein–DNA complexes. (a) C.Esp1396I dimer bound to a 25 bp DNA duplex
containing the native operator OL and half of the OR sequence (PDB entry 4iwr).
(b) C.Esp1369I dimer interacting with a 19 bp DNA duplex containing the native
operator OR (PDB entry 4i8t).
2.2. X-ray diffraction data collection and refinement
The 19OR and 25OL crystals were transferred to a cryoprotectant
containing 25%(v/v) glycerol or 20%(v/v) PEG 400, respectively, and
flash-cooled in liquid nitrogen. For the 19OR crystal, 180 images of
1 oscillation were collected on beamline I02 at the Diamond Light
Source (DLS), Oxfordshire at a wavelength of 0.98 A˚ using an ADSC
Quantum 315r CCD detector at 100 K. For the 25OL crystal, 120
images of 1 oscillation were collected using an ADSC Q4R CCD
detector at 100 K on beamline ID14-4 at the ESRF, Grenoble.
The data were processed using either MOSFLM (Leslie, 1992)
and AIMLESS (Winn et al., 2011; Evans, 2006, 2011) or XDS and
XSCALE (Kabsch, 2010) and a molecular-replacement solution was
found by Phaser (McCoy et al., 2007) using the native free protein
structure as a search model (Ball et al., 2009; PDB entry 3g5g). The
DNA was built by hand in Coot (Emsley & Cowtan, 2004) and was
subsequently refined using REFMAC5 (Murshudov et al., 2011) and
phenix.refine (Afonine et al., 2005). Data-processing and refinement
statistics are summarized in Table 1. The completed models were
deposited in the PDB with accession codes 4i8t (19OR) and 4iwr
(25OL).
3. Results
3.1. X-ray diffraction and structure solution
The 19OR crystals showed weak isotropic diffraction extending to
3 A˚ resolution. The scaling program AIMLESS (Evans, 2006, 2011;
Winn et al., 2011) gave a high Rmerge for the outer shell, but inspection
of the electron-density maps and use of the CC1/2 metric (Karplus &
Diederichs, 2012) gave a clear indication that the data were accep-
table to 3 A˚ resolution, with a final Rwork and Rfree of 0.28 and 0.36 for
the outer shell. The structure was refined in space group C2 with one
copy of the complex per asymmetric unit (Fig. 2). The resulting
2Fo  Fc maps were of good quality for the resolution (Fig. 3).
The best crystals of the 25OL complex diffracted to 2.3 A˚ reso-
lution. The structure was refined in space group P32 with two copies
of the complex per asymmetric unit. The DNA was easily modelled
into the electron density for the section that was bound to C.Esp1396I
(McGeehan et al., 2012). However, owing to the high degree of
flexibility of the additional six base pairs, these were more difficult to
model and were primarily based on the positions of the backbone
phosphate groups since these gave much higher peaks in the electron
density relative to the bases. This flexibility resulted in B factors of
approximately 130 A˚2 in this unbound section of the DNA compared
with an average B factor of approximately 15 A˚2 in the protein-bound
portion of the DNA (Supplementary Fig. S11). DNA groove-width
analysis (Fig. 4) was performed using the Curves+ server (Lavery et
al., 2009).
3.2. The 19OR structure
The overall fold of C.Esp1396I in the 19OR structure closely
matches that of the free protein structure (PDB entry 3g5g; Ball et al.,
2009), with an overall r.m.s.d. of 0.65 A˚ over all observable main-
chain atoms. The flexible loop regions are found in the major loop
conformation observed in the free protein structure (Ball et al., 2009).
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Figure 3
Representative 2Fo  Fc electron-density maps. (a) Base pairs of T14 and C15 of
chain C with G6 and A7 of chain D from the 19OR DNA. (b) Base pairs between
chain G (C7 and T8) and chain H (A18 and G19) from the 25OL DNA. Hydrogen
bonds are shown as dashed lines. 2Fo  Fc electron-density maps are contoured at
0.16 and 0.32 e A˚3 for 19OR and 25OL, respectively. The images were generated
using PyMOL.
Table 1
X-ray crystal data, refinement and model statistics.
Values in parentheses are for the highest resolution shell.
Complex 19OR 25OL
PDB code 4i8t 4iwr
Space group C2 P32
Unit-cell parameters (A˚, ) a = 75.51, b = 60.86,
c = 80.35,
 =  = 90,
 = 113.47
a = b = 48.02,
c = 218.35,
 =  = 90,
 = 120
Solvent content (%) 50 44
Complexes in asymmetric unit 1 2
R.m.s. distance between complexes (A˚) N/A 0.25
Data collection
Beamline I02, DLS ID14-4, ESRF
Detector ADSC Q315r ADSC Q4R
Wavelength (A˚) 0.979 0.933
Resolution (A˚) 3.0 2.4
No. of measured reflections 22560 56668
No. of unique reflections 6809 11658
Completeness (%) 99.9 (100) 97.8 (94.6)
hI/(I)i 5.9 (0.9) 10.2 (2.0)
Multiplicity 3.3 (3.3) 4.9 (4.3)
Rmerge† 0.158 (1.07) 0.048 (0.542)
CC1/2‡ 0.988 (0.652) N/A
Wilson B factor (A˚2) 58 59
Refinement parameters
Rwork/Rfree 0.235/0.300 0.197/0.259
No. of atoms
Protein 1253 2463
DNA 776 2050
Average B factor (A˚2)
Protein 83 14
DNA 93 30
R.m.s. deviations from ideal geometry§
Bond lengths (A˚) 0.002 0.011
Bond angles () 0.675 1.52
Ramachandran outliers (%) 3.6 2.7
MolProbity} score 2.8 2.5
Clashscore 11 6
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where hI(hkl)i is the average of
Friedel-related observations of a unique reflection. ‡ CC* = [2CC1/2/(1 + CC1/2)]
1/2,
where CC* is as estimate of CCtrue based on a finite sample size. § Engh & Huber
(2001). } Chen et al. (2010).
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: KW5075).
However, owing to the limited resolution, not all side chains could be
placed with high confidence other than those that are highly ordered
and binding to symmetry-related protein chains or to the DNA.
Surprisingly, the protein dimer does not bind to the DNA in
the usual manner via the helix–turn–helix (HTH) motif; instead, it
binds ‘end-on’ to the DNA helix, resulting in very few protein–DNA
interactions (Fig. 2b). This non-biological complex reflects the low
intrinsic binding affinity at a single OR site. It is only when a C-protein
dimer is bound to the adjacent OL site that the protein binds in the
expected manner (as observed in the complex with the 35 bp OL + OR
operator DNA). This arises from the high degree of cooperativity
that increases the affinity for the OR site by two orders of magnitude
when a C-protein dimer is bound at the OL site.
In the 19OR crystal structure, each protein dimer contacts four
DNA duplexes and two protein subunits belonging to adjacent
asymmetric units. The protein–protein contacts involve two tyrosines
(Tyr29 from each subunit) stacking against each other in a manner
similar to that previously observed, but with the addition of hydrogen
bonds between Tyr29 and Glu25 and Asp26 (Ball et al., 2009, 2012;
McGeehan et al., 2012). The only clear contacts between the
C-protein and the DNA occur between the protein side chains and
the phosphate groups in the DNA backbone.
The overall conformation of the DNA duplex in the 19OR struc-
ture does not conform to the canonical B-form; it is significantly
distorted and resembles the biologically bound conformation
previously observed in the 19OL structure (Figs. 4 and 5). The overall
bend of 42 is a little less than that observed in the biologically bound
OL complex (54
), but the DNA retains the reduced minor groove
in the central spacer between the two C-boxes, despite the lack of
significant interactions with the HTH motif. The bend in the DNA
is centred at the TATA sequence between the C-boxes (Fig. 1), as
observed in other C-protein complexes. The bent DNA structure that
we observe here is most likely to reflect a natural propensity to bend
at this sequence, and in biologically relevant complexes is enhanced
and stabilized by interactions with the HTH motif, as observed in the
tetrameric complex and in the higher affinity OL and OM complexes
(McGeehan et al., 2008, 2012; Ball et al., 2012).
3.3. The 25OL structure
There were no significant differences between the conformations
of the two complexes in the asymmetric unit. The 25OL protein
structure (Fig. 2a) closely resembles that of the previously published
19OL protein–DNA complex structure, with an overall r.m.s.d. of
0.48 A˚ for the main-chain atoms of the protein monomers and 0.92 A˚
for the corresponding 18 bp of the DNA (Fig. 5). The same specific
and nonspecific protein–DNA contacts were visible in the structure.
However, owing to the longer DNA component of the complex,
the crystal-packing interactions between the proteins are markedly
different.
The only observable protein–protein contacts between crystallo-
graphic symmetry-related dimers again involve the stacking of Tyr29
side chains, together with a hydrogen bond between Tyr29 and Asp26
of the symmetry-related subunit. There are very few protein–DNA
interactions between chains that are not within the biological
complex and all involve interactions between protein side chains
and phosphate groups on the DNA backbone. The crystallographic
DNA–DNA interactions between symmetry-related molecules are
limited to stacking between the terminal base pair A1–T25 (chains C
and D) and the corresponding A–T base pair of chains G and H. This
causes the DNA to form a pseudo-continuous double helix.
The width of the major groove in the 25OL DNA varies from 10 to
15 A˚ in a sequence-dependent manner (Fig. 4). Likewise, the minor-
groove width varies from 2 to 9 A˚. The portion of the 25OL structure
that contains the first C-box (OL) overlays very closely with the
relevant sequence in the 35OL+R tetramer structure, with an r.m.s.d.
of 0.92 A˚ (Fig. 4). The remainder of the DNA that is not bound by
the protein also follows a similar path to that of the DNA in the
tetrameric complex. It is noteworthy that the major groove that is
significantly widened in the centre of the tetrameric 35 bp complex is
also widened in the equivalent region of the 25OL complex, even
though this region of the DNA is unbound (Figs. 4 and 5).
4. Discussion
These novel protein–DNA complexes enable comparison of the
conformation of the DNA sequence before and after C-protein
binding. C-proteins, in common with many helix–turn–helix DNA-
binding proteins, bend and distort their DNA-binding sites in order to
access the bases for sequence recognition (Kita et al., 2002; Papa-
panagiotou et al., 2007; McGeehan et al., 2008, 2012; Ball et al., 2012).
The 19OR structure presented here shows that even in the absence
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Figure 5
DNA structural comparisons. The 25OL DNA (cyan) and the 19OR DNA (yellow)
are aligned against the 35OL+R DNA (magenta). The protein dimers in the latter
complex are displayed in grey.
Figure 4
DNA groove-width analysis of the 25OL DNA. Groove-width analysis of the 25OL
DNA (cyan) compared with the published 35OL+R complex (PDB entry 3clc;
magenta; McGeehan et al., 2008). Upper curve, major groove; lower curve, minor
groove. The DNA sequence of the 25OL sequence is shown below. The TATA
sequences are shown in bold and the DNA recognition bases are underlined.
of specific protein–DNA contacts the DNA sequence at the OR
operator is compressed at the minor groove, greatly reducing the
energy penalty of DNA distortion following C-protein binding. Using
circular dichroism, it has been shown that significant structural
deformation of the DNA occurs when the controller protein C.AhdI
binds its operator sequence in solution (Papapanagiotou et al., 2007).
Presumably, the same will apply to the OL and OM operators of the
Esp1396I RM system, which all contain the central TATA sequence.
The observed path of the DNA within the 25OL complex supports
the proposal that the binding of the first C-protein to the OL site
assists in opening up the major groove of the OR site in preparation
for binding the second C-protein dimer, thus compensating for
the weaker intrinsic binding affinity of the OR site. This provides
a significant component of the observed cooperativity of binding
between the two adjacent operator sites, in addition to specific
protein–protein contacts between adjacent dimers (McGeehan et al.,
2008). A similar mechanism based on DNA distortion has been
proposed for the cooperative binding of the QacR transcriptional
regulator to its operator site (Schumacher et al., 2002), but in this case
there were no additional protein–protein interactions contributing
to the cooperativity. The downstream effects of binding one protein
dimer on the structure of the adjacent DNA, thereby enhancing its
DNA-binding affinity for a second protein dimer, could represent a
more general mechanism of transcriptional control.
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